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Abstract
Proteins are central to virtually all processes within the cell. The vast amount of
functions performed by proteins in biological processes is conferred by their ability
to bind in a selective and speciﬁc manner to other molecules. The nature of these
interactions is, in general terms, three-dimensional, as binding sites normally consist
of a pocket or a groove on the protein surface. However, in many cases such inter-
actions contain a linear component and can be more conveniently represented, or
approximated, by a protein-peptide interaction. Whereas time-consuming structural
studies are necessary in systems where the three-dimensional aspect of the interac-
tion is prevalent, protein-peptide interactions can normally be represented simply by
a linear bindingmotif. Phage display and peptidemicroarray technologies allow gen-
erating large libraries of peptide sequences and the parallel detection of thousands
of interactions in a single experiment, with virtually unlimited choice of potential
targets and variants of these targets.
However, the amount and complexity of data produced by high-throughput tech-
niques poses serious challenges to researchers of limited bioinformatics expertise
who need to analyze and interpret such data. The ﬁrst paper in this thesis presents
a new, publicly available method based on artiﬁcial neural networks that allows cus-
tom analysis of quantitative peptide data. The online NNAlign web-server provides
a simple yet powerful tool for the discovery of sequence motifs in large-scale peptide
data sets. It was successfully applied to characterize the bindingmotifs of MHC class
I and class II molecules, and for the prediction of protease cleavage on data generated
by a large-scale peptide microarray technology.
In the second paper, NNAlign was applied to binding data for HLA-DP and DQ
molecules, two classes of HLA molecules with recognized importance in immune
response but poorly characterized sequence motifs. The sequence logos of 5 HLA-
DP and 6 HLA-DQmolecules provide a characterization of their bindingmotifs at an
unprecedented level of detail.
The third paper in this thesis deals with the presence of multiple motifs, due
to the experimental setup or the actual poly-speciﬁcity of the receptor, in peptide
data. A new algorithm, based on Gibbs sampling, identiﬁes multiple speciﬁcities by
performing two tasks simultaneously: alignment and clustering of peptide data. The
method, available online as a web-server, was applied to various data sets including
mixtures of MHC binding data and distinct classes of ligands to SH3 domains.
Next, we investigated how string kernels could be used to identify pattern in pep-
tide data, with particular focus on theMHC class I system. We suggest a strategy that,
unlike most available methods, allows to learn from peptides of multiple lengths to
achieve improved predictive performance. This appeared particularly important in
alleles and peptide lengths where experimental data was limited.
The last chapter presents a method to rationally guide the discovery of T-cell epi-
topes from ELISPOT and ICS assays based on peptide pool matrices. By prediction
of binding aﬃnity, analysis of peptide pools intersections, and combination of infor-
mation from diﬀerent donors, we show that themethod can eﬀectively rank potential
epitope candidates and reduce the number of experimental tests needed to identify
new epitopes.
Taken as a whole, this thesis provides a valuable series of algorithms and tools
for the analysis of peptide data, both from the point of view of characterization of
sequence motifs and the prediction of protein-peptide interactions.
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Dansk resumé
Proteiner spiller en central rolle i næsten alle processer i cellen. Proteiner udfører
talrige funktioner i biologiske processer takket være deres evne til at binde selektivt
og speciﬁkt til andre molekyler. Disse interaktioner er generelt af tredimensionel
karakter, fordi binding sites normalt består af en "lomme" eller en sprække på pro-
teinoverﬂaden. I mange tilfælde indeholder sådanne interaktioner en lineær kompo-
nent og kan nemmere repræsenteres, eller tilnærmes, med en protein-peptid inter-
aktion. Tidskrævende strukturelle undersøgelser er nødvendige når det tredimen-
sionelle aspekt af interaktionen ikke kan ignoreres, hvorimod protein-peptid inter-
aktioner kan repræsenteres som et lineært bindingsmotiv. Phage display og peptid-
microarrays gør det mulig at generere store biblioteker af peptidsekvenser og lave
parallelle målinger af tusinder af interaktioner i et enkelt eksperiment.
Mængden og kompleksiteten af de data, disse high-throughput teknikker pro-
ducerer, skaber store udfordringer for forskere med begrænset bioinformatisk
ekspertise, som har brug for at analysere og fortolke den slags data. Den første ar-
tikel i denne afhandling beskriver en ny, oﬀentligt tilgængelig metode baseret på
artiﬁcial neural networks, der tillader brugerdeﬁnerede analyser af kvantitative pep-
tid data. Web-serveren NNAlign er en simpel men eﬀektiv metode til opdagelsen af
sekvensmotiver i store peptid datasæt. Den blev brugt med succes til at karakteris-
ere bindingsmotiver for MHC klasse I og klasse II molekyler, og til forudsigelse af
proteaseskløvning udfra et stor peptid-microarray datasæt.
I den anden artikel, blev NNAlign brugt på bindingsdata for HLA-DP og DQ
molekyler. Disse molekyler spiller en vigtig rolle i immunresponset, men har
dårligt karakteriserede sekvensmotiver. Sekvenslogoer for 5 HLA-DP og 6 HLA-DQ
molekyler giver et billede af deres bindingsmotiver med en hidtil uset detaljegrad.
Den tredje artikel i denne afhandling omhandler detektion af multiple motiver i
peptid-data, som kan fremkomme enten på grund af den eksperimentelle opsætning
eller fordi receptoren faktisk er polyspeciﬁk. En ny algoritme baseret på Gibbs sam-
pling, identiﬁcerer multiple speciﬁciteter ved at udføre to opgaver samtidig: align-
ment og clustering af peptidsekvens data. Metoden, som er tilgængelig online som
web-server, blev anvendt til forskellige datasæt blandt andet blandinger af MHC
bindingsdata og forskellige klasser af ligander til SH3 domæner.
Derefter, undersøgte vi hvordan string kernels kan bruges til at identiﬁcere mo-
tiver i peptid data, med særlig fokus på MHC klasse I molekyler. Vi foreslår en
strategi, der i modsætning til de ﬂeste tilgængelige metoder, gør det muligt at lære
fra peptider med forskellige længder og derved opnå en bedre prediktiv ydeevne.
Dette så ud til at være særlig vigtigt for alleler og peptid længder, hvor mængden af
eksperimentelle data var begrænset.
Det sidste kapitel fremlægger en metode til at hjælpe opdagelsen af T-celle epi-
toper fra ELISPOT og ICS assays, på baggrund af peptid-pool matricer. Metoden
kombinerer eksperimentelle målinger fra forskellige donorer med forudsigelser af
peptid-MHC bindingsaﬃnitet, til at eﬀektivt rangordne potentielle epitopkandidater
og reducere antallet af eksperimentelle tests der er nødvendige for opdagelse af nye
epitoper.
Som en helhed giver denne afhandling en værdifuld samling algoritmer og
metoder til analyse af peptid data, både med hensyn til karakterisering af sekvens-
motiver og forudsigelse af protein-peptid interaktioner.
x CONTENTS
Papers included in this thesis
• Paper I: Andreatta M, Schafer-Nielsen C, Lund O, Buus S, Nielsen M
(2011) NNAlign: Aweb-based predictionmethod allowing non-expert
end-user discovery of sequence motifs in quantitative peptide data.
PLoS ONE 6(11): e26781. doi:10.1371/journal.pone.0026781
• Paper II: Andreatta M, Nielsen M (2012) Characterizing the binding
motifs of 11 common human HLA-DP and HLA-DQ molecules using
NNAlign.
Immunology 136(3): 306-311. doi: 10.1111/j.1365-2567.2012.03579.x
• Paper III: AndreattaM, LundO, NielsenM (2012) Simultaneous align-
ment and clustering of peptide data using a Gibbs sampling approach.
Accepted with minor revision in Bioinformatics
Papers not included in this thesis
• Paper IV: Andreatta M, Nielsen M, Møller Aarestrup F, Lund O (2010)
In Silico Prediction of Human Pathogenicity in the g-Proteobacteria
PLoS ONE 5(10):e13680. doi:10.1371/journal.pone.0013680
• Paper V: Roque FS, Jensen PB, Schmock H, Dalgaard M, Andreatta M,
Hansen T, Søeby K, Bredkjær S, Juul A, Werge T, Jensen L J, Brunak
S (2011) Using Electronic Patient Records to Discover Disease Correla-
tions and Stratify Patient Cohorts
PLoS Comput Biol 7(8): e1002141. doi:10.1371/journal.pcbi.1002141
ABBREVIATIONS xi
Abbreviations
AA Amino acid
ANN Artiﬁcial neural network
ARI Adjusted Rand index
AUC Area under the ROC curve
CD Cluster of diﬀerentiation
CTL Cytotoxic T lymphocyte
CV Cross-validation
HLA Human leukocyte antigen
HMM Hidden Markov model
ICS Intracellular cytokine staining
KLD Kullback-Leibler distance
LO Log-odds
MC Monte Carlo
MCC Matthews correlation coeﬃcient
MHC Major histocompatibility complex
MSA Multiple sequence alignment
PFR Peptide-ﬂanking region
PSSM Position-speciﬁc scoring matrix
RLS Regularized least squares
RMSE Root-mean-square error
ROC Receiver operating characteristic
SVM Support vector machine
TCR T-cell receptor
YF Yellow fever

Chapter 1
Introduction
P  are short amino acid sequences occurring ubiquitously in bi-ological processes, such as metabolism, signal transduction and im-mune response. They are also extensively used in research to mimic
functional or (linear) structural aspects of proteins and protein interactions.
These include families of peptide-recognition domains (SH3, PDZ, WW,
etc.), membrane receptors (e.g. the Major Histocompatibility Complex) and
enzymes (e.g. kinases and phosphatases). Given the linear component of the
interaction, the speciﬁcities of these systems can be eﬀectively characterized
by means of linear peptides [1].
If a protein-protein interaction can be represented, or approximated, by
a protein-peptide interaction, the ﬁrst evident advantage is a far lesser com-
plexity of the system [2]. Whereas time-consuming structural studies are
necessary in systemswhere the three-dimensional aspect of the interaction is
prevalent, protein-peptide interactions can normally be represented simply
by a linear binding motif. Another important advantage of using peptides
lies in the relative ease in generating large libraries of sequences, such as in
phage display or peptide microarrays [3, 4]. These technologies allow the
parallel detection of thousands of interactions in a single experiment, with
virtually unlimited choice of potential targets and variants of these targets.
In this thesis, we address the challenges of extracting information from
very large peptide data sets. Firstly, the capability of high-throughput tech-
nologies presents the experimentalist with massive amounts of data, which
can eﬀectively only be interpreted with the aid of computational methods.
This is addressed in chapter 2, where an interpretation service able to handle
large-scale peptide data sets is presented.
Secondly, motifs contained in linear peptides are oftenweak and short. In
these conditions, identifying the binding register within peptides is a chal-
lenging task. We will refer to this as the "alignment" problem. In chapter
1
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3 we discuss how neural networks are capable of capturing such weak mo-
tifs and accurately describe the promiscuous protein-peptide interactions of
HLA-DP and HLA-DQ molecules.
Thirdly, receptor-ligand data sets often contain multiple motifs. We will
call this the "poly-speciﬁcity" problem. The presence ofmultiple patterns can
either be due to the experimental setup or to the actual poly-speciﬁcity of the
receptor. Chapter 4 tackles these issues, and presents a method that solves
simultaneously the alignment problem and the poly-speciﬁcity problem.
Chapter 5 takes inspiration from a recently published method based on
string kernels to suggest how to improve MHC class I binding predictions
by training the method on peptides of multiple lengths. Finally, in chapter 6
we present a strategy to aid the discovery of T-cell epitopes from ELISPOT
and ICS assays based on peptide pool matrices.
Before venturing into these aspects, we use this introductory chapter for a
brief review the applications of peptides in protein science, howpeptide data
are harvested andwhat methodsmay be applied to extract information from
these data. For the reader who is not completely familiar with the bioinfor-
matics jargon and methods, we introduce some basic concepts of machine
learning and data representation that are crucial to understand the rest of
this thesis.
1.1 Peptide-based data
A ﬁrst, essential distinction to be made is between qualitative and quanti-
tative peptide data. Qualitative data are binary, whereas quantitative data
span a spectrum of values between a minimum and a maximum. For in-
stance, consider the interaction between peptides and a given molecule. A
qualitative assessment of such interaction returns a binary answer: peptides
either bind or do not bind to the molecule, without any intermediate levels.
Conversely, quantitative measurements provide a scale of real values which,
in this example, would represent the strength of the peptide-protein inter-
action. A quantitative scale therefore ranges from absolute non-binders to
very strong binders with all the intermediate levels of binding strength in
between.
It would appear that quantitative data is alwaysmore informative than its
qualitative counterpart. However, due to the nature of the problem at hand
or the characteristics of the assay used to study it, only qualitative observa-
tions may be available. For example, proteolytic cleavage of peptides by a
protease may be regarded as a binary event. The amino acid chain is either
cleaved or not. In other cases, where there actually is a measurable quantity,
the experimental method may not be designed to detect it. The bioinformat-
ics tools used to interpret the data are also subject to the qualitative/quanti-
tative distinction. For instance, one of the strengths of the NNAlignmethod
discussed in chapter 2 compared to other approaches, lies in its ability to
exploit quantitative data and produce quantitative predictions.
1.1. PEPTIDE-BASED DATA 3
Another major distinction into two groups can be made based on the bi-
ological properties of the receptor being investigated: the "aligned" case and
the "unaligned" case. In the aligned case, the receptor binds peptides that are
in the same register and have known length (the data is pre-aligned). The un-
aligned case is more complex, as the location of the binding core within the
peptides is unknown, and bioinformatics methods aiming at analyzing such
data must perform a sequence alignment to extract a sequence motif. Promi-
nent examples of these two kinds of peptide data are the peptide interactions
with respectively the Major Histocompatibility Complex (MHC) class I and
MHC class II. We discuss these two systems next.
1.1.1 Aligned data - MHC class I
MHC class I molecules are transmembrane receptors that play an essential
role in the immune system. Their function is to present peptide fragments
derived from cytosolic proteins to cytotoxic T-cells (CTLs). If the peptide
bound to the MHC class I molecule is recognized as foreign, CTLs will acti-
vate an immune response to destroy the infected cells.
Antigen presentation through the MHC class I pathway is a highly spe-
ciﬁc process, with only 1-5% of a set of random natural peptides binding to
any given MHC molecule [5]. Moreover, in the vast majority of cases only
peptides with length of 8-11 amino acids (andmost commonly 9 AAs) can be
recognized byMHCclass Imolecules. This is due to the particular conforma-
tion of the binding cleft of class I proteins, which is closed at both ends and
can accommodate only peptides of limited length. In Figure 1.1a is shown
the structure of a MHC class I molecule with a peptide in its binding cleft.
In humans, theMHC is also referred to as the Human Leukocyte Antigen
(HLA) system. HLA class I molecules are extremely polymorphic, with up
to 4,000 HLA-A, -B and -C alleles identiﬁed to date in the human population
[6]. Polymorphism, which aﬀects mostly the residues placed within or close
to the binding cleft, implies that diﬀerent allelic variants recognize peptides
with diﬀerent properties. However, despite such large polymorphism, class
I molecules can be clustered into groups of molecules that bind largely over-
lapping peptide repertoires. Such groups of alleles, denominated as super-
types, have been quantiﬁed around 9-12 depending on themethod employed
[7, 8].
1.1.2 Unaligned data - MHC class II
As opposed toMHC class I, which samples antigens from cytosolic proteins,
MHC class IImolecules present peptides derived from extracellular proteins.
Peptides bound to class II molecules are displayed to helper T-cells, which
are capable of aﬀecting and activating other cells of the immune system in
response to a foreign fragment, for example derived from a bacterium infect-
ing the blood.
From a structural point of view, MHC class II molecules diﬀer function-
ally from class I proteins primarily in terms of the conformation of their
4 CHAPTER 1. INTRODUCTION
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Figure 1.1. The MHC class I and class II molecules with bound peptide ligand. a)
MHC class I molecule HLA-A2.1 (A2) with bound 9-mer peptide FLKEPVHGV in red
sticks (PDB entry 1I1F [9]). Note that the binding groove is closed at both ends and can
accommodate only peptides of limited length. b)MHC class II molecule HLA-DR1 with
bound 14-mer peptide VSKMRMATPLLMQA (PDB entry 3QXA [10]). The a chain is in
light blue, the b chain in dark blue. The HLA binding groove is open at both ends and the
ligand can extend outside the extremities of the pocket. Figures made using the PyMOL
software [11].
binding cleft. As shown in Figure 1.1b, the binding groove of MHC class
II molecules is open at both extremities. This does not pose constraints on
the length of the peptide ligand, which can stick out freely at both ends of
the pocket. Although normally only about 9 amino acids of the ligand are
directly interactingwith residues of the binding cleft (the binding core), pep-
tides of up to 30 amino acids (even whole proteins) can be loaded ontoMHC
class II molecules [12]. This is whywe refer to this system as "unaligned": the
position of the binding core within the entire peptide is not known a priori,
unlike in the class I system where the ends of the binding groove constrain
peptides to a ﬁxed length.
1.2 Peptide microarrays
Peptide microarrays consist of a library of peptides immobilized on a pla-
nar solid surface (typically a glass or coated slide). Such slides can be in-
cubated with a biological sample, allowing the parallel detection of many
peptide-target interactions. A wide range of biological systems can be inves-
tigated by means of peptide arrays, including antibody-antigen interactions,
protease cleavage sites, kinase and phosphatase speciﬁcities, peptide-MHC
binding, and in general all interactions where peptides can act as short linear
analogues of proteins [4, 13, 14, 15, 16, 17].
In general terms, there are two kinds of peptide array technologies: par-
allel in situ synthesis arrays, and spotting arrays. With the ﬁrst method, the
peptide sequences are built directly on the slide starting from a matrix of
linker groups coupled to the surface. Peptides are then elongated one amino
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1. Chip design and 
synthesis!
2. Binding experiment!
3. Detection of 
fluorescence!
5. Interpretation 
of the data!
4. Data processing and 
normalization!
Peptide 1    Signal 1!
Peptide 2    Signal 2!
Peptide 3    Signal 3!
... ! !    ...!
Peptide n    Signal n!
Figure 1.2. Diagram of a peptide microarray experiment. After synthesis of the peptide
chains on the chip surface, the slide can be assayed with a target molecule (for example,
antibodies). Interactions are detected by imaging devices and translated to an image of
spots with varying intensity. As each spot can be mapped to a certain peptide, the matrix
can be described as a list of peptides with a relative intensity value. Finally, bioinformat-
ics analysis extrapolate from the quantitative measurements the pattern(s) governing the
biological event under analysis.
acid at a time by means of photomasks that selectively de-protect, at each
photolithographic iteration, the N-terminal of selected peptide chains. As a
consequence, an exposed chain is coupled to a new amino acid, and the pep-
tide grows by one unit. The process is repeated until all amino acid chains
reach the desired length. In spotting arrays, on the other hand, peptide li-
braries are pre-synthesized and then applied to the slide in a determined
order. Both approaches have advantages and disadvantages, reviewed for
example in [4] and [18].
By means of ﬂuorescent labels, interactions of the target molecules with
peptides on a slide can be detected as luminous spots. The interaction may
often also be regarded as quantitative, where diﬀerent levels of signal inten-
sity can be related to diﬀerent strength or equilibrium of interaction. Such
quantitativemeasurements allow representing the outcome of a peptide chip
experiment as a list of peptides eachwith a paired value of intensity, a conve-
nient format for pattern recognition by bioinformaticsmethods. The pipeline
of a typical peptide chip experiment is depicted in Figure 1.2.
Over the past few years high-density peptide chips technologies have
evolved rapidly, increasing by orders of magnitude the number of peptides
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that can be screened in a single experiment. For example, in Paper I is shown
the application of microarrays containing more than 100,000 peptides on a
single slide for the analysis of protease cleavage speciﬁcities. Considering
the growing capabilities of peptide chips to generate high-throughput data,
including virtually all kinds of mutations and modiﬁcations of the original
peptide sequence, they are an extremely powerful tool for studying vari-
ous aspects of proteins and protein interactions. However, one must keep
in mind that peptides can only explore the linear components of proteins.
For instance, peptide arrays enable the detection of antibodies against lin-
ear epitopes, but not directly the identiﬁcation of conformational epitopes
formed by amino acids that are only in close proximity in the tertiary pro-
tein structure [14].
1.3 Sequence motifs and PSSMs
A sequence motif is an amino acid or nucleotide pattern shared by several
sequences and presumably related to some biological function. Very sim-
ple sequence motifs can be represented by a regular expression listing the
allowed and disallowed amino acids at each position in the motif. For in-
stance, the general WW domain binding motif can be expressed as [AP]-P-
P-[AP]-Y, where [AP] means either A or P. However there are exceptions,
and they would have to be spelled out individually. But most importantly,
the regular expression description does not say anything about the impor-
tance of diﬀerent positions in the motif, and the relative importance of dif-
ferent amino acids at each position (in the WW domain example, are A and
P equally probable? and are all prolines equally important?).
A quantitative representation of a bindingmotif may be derived from the
data. Given a set of aligned sequences known to contain the motif, we can
construct a matrix of probabilities pi,a expressing the frequency of all amino
acids a at each position i of the alignment. These probabilities are commonly
compared to the frequency qa of each residue a in randomproteins, resulting
in a matrix of log-odds ratios:
LOi,a = log2
pi,a
qa
(1.1)
The background amino acid frequencies qa can be regarded as uniform for all
symbols (qa = 0.05 for a 20 amino acids alphabet), but as some amino acid are
more abundant than others in natural proteins, the background frequencies
are commonly estimated from a large data set of proteins. In Table 1.1 are
listed the qa values calculated from the UniProt database [19].
The log-odds matrix can be used as a Position-Speciﬁc Scoring Matrix
(PSSM), allowing the detection of the motif in other sequences that were
not used to construct the PSSM. By simply summing the (position-speciﬁc)
scores of each amino acid in the query sequence, one obtains a quantita-
tive measure of how closely the query matches the motif. However, there
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Table 1.1. Amino acid background frequencies calculated from UniProt entries
Amino acid Abb Frequency
Alanine A 0.074
Arginine R 0.052
Asparagine N 0.045
Aspartic acid D 0.054
Cysteine C 0.025
Glutamine Q 0.034
Glutamic acid E 0.054
Glycine G 0.074
Histidine H 0.026
Isoleucine I 0.068
Leucine L 0.099
Lysine K 0.058
Methionine M 0.025
Phenylalanine F 0.047
Proline P 0.039
Serine S 0.057
Threonine T 0.051
Tryptophan W 0.013
Tyrosine Y 0.032
Valine V 0.073
are a few caveats about PSSM construction, and in particularly two deserve
some discussion: data redundancy and small data sets. Data redundancy
can be controlled by sequence weighting methods, and pseudocount correc-
tion deals with data sets composed of few points.
1.3.1 Sequence weighting
Data redundancy occurswhen there is a sampling bias in the set of sequences
containing the motif. The presence of several identical or nearly identical
sequences may excessively skew the motif towards the presence of certain
features that are only abundant because of over-sampling of a certain region
of the sequence space. Ideally, one would want to downweigh such nearly
identical sequences, and thereby enhance sequence diversity in the align-
ment. There are several strategies to implement sequence weighting, but we
will mention two: heuristic weighting and sequence clustering.
Heuristicweighting, in its implementation byHenikoﬀ andHenikoﬀ [20],
calculates a weight wx for each sequence x according to the relationship:
wx =
L
å
i=1
1
risi
(1.2)
8 CHAPTER 1. INTRODUCTION
where ri is the number of diﬀerent amino acids at position i in the align-
ment, si is the number of occurrences in the alignment of the amino acid
found at position i in sequence x, and L is the length of the alignment.
Heuristic sequenceweighting is very fast, and its computation time increases
linearly with the number of sequences.
Sequence clustering is based on the Hobohm 1 algorithm [21]. In
Hobohm 1, sequences are considered in order, one at a time. The ﬁrst se-
quence will always form a cluster. The second sequence is compared to the
ﬁrst, and if they have % identity larger than a certain threshold (commonly
62%) they are placed together in the same cluster, otherwise the second se-
quence opens a new cluster. And so on, each sequence is compared to the
previously accepted sequences and clustered accordingly. After clustering,
a sequence x in cluster c receives a weight wx = 1/Nc, where Nc is the num-
ber of sequences in cluster c. Since each data point must be compared to any
other data point in the set, the complexity of the algorithm is proportional
to the square of the number of sequences.
1.3.2 Pseudocount correction
When a data set is small, the amino acid frequencies used to calculate the log-
odds scores (equation 1.1) are only based on very few observations. While
the data redundancy problem had to do with over-sampled regions of se-
quence space, here we are facing the opposite problem: the availability of
only few data points leaves large uncovered holes in sequence space. Pseu-
docounts aim to partially cover these holes by exploiting similarities between
diﬀerent amino acids. For example, in many cases hydrophobic amino acids
are to some extent interchangeable. If a position in the alignment appears
to be preferentially composed by hydrophobic amino acids, it is likely that
other hydrophobic amino acids are allowed at that position even though they
were not directly observed due to lack of data. Similarities between amino
acids are commonly measured in terms of BLOSUM scores [22]. Following
the implementation by Altschul et. al [23], the pseudocount frequencies ga
for a given column in the alignment are calculated using:
ga =
20
å
b=1
fbq(ajb) (1.3)
where fb is the observed frequency for amino acid b in the column, and
q(ajb) is the conditional probability of having amino acid b substituted with
amino acid a, as given by BLOSUM scores. It follows that, although a given
amino acid a may be rarely observed at a certain position (low fa), if other
amino acids b similar to a (high q(ajb)) are very frequent (high fb) then the
pseudocount frequency ga can be boosted to higher values.
The eﬀective amino acid frequency p0a for amino acid a can then be calcu-
lated with:
p0a =
a fa + bga
a+ b
(1.4)
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where a and b are the relative weights given to the observed ( fa) and
pseudocount (ga) frequencies. a is the number of sequences in the alignment
minus 1. However, if sequence weighting is employed to reduce redundancy
as described in the previous section, a may be more properly considered as
the eﬀective number of sequences. In the case of sequence weighting based
on clustering, a would be the number of clusters estimated by the Hobohm
1 algorithm, which reﬂects better the number of actual data points in the
alignment. With heuristic sequence weighting, a can be estimated as the
average number of diﬀerent amino acids (average ri from equation 1.2) across
the alignment columns.
1.4 Artiﬁcial neural networks
Scoring matrices are based on the assumption that positions in the motif are
independent from each other. That is, presence of a given residue at some
position does not inﬂuence the amino acid preference at another position in
the motif. However, such an assumption is often not true. For example, sig-
niﬁcant correlations between diﬀerent positions have been found in peptide
recognition domains [24]. In MHC-binding, it has been shown that there are
signals of higher order correlation in amino acids located between the anchor
positions [25].
Such correlations can be captured by artiﬁcial neural networks (ANN)
with hidden layers. As in biological networks of neurons in the brain, the ba-
sic units of the system (the neurons) do not have predeﬁned tasks but rather
act collectively by inﬂuencing each other's behavior. Such interconnected
structure allows simple units of basic function to exhibit complex (or "intel-
ligent") global behavior. The simplest kind of ANN, widely used in bioinfor-
matics, is the feedforward neural network, where signal travels from input
to output without loops or cycles. A schematic depiction of a feedforward
network is shown in Figure 1.3.
A given input example x is presented, through some kind of encoding, to
the input layer of the network. Then, the values stored in the input neurons
are passed to the hidden layer. Each hidden neuron receives a number of sig-
nals from the input neurons each with an associated weight. These weights,
which are the parameters of the network, quantify the inﬂuence of a partic-
ular input on stimulating the neuron, and can also have negative values if
that particular input tends to deactivate the neuron. The weighted inputs
for a given neuron are commonly summed, and if the combined inputs are
above a certain threshold the neuron is "active" and will transmit a positive
signal to the next layer, otherwise the neuron is oﬀ. Rather than a sharp step
function, a sigmoid function is commonly used for its mathematical proper-
ties in diﬀerentiation, taking the form f (x) = 11+e x (see inset box in Figure
1.3). The same applies for any subsequent hidden layers and for the output
layer: the weighted inputs for each neuron are summed and ﬁltered through
a sigmoid function, to generate output for the next layer (or global output,
in the case of the ﬁnal layer).
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The above procedure describes how a given input is streamed through
the network to produce output. In other words, how a prediction can be ob-
tained from an already trained ANN. But ﬁrst, a network must be trained for
the problem at hand, i.e. it must identify the optimal set of parameters (the
weights connecting neurons) that produce output values as close as possible
to some desired target values. This can be done using a back-propagation
algorithm, which iteratively updates the weights to minimize the error be-
tween predicted and target outputs. In online learning, the error is back-
propagated from output to input layer every time a training example is pre-
sented to the network. Each training point may have to be presented up to
hundreds of times to the network to ensure that the error converged to a
minimum.
In order to train ANNs on protein/peptide data, amino acids must be
translated to numbers using some kind of encoding scheme. Two common
encoding schemes, both used in theNNAlignmethod described in chapter 2,
are sparse encoding and BLOSUM encoding. In Sparse encoding, a vector of
length 20 represents each amino acid, where all values are set to zero apart
from the one indexing the observed amino acid. For example, the ﬁrst amino
acid in the alphabetAlaninewould be represented as 10000000000000000000,
the second amino acid Arginine as 01000000000000000000 and so on. An ad-
ditional digit may be added to identify the unknown amino acid X. BLOSUM
encoding is diﬀerent as it takes into account amino acid similarity, and pro-
duces a vector with the 20 BLOSUM matrix values for the observed amino
acid. Such vectors are presented to the input layer of the neural networks
to represent each position of a sequence alignment. More details about im-
plementation and ensembling of ANNs on peptide data are given in chapter
2.
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Figure 1.3. Schematic representation of a typical feedforward neural network. In this
example the ANN consists of an input layer composed of 5 neurons (i1-i5), one hidden
layer with 3 neurons (h1-h3) and a single output neuron (o1). Note that in the general case
there may be multiple hidden layers and/or multiple output neurons. In the inset box is
shown the behavior of a single neuron i: the inputs yj are multiplied by their weights wij
and summed, and the output yi of the neuron depends on the activation function f (x)
where x is the weighted sum of the inputs.
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1.5 Sequence logos
Sequence logos were introduced by Schneider et al. [26] as a visualization
tool for DNA and amino acid patterns. Given amultiple sequence alignment
(MSA), the pattern is represented as a stack of letters for each position in the
alignment, where the height of each letter represents the relative frequency
of the element at that position. Sequence logos are very popular because
they condense several pieces of information in a single plot: i) the general
consensus of the alignment; ii) the favored residues at each position; iii) the
relative frequencies of every residue at every position; iv) the information
content at each position in theMSA; v) signiﬁcant locations in the alignment,
such as anchor positions for binding.
In a Shannon sequence logo, the height Ri of a column i in the logo is
given as the information content in bits at that particular position, calculated
using
Ri = log2A +
A
å
a=1
fa,ilog2 fa,i (1.5)
where fa,i is the frequency of amino acid a at position i, and A is the size
of the alphabet (normally A = 20 for proteins and A = 4 for nucleic acid
sequences).
The height ha,i of symbol a at position i is given by
ha,i = Ri fa,i (1.6)
The value of Ri ranges from 0, for a position where all symbols have the
same frequency (maximum entropy), to log2A for a completely conserved
position in the alignment.
If the number of sequences in the MSA is limited, equation 1.5 tends to
underestimate entropy [27]. The small sample bias is normally accounted for
using a correction factor [27, 28] or by means of pseudocounts [23]. Another
aspect to consider when making a sequence logo is data redundancy: when
closely related sequences are over-represented in a MSA, this bias would re-
ﬂect in the motif visualized by the logo, emphasizing excessively the contri-
bution of the redundant sequences. Data redundancy in MSAs can be con-
trolled by means of position-based sequence weights [20].
The most popular webserver for the generation of sequence logos from a
sequence alignment is WebLogo [28] but several others exist [29, 30, 31, 32].
Among these, Seq2Logo [32] is particularly attractive as it allows for se-
quence redundancy reduction, pseudocount correction, and provides dif-
ferent types of logo besides the Shannon sequence logo. Starting from the
consideration that diﬀerent amino acids occur in nature with diﬀerent back-
ground frequencies qa, equation 1.5 can be re-written as
Ri =
A
å
a=1
fa,ilog2
fa,i
qa
(1.7)
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Figure 1.4. Sequence logos made using WebLogo [28] and Seq2Logo [32]. Both se-
quence logos were derived from the same data set of 100 binders to the MHC molecule
HLA-B*07:02.
The logo representation derived from equation 1.7 is termed Kullback-
Leibler (KL) logotype. In this context, a residue observed with higher fre-
quency than expected by chance ( fa,i > qa) is called an 'enriched' amino acid,
whereas a residue observed more rarely than the background frequency
( fa,i < qa) is called a 'depleted' amino acid. In Seq2Logo enriched amino
acids are shown on the positive side of the y-axis and depleted amino acids
as upside-down letters on the negative side of the y-axis.
Throughout this thesis we use both WebLogo and Seq2Logo to display
motifs in MSAs. As a reference for comparison, Figure 1.4 shows the se-
quence logos produced by the two methods on the same data set of 100
binders to the HLA-B*07:02 molecule. The WebLogo representation is a
Shannon logo, plotting the information content at each position and the re-
lative frequency of each amino acid in the alignment. The Kullback-Leibler
representation made with Seq2Logo displays also under-represented amino
acids on the negative y-axis. Notice how certain amino acids such as Ala-
nine (A) and Leucine (L) appear favored in the Shannon logo but depleted
in the KL logo. This is mainly because A and L are rather frequent in natu-
rally occurring sequences (respectively 7.4% and 9.9% as opposed to the 5%
expected on average for a 20 letter alphabet), and this bias is only taken into
account by the KL logotype. The latter should arguably be the favored logo
representation on non-equiprobable alphabets.
Chapter 2
Peptide sequence alignment using
ANNs
A essential step in extracting information from peptide data is se-quence alignment. Multiple local sequence alignment aims at identi-fying recurrent sub-sequences in a set of peptides, with the assump-
tion that sequence similarity is related to some biological property shared
by the peptides. However, when the shared sequence motif is weak and
short, as is often the case with peptide data, conventional sequence align-
ment approaches tend to fail at this task [33]. Several bioinformatics meth-
ods have been developed to identify such subtle sequence signals including
Gibbs sampling [34], Hidden Markov Models [35] and artiﬁcial neural net-
works [36]. In particular, artiﬁcial neural networks (ANNs) have shown high
performance on this kind of data [37]. Part of their success resides in the
ability of capturing higher order correlations, that is, the presence of a given
residue at some position may aﬀect the amino acid preference at another
position in the alignment core.
Recently our group described a neural network-based method,NN-align,
which has been shown to perform signiﬁcantly better than any other pub-
lished method for MHC class II binding prediction [36]. In the following
section (2.1), we describe how the method was extended and adapted to
handle quantitative peptide data in general, including applications to high-
throughput peptide array data. Themethodwas also implemented as a user-
friendly web server allowing the non-expert end user to perform advanced
bioinformatics analysis of large peptide data sets.
One important feature introduced in NNAlign is a new oﬀset correction
algorithm to improve the motif visualization of neural network ensembles.
In section 2.2wediscuss inmore detail the algorithmand its implementation.
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2.1 Paper I
NNAlign: a web-based prediction method
allowing non-expert end-user discovery of
sequence motifs in quantitative peptide data
PLoS ONE, November 2011 vol. 6(11): e26781. doi:10.1371/journal.pone.002678
Massimo Andreatta?1, Claus Schafer-Nielsen2, Ole Lund1, Søren Buus3 and
Morten Nielsen1
1Center for Biological Sequence Analysis, Department of Systems Biology, Technical
University of Denmark, DK-2800 Lyngby, Denmark 2Schafer-N, DK-2100
Copenhagen, Denmark 3Laboratory of Experimental Immunology, Faculty of
Health Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark
? Corresponding author - massimo@cbs.dtu.dk
16 CHAPTER 2. PEPTIDE SEQUENCE ALIGNMENT
Abstract
Recent advances in high-throughput technologies have made it pos-
sible to generate both gene and protein sequence data at an unprece-
dented rate and scale thereby enabling entirely new "omics"-based ap-
proaches towards the analysis of complex biological processes. How-
ever, the amount and complexity of data that even a single experiment
can produce seriously challenges researchers with limited bioinformat-
ics expertise, who need to handle, analyze and interpret the data be-
fore it can be understood in a biological context. Thus, there is an
unmet need for tools allowing non-bioinformatics users to interpret
large data sets. We have recently developed a method, NNAlign, which
is generally applicable to any biological problem where quantitative
peptide data is available. This method eﬃciently identiﬁes underly-
ing sequence patterns by simultaneously aligning peptide sequences
and identifying motifs associated with quantitative readouts. Here, we
provide a web-based implementation of NNAlign allowing non-expert
end-users to submit their data (optionally adjusting method parame-
ters), and in return receive a trained method (including a visual rep-
resentation of the identiﬁed motif) that subsequently can be used as
prediction method and applied to unknown proteins/peptides. We
have successfully applied this method to several diﬀerent data sets in-
cluding peptide microarray-derived sets containing more than 100,000
data points. NNAlign is available online at http://www.cbs.dtu.dk/
services/NNAlign.
2.1.1 I
Proteins are extremely variable, ﬂexible and pliable building blocks of life
that are crucially involved in almost all biological processes. Many diseases
are caused by protein aberrations, and proteins are frequent targets of inter-
vention. A plethora of high-throughput methods are currently being used to
study genetic associations and protein interactions, and intense ongoing in-
ternational eﬀorts aim at understanding the structures, functions andmolec-
ular interactions of all proteins of organisms of interest (e.g. the Human Pro-
teome Project, HPP). In some cases, linear peptides can emulate functional
and/or structural aspects of a target structure. Such peptides are currently
identiﬁed using simple peptide libraries of a few hundreds to thousands
peptides whose sequences have been systematically derived from the tar-
get structure at hand   that is, if this is known. Even when the native target
structure is unknown, or too complex (e.g. discontinuous) to be represented
by homologous peptides, the enormous diversity and plasticity of peptides
may allow one or more peptides to mimic relevant aspects of a given target
structure [38, 39].
Peptides are therefore of considerable biological interest and so aremeth-
ods aimed at identifying and understanding peptide sequence motifs asso-
ciated with biological processes in health and disease. Indeed, recent devel-
opments in large-scale, high-density peptide microarray technologies allow
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the parallel detection of thousands of sequences in a single experiment, and
have been used in a wide range of applications, including antibody-antigen
interactions, peptide-MHC interactions, substrate proﬁling, identiﬁcation of
modiﬁcation sites (e.g. phosphorylation sites), and other peptide-ligand in-
teractions [40, 13, 41, 42, 43]. One of the major advances of peptide microar-
rays is the ease of generating large numbers of potential target structures and
systematic variants hereof [4].
Given the capability for large-scale data generation already realized in
current "omics" and peptide microarray-based approaches, experimentalists
will increasingly be confronted with extraordinary large data sets and the
consequent problem of identifying and characterizing features common to
subsets of the data. These are by no means trivial problems. Up to a certain
level of size and complexity, data can be presented in simple tabular forms or
in charts, however, larger and/or more complex bodies of data (e.g. in pro-
teome databases) will need to be fed into bioinformatics datamining systems
that can be used for automated interpretation and validation of the results,
and eventually for in silico mapping of peptide targets. Moreover, such sys-
tems can conveniently be used to design next-generation experiments aimed
at extending the description of target structures identiﬁed in previous anal-
yses [44].
A wealth of methods has been developed to interpret quantitative pep-
tide sequence data representing speciﬁc biological problems. By way of ex-
amples, SignalP, which identiﬁes the presence of signal peptidase I cleav-
age sites, is a popular method for the prediction of signal peptides [45];
LipoP, which identiﬁes peptidase II cleavage sites, predicts lipoprotein sig-
nal peptides in Gram-negative bacteria [46]; various predictionmethods pre-
dict phosphorylation sites by identifying short amino acid sequence mo-
tifs surrounding a suitable acceptor residue [47, 48, 49, 50] etc. In general
terms, these methods can be divided in two major groups depending on
the structural properties of the biological receptor investigated, and of the
nature of the peptides recognized. The simplest situation deals with inter-
actions where a receptor binds peptides that are in register and of a known
length. In this case, the peptide data is pre-aligned, and conventional ﬁxed
length, alignment-free pattern recognition methods like position speciﬁc
weight matrices (PSSM), artiﬁcial neural networks (ANN), and support vec-
tor machines (SVM) can be used. Peptide-MHC class I binding is a promi-
nent example of the successful use of such methods to characterize receptor-
ligand interaction represented by pre-aligned data (reviewed in [51]). An-
other more complex type of problems deals with interactions where either
themotif lengths, and/or the binding registers, are unknown. In these cases,
the peptide data must a priori be assumed to be unaligned and any bioinfor-
matics method dealingwith such data is facedwith the challenge of simulta-
neously recognizing the binding register (i.e. performing an alignment) and
identifying the bindingmotif (i.e. performing a speciﬁcity analysis). Peptide-
MHC class II binding is a preeminent example of a receptor-ligand interac-
tion represented by unaligned data. Several bioinformatics methods have
18 CHAPTER 2. PEPTIDE SEQUENCE ALIGNMENT
been developed to identify binding motifs in such peptide data including
Gibbs sampling [33], hidden Markov models (HMM) [52], stabilization ma-
trix method (SMM) alignment [53], and alignment using artiﬁcial neural net-
works [36] (for more references see [6]). Another example of unaligned pep-
tide data is that of antibodies interacting with linear peptide epitopes. Al-
though B-cell epitopes frequently are conformational and three-dimensional
in structure, some do contain linear components that can be represented by
peptide interaction with the corresponding antibodies [54, 55, 56].
Even thoughmost of the methods described above are standardmethods
for data-driven pattern recognition, the development of a predictionmethod
for any given biological problem is far from straightforward, and the non-
expert userwill rarely be able to develop their own state-of-the-art prediction
methods. We have recently described a neural network-based data driven
method, NN-align, which has been speciﬁcally designed to automatically
capture motifs hidden in unaligned peptide data [36]. NN-align is imple-
mented as a conventional feed-forward neural network and consists of a two-
step procedure that simultaneously identiﬁes the optimal peptide-binding
core, and the optimal conﬁguration of the network weights (i.e. the motif).
This method is therefore inherently designed to deal with unaligned peptide
data, and it identiﬁes a core of consecutive amino acids within the peptide
sequences that constitute an informative motif. Note that the method does
not allow for gaps in the alignment. AlthoughNN-alignwas originally devel-
oped with the unaligned nature of peptide-MHC class II interaction in mind
  and independent validations have shown that NN-align indeed performs
signiﬁcantly better than any previously published methods for MHC class II
motif recognition [37]   the unique ability of this method to capture subtle
linear sequence motifs in quantitative peptide-based data and its adaptabil-
itymakes it extremely attractive for other applications aswell. Here, we have
adapted and extended the NN-align method so that it can handle quantita-
tive peptide-based data in general. Making this method generally available
for the scientiﬁc community, we have embedded it into a public online web-
interface that facilitates both handling of input data, optimization of essen-
tial training parameters, visual interpretation of the results, and the option of
using the resulting method to predict on user-speciﬁed proteins/peptides.
Through the server the user can easily set up a cross-validation experiment
to estimate the predictive performance of the trainedmethod, and automati-
cally reduce redundancy in the data. The logo visualization is also improved
with an algorithm that aligns individual neural networks to maximize the
information content of the combined alignment. This web-based extension
of the NN-align method empowers experimentalists of limited bioinformat-
ics background with the ability to perform advanced bioinformatics-driven
analysis of his/her own sets of large-scale data.
2.1.2 R
Enabling any non-expert end-user to extract speciﬁc information from quan-
titative peptide data using an advanced bioinformatics approach, we have
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used our recently published NN-align method to generate a web-based ex-
tensionwith a reasonably simple, yet adaptable, web-interface andmade this
server publicly available at http://www.cbs.dtu.dk/services/NNAlign. Using
this web server any user can submit quantitative peptide data (optimally
based on actual discrete measurements, but even assigned classiﬁcation, e.g.
0 and 1, can be used) and in return receive a trained method including train-
ing details and estimated predictive performance, a visual interpretation of
the identiﬁed peptide pattern, and the trained model itself. The latter can be
re-submitted to the web server at any later time and used to predict the oc-
currence of the learnedmotif in one or more concurrently submitted peptide
sequences or FASTA format sequences.
The truly non-expert user has the option of using a set of default settings.
Using these settings, the data is preprocessed using a linear transformation
to make the data fall in the range from 0 to 1, and the NN-align method is
trained using ﬁve-fold cross-validation. For each cross validation partition
ﬁve networks, each initiated from diﬀerent initial conﬁgurations, are trained
with 3 hidden neurons. The only critical parameter that the user is required
to specify is the motif length. The value used for this parameter is speciﬁc
to each problem and the user is recommended to deﬁne a motif length (or
an interval of motif length) that is relevant to the biological problem inves-
tigated by the peptide data. The default settings will in most cases allow
the user to obtain a ﬁrst impression of the motif contained in the data, and
achieve a predictionmethod that allows the user tomake prospective studies
on uncharacterized proteins/peptides. The more experienced user has sev-
eral advanced options to customize the training. For details on these options
refer toMaterials andMethods section, or the help section of the web-server.
An example output from the NNAlign Server is shown in Figure 2.1. In-
formation about the training data is accompanied by a plot of the data dis-
tribution before and after the data processing needed to train the neural net-
works. An important feature is the possibility to download and save the
trained model, and use it subsequently for predictions on new data. The
results page also returns the performance of the method as estimated by
cross-validation, and provides links to a scatter-plot showing the correlation
between measured and predicted values, as well as the complete alignment
core on the trainingdata. A sequence logo gives a visual representation of the
identiﬁed sequence motif, which can also be viewed in a log-odds position-
speciﬁc scoring matrix format. If any evaluation data has been provided at
the time of method training, a section of the results will report the predic-
tions of this evaluation set.
A few example applications illustrating the power of the NNAlign
method are presented in the following sections. First, the method is applied
to examples of pre-aligned peptide data using examples ofMHC class I bind-
ing. Next, the alignment problem is included using MHC class II binding
data, showing the ability of the method to identify at the same time the cor-
rect length of the motif, the binding register, and the sequence motif itself.
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NNAlign output
Technical University of Denmark
Run ID: 180135 !
Run Name: DRB1_0101.th08.lg9
Training data
Trained ANNs on 6427 sequences 
View data distribution
(See Instructions for optimal data distribution)
Pre-processing: Linear rescale
Neural network architecture
Motif length: 9
Flanking region size: 3
Number of hidden neurons: 20
Encode peptide length: Yes
Encode flank region length: Yes
Neural network encoding: Blosum
Number of training cycles: 500
Number of NN seeds: 10
Number of networks in final ensemble: 20
Stop training on best test-set performance: No
Cross-validation method: Fast
Subsets for cross-validation: Hobohm clustering (thr=0.8)
RESULTS
Motif length = 9
Sequence motif
Cores realigned with offset correction
 
Click here if you have problems visualizing this image
Figure: Visualization of the sequence motif using the
WebLogo program
View a Log-odds matrix representation of the motif
Performance measures
Folds for cross-validation = 5
RMSE = 0.194155 
Pearson correlation coefficient = 0.6877 
Spearman rank coefficient = 0.6832 
View scatterplot of predicted vs. observed values 
Download complete alignment core on the training data
Save the trained MODEL. You may use this model for a
new submission 
Evaluation data
No evaluation data uploaded
Figure 2.1. Example of output from the NNAlign server trained on MHC class II bind-
ing data for allele HLA-DRB1*01:01. Links on the results page (in pink) redirect to ad-
ditional ﬁles and ﬁgures relevant for the analysis. Run ID is a sequential identiﬁer for
the current job, and Run Name a user-deﬁned preﬁx that is added to all ﬁles of the run.
The ￿view data distribution￿ link shows the transformation applied to the data in pre-
processing, which can be either a linear or logarithmic transformation. In this case the
method was trained with a motif length of 9, including a PFR of size 3 to both ends of
the peptide, and encoding in the network input layer peptide length and PFR length. The
hidden layer was made of a ﬁxed number of 20 neurons. Peptides were presented to the
networks using a Blosum encoding to account for amino acid similarity, for 500 hundred
iterations per peptide without stopping on the best test set performance. At each cross-
validation step, 10 networks were trained starting from 10 diﬀerent initial conﬁgurations.
The subsets for cross-validation were constructed using a Hobohm1 method that groups
in the same subset sequences that align with more than 80% identity (thr = 0.8). The
model can be downloaded to disk using the dedicated link, and can be resubmitted to
NNAlign to ﬁnd occurrences of the learned pattern in new data. The estimated perfor-
mance of the trained method is expressed in terms of Root Mean Square Error, Pearson
and Spearman correlation. A visual representation of the correlation can be obtained
from the scatterplot of predicted versus observed values. The ￿complete alignment core￿
link allows downloading the prediction values in cross-validation for each peptide, and
where the core was placed within the peptides. Next follows a section on the sequence
logo, showing a logo representation of the binding motif learned by the network ensem-
ble. If the relative option is selected, links to logos for the individual networks in the
ﬁnal ensemble are also listed here. Finally, if an evaluation set is uploaded, an additional
section shows performance measures and core alignment for these data.
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An important output from theNNAlignmethod is a sequence logo represent-
ing the identiﬁed binding motif. Such sequence logos provide a highly in-
tuitive representation of single-receptor speciﬁcities (as is the case for MHC
class I and II binding data). Finally, to illustrate how the method is capable
of handling and guide the semi-expert user in interpreting large-scale data
sets, NNAlign is applied to data generated by a large-scale peptide microar-
ray technology.
MHC class I
Binding of peptides to MHC class I molecules is highly speciﬁc, with only 1-
5% of a set of random natural peptides binding to any given MHCmolecule
[5]. Moreover, in the vast majority of cases only peptides with length 8-10
amino acids can ﬁt in the binding pocket of MHC class I molecules. The pre-
dictive performance of NNAlign on 12 human MHC class I alleles from data
by Peters et al. [57] is shown in Table 2.1 (see the table footnote for the pa-
rameters used). The benchmark data sets contain quantitative binding data
of a given length (9 amino acids) covering the whole spectrum from non-
binding to strong-binding peptides, hence serving as a perfect illustration of
the strength of theNNAlignmethod to handle pre-aligned peptide data. The
overall performances of the three methods are comparable demonstrating
that NNAlign competes with state-of-the-art methods designed speciﬁcally
for MHC class I prediction.
MHC class II
As opposed to MHC class I binding, which is mostly limited to peptides of
similar length, the MHC class II molecule interacts with peptides of a wide
length distribution and high compositional diversity [60]. Binding of a pep-
tide to an MHC class II molecule is primarily determined by a core of nor-
mally 9 amino acids, but the composition of the regions ﬂanking the binding
core (peptide ﬂanking region, PFR) has been shown to also aﬀect the bind-
ing strength of a peptide [61, 62]. Identifying the binding motif and binding
register for MHC class II binding peptides is thus a problem that inherently
requires simultaneous alignment and binding aﬃnity identiﬁcation. Here,
an MHC class II benchmarking was obtained from the recent publication
by Wang et al. [37]. The performance was estimated for each allele using a 5
fold cross validation, where at each step 4/5 of the datawere used to train the
neural networks, and 1/5 were left out for evaluation. For cross-validation,
we preserved the same data partitioning as used in the original publication.
In Table 2.1, the performance of NNAlign on the Wang set is compared to
other publicly available methods for MHC class II prediction. These include
SMM-align [53], ProPred/Tepitope [58, 59], as well as the original version of
the NN-align algorithm [36]. The NN-align-based methods outperform their
competitors on all alleles, conﬁrming the ability of the neural networks in
dealing with alignment problems. The diﬀerence with the originalNN-align
method, which is due to diﬀerences in network architecture, is small and not
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signiﬁcant (p>0.2, binomial test). For this example involving unaligned data,
the NNAlign server competes with comparable state-of-the-art methods.
Choosing the optimal motif length
Diﬀerent positions in a bindingmotif can bemore or less informative, and the
ends of amotif can often not be clearly delineated. This prompts the question
of howmany positions are necessary and suﬃcient to represent a givenmotif
and how the length of a motif is deﬁned. NNAlign allows searching for the
optimal motif length in a quantitative peptide data set. Here, the best motif
length is the one that yields, in a cross-validation experiment, the lowest root
mean square error (RMSE) between observed and predicted values. By this
token, a terminal position is included in the motif if it contributes with infor-
mation at a level above what could be considered to be noise. In contrast, if
the inclusion of a putative terminal position does not lead to a reduction in
the RSME then it can be concluded that it does not add useful parameters to
the model; rather, it lowers the predictive performance and should be omit-
ted. This approach was used to suggest the motif length of the 14MHC class
II HLA-DR alleles, which were searched for optimal predictive performance
by scanning through possible lengths from 6 to 11 amino acids. NNAlignwill
report the length associated with the lowest RMSE value as the optimal mo-
tif length (see Figure 2.2, left hand panel). Nonetheless, the user is advised
to inspect the sequence logo as well as the performance plot of the RMSE
as a function of the motif length to evaluate whether the dependence upon
length appears signiﬁcant. As deﬁned here and illustrated in Figure 2.2 right
Figure 2.2. Identiﬁcation of optimal motif length using the NNAlign method. Left
panel: Histogramof the optimalmotifs lengths for the 14HLA-DRmolecules in theWang
dataset as identiﬁed by the NNAlignmethod. Right panel: Predictive performance mea-
sured in terms of the rootmean square error (RMSE) between observed and predicted val-
ues as a function of the motif length for the two molecules DRB1*01:01 and DRB1*15:01.
NNAlignwas trained using the same parameters settings described in Figure 2.4. At each
motif length are shown the mean and standard error of the mean RMSE as estimated by
bootstrap sampling. For DRB1*01:01 a single consistent optimal motif length of 9 amino
acids is found. For DRB1*15:01 all motif lengths 8-11 had statistically indistinguishable
performance (paired t-test).
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panel, the 9-mer preference of HLA-DRB1*01:01 is signiﬁcant, whereas the
apparent 8-mer preference of HLA-DRB1*15:01 is not signiﬁcant. In fact, for
the 14 HLA-DR molecules included in the benchmark, only one was found
to have a single consistent optimal motif length (DRB1*01:01 with a motif
length of 9 amino acids). For all other molecules the method did identify
more than one possible optimal motif length. However, all motif lengths
fell in the range of 7 to 10 amino acids, and in all cases a 9-mer motif was
compatible with being the optimal motif length.
Improving the LOGO sequence motif representation by an oﬀset
correction
In order to enhance predictive performance, the NNAlign method exploits
an ensemble of neural networks [36, 63], which have been trained on diﬀer-
ent subsets of the data, and/or from alternative conﬁgurations of the net-
work architecture (i.e. diﬀerent number of hidden neurons and/or encoding
schemes). As a consequence of diﬀerent architectures and starting condi-
tions, individual networks might disagree on the exact boundaries of the
motif. This disagreement would complicate the visualization of the motif if
this was represented as a simple overlay of the individual motifs as exem-
pliﬁed in Figure 2.3, where sequence logos for four diﬀerent networks from
the ensemble trained on HLA*DRB1-04:01 binding data are shown in panels
A through D. The individual networks agree on identifying the same strong
primary anchor residues and positions, however, each single network identi-
ﬁes diﬀerent ends (i.e. suggests diﬀerent registers of the same motif; in casu
starting at positions 1, 2, 2 and 3 of the predicted nonamer peptide). The
weak C-terminal primary anchor residue of HLA*DRB1-04:01 probably ex-
plains why the boundaries are diﬃcult to determine. A simple overlay of
the predictions from individual networks would result in a muddled motif
as depicted in Figure 2.3, panel E. Implementing a Gibbs sampler approach,
where matrix representations of the core motifs of diﬀerent networks are
aligned, we introduced an oﬀset correction for each network aiming at max-
imizing the information content of a combined logo representation of the
motif. This approach led to a considerable improvement in the visual logo
representation of the binding motif (Figure 2.3, panel F). Oﬀset correction is
included as an integral part of the method to enhance motif visualization.
Characterizing the binding motif of HLA-DR molecules using the
NNAlignmethod
To illustrate the power of theNNAlignmethod to capture the binding motifs
within unaligned quantitative peptide data, we applied themethod to derive
sequence logo representations of the 14 MHC class II HLA-DR molecules
included in the Wang dataset. NNAlign was trained with a binding motif
length of 9 amino acids, Blosum encoding, including peptide length and
ﬂanking region length, and PFRs of 3 amino acids, homology clustering at
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Figure 2.3. Sequence logos for HLA*DRB1-04:01. In panels a) to d) are shown sequence
logos for 4 single networks from the network ensemble created with NNAlign. The fun-
damental pattern appears in all these networks, but they place the anchors at diﬀerent
position of the core. e) shows the core of the 20 networks ensemble without oﬀset correc-
tion; in f) oﬀset correction was used to realign the logos to a common register.
threshold 0.8 using all data points, 20 hidden neurons and a 5-fold cross-
validation without stopping at the best test set performance. These parame-
ters were found to be optimal in the originalNN-align paper forMHC class II
binding prediction [36], with the only diﬀerence that here we choose a single
value for hidden layer size for a matter of prediction speed. Individual net-
works are aligned to a common register using the oﬀset correction strategy
previously described. The sequence logos obtained are shown in Figure 2.4.
The sequence logos reﬂect the overall consensus of the binding motifs for
HLA-DRmolecules, namely a prominent P1 anchor with strong amino acids
preference towards hydrophobic amino acids in general, and aromatic amino
acids as F and Y in particular, and the presence of two ormore additional an-
chors at P4, P6 and/or P9 each with a unique amino acid preference. Even
thoughmost of these motifs exhibit a strong preference for hydrophobic and
neutral amino acids atmost anchor positions, somedramatic deviations from
this general pattern exist. Examples of this are the motifs of DRB1*03:01 and
DRB1*11:01 molecules that have strong preferences for charged amino acids
at P4 and P6, respectively.
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Figure 2.4. Sequence logo representation of the binding motifs for the 14 HLA-DR
molecules contained in the Wang MHC class II data set. NNAlign was trained with
Blosum encoding, including peptide length and ﬂanking region length, PFRs of 3 amino
acids, homology clustering at threshold 0.8 using all data points, 20 hidden neurons and a
5-fold cross-validationwithout stopping on the best test set performance.. Sequence logos
are calculated as described in material and methods and visualized using the WebLogo
program [28].
Handling large data sets exempliﬁed by protease recognition of
high-density peptide microarrays
Apeptidemicroarray containing a total of >100,000 peptides (49,838 ofwhich
were unique) was digestedwith the protease trypsin. The peptide sequences
had been synthesized using the theme Ac-GAGAXXXXXGAGA, where Ac-
is acetyl blocking the peptide alpha-amino group prior to digestion, and X
represents amino acids chosen randomly from the 20 natural amino acids
(except lysine, as this residue contains an epsilon-amino group, which even
without digestion would be detectable (see Materials and Methods for de-
tails)). As a result, free amino groups can only be expressed by trypsin
cleaved peptides, which can then be labeledwithDylight549 and quantitated
by ﬂuorescence microscopy. A ﬂuorescence microscopy picture of such a di-
gested and stained peptide microarray (Figure 2.5a) demonstrates both the
resolution of the photolithographic peptide synthesis strategy and the dy-
namic range of the free amino group detection strategy. The resulting data
was log-transformed and rescaled to obtain a data distribution covering the
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Figure 2.5. Analysing high-density peptide array data with NNAlign. a) Fluorescence
microscopy picture of a peptide microarray. The image is a magniﬁed segment of the
peptide chip used in the trypsin cleavage analysis. b) Trypsin peptide-chip data. The
normalized observed (target) likelihood of cleavage as a function of the prediction score
for the trypsin data set. Localizations of peptides containing the pairs of amino acids
RP, RA or RR are highlighted in the plot. Proline (P) is known to prevent cleavage af-
ter arginine (R), whereas cleavage is observed with other amino acids such as R and A.
c) Chymotrypsin peptide-chip data. Correlation plot between predicted and measured
(target) data from the chymotrypsin data set. Values are binned by their x,y proximity, so
that the scatterplot represents the density of data in each bin. NNAlign was trained with
linear rescaling of the quantitative data, a motif length of 4 amino acids without inclusion
of PFR encoding, Blosum encoding of peptide sequences, a combination of 3,7,15 hidden
neurons, 10 initial seeds, 5-fold exhaustive cross-validation, training was stopped on the
best test set performance.
spectrum between 0 and 1 which, along with the corresponding peptide se-
quences encoded as Blosum scores without ﬂanking regions, were used to
train theNNAlignmethod. Trainingwas donewith amotif length of 5, a ﬁxed
number of 3 hidden neurons, 5-fold exhaustive validation, and stopping at
the best test set performance.
The prediction method yielded a Pearson correlation between measured
values and predictions of r = 0.971, a Spearman correlation of r = 0.910, and
receiver operating characteristic (ROC) area under the curve (AUC) of 0.997
(using a target threshold of t = 0.5). The very high performance measures
of the resulting NNAlign method demonstrate both that the recorded pep-
tide digestion data contains a consistent and intelligible signal, and that the
NNAlign method is capable of deciphering and predicting this extraordi-
nary large number of sequence-dependent peptide signals. The correlation
scatterplot feature of the NNAlign web-server output, which compares pre-
dicted vs. observed values, further supports the validity of both the pep-
tide microarray and of the NNAlign method. The correlation scatterplot for
the trypsin digestion data reveals two major populations of peptides, one
composed of non-degradable, non-predicted peptides and one containing
weakly to strongly degradable, predicted peptides (Figure 2.5b). Few (0.7%)
of the former peptides contained Arginine, whereas most (97.1%) of latter
peptides contained Arginine. This is exactly what one would have expected
from a peptide digestion with trypsin, which is known to cleave at the C-
terminal side of amino acids Arginine (and Lysine, which has been excluded
here, see above) [64]. For illustration purposes, Figure 2.5b includes a color-
enhanced visualization of certain dipeptide sequences (note, this is not a
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standard feature of the NNAlign server) showing that RP sequences are re-
sistant, RA sequences are quite susceptible, and RR sequences appear ex-
tremely susceptible to trypsin digestion. Thus, the known trypsin resistance
of RP sequences is both demonstrated by the peptide microarray and sub-
sequently captured by the NNAlignmethod. Note that both the peptide mi-
croarray and the NNAlign generate a continuous set of measurements and
predictions showing that trypsin cleavage involves a more complex interac-
tion than a simple recognition solely of an Arginine residue (and by infer-
ence a Lysine residue), which would have resulted in a cleaved/non-cleaved
classiﬁcation [65]. It is also important to note that the detection strategy
employed here does not reveal where the protease cleavage has occurred,
but merely that the protease has recognized the peptide as a substrate and
cleaved it somewhere.
A similar high-density peptide microarray driven approach was next
used to address the speciﬁcity of the protease chymotrypsin, which is known
to preferentially cleave at the C-terminal of tyrosine, phenylalanine and tryp-
tophan (albeit not if followed by a proline). A high-density peptide microar-
ray containing about 50,000 peptides (16,526 unique peptides) was generated
according to the theme Ac-GAGAXXXXGAGA, treated with chymotrypsin,
labeled with TAMRA and quantitated by ﬂuorescence microscopy. The re-
sulting data was used to train an NNAlign method (using the settings de-
scribed in Figure 2.5c). The correlation scatterplot of the measured versus
predicted values exhibits a very strong linear correlation with a Pearson of r
= 0.943 demonstrating that the peptide microarray data contains a consistent
signal that reliably has been captured by the NNAlignmethod.
2.1.3 D
The amount of data deposited in genomic and proteomic databases has been
growing exponentially for many years [66]. Due to recent technological
advances that have enabled whole-genome sequencing and made whole-
proteome analysis a realistic goal, sequence data will accumulate at an even
faster pace in the future where single laboratories, even single experiments,
can generate data at the "omics" level. This is amply illustrated here where
a high-density peptide microarray technology allowed the parallel synthesis
of more than 100,000 discrete peptide sequences per array, and the collection
of a corresponding number of quantitative peptide-receptor interaction data
  all within a single experiment.
The biggest hurdle of future "omics" research may easily become that
of making sense of such large-scale biologic sequence data [67]. Presently,
the "omics" experimentalist requires assistance from specialized and highly
trained bioinformaticians capable of large-scale data handling and interpre-
tation. Ideally, however, he or she should not only be armed with high-
throughput data-generation technologies, but also with reasonably easy and
robust bioinformatics methods allowing the experimentalist to analyze his
or her own data. This would permit an immediate analysis of experimental
2.1. PAPER I 29
results and assist in rational designs of next generation experiments aimed
at extending the original analysis e.g. providing in silico tools for searches
that potentially could encompass entire proteomes. Enabling the same per-
son to do large-scale experiments and analysis should result in a better in-
tegration between design, experiment, and interpretation ￿ and eventually
support the development of new hypotheses. Unfortunately, suitable bioin-
formatics resources aimed at the non-expert user are currently scarce, and
rarely web-based. In our experience, open source software packages such
as Weka [68] are not capable of performing concurrent alignment and motif
identiﬁcation, and are not suited for treating large-scale data sets. A widely
used method for motif discovery, MEME [69], can perform searches for un-
gapped sequence patterns in DNA or protein sequences, and oﬀers a user-
friendly online server to the untrained user. However, this method is not
designed for use in quantitative data, such as peptide-MHC binding or pep-
tide microarray data.
To the best of our knowledge,NNAlign is the ﬁrst web-based bioinformat-
ics solution that allows non-expert users to discover short sequence motifs
in quantitative peptide data. As shown here, NNAlign easily competes with
state-of-the-art methods for identifying peptide-binding motifs of aligned
(exempliﬁed by MHC class I) as well as unaligned (exempliﬁed by MHC
class II) quantitative peptide sequence data. Further, demonstrating the gen-
eral utility of NNAlign, we have used it to characterize the cleavage speci-
ﬁcities of proteases from high-throughput peptide array data. If a suﬃ-
cient number of training examples can be generated, including negative in-
stances, we could envision applying the method also on data generated by
phage display peptide libraries. Other instances of recognition of short spe-
ciﬁc peptide motifs occurs frequently in biology where they are involved in
molecular interaction, recognition, signaling, internalization, modiﬁcation
etc (e.g. phosphorylation, dephosphorylation, traﬃcking motifs, SH2 and
SH3 domains, glycosylation, lipidation, etc.). In contrast to domain recog-
nition, short linear peptide sequences are thought to be particularly diﬃcult
to identify due to their unordered structure [70]. NNAlign appears to be ide-
ally suited to identify such short linear peptide targets. Due to its simple
interface and robust performance, we believe the method to constitute a sig-
niﬁcant tool providing the non-bioinformatician end-user with the ability to
perform advanced bioinformatics-driven analysis of large-scale peptide data
sets.
2.1.4 M  M
MHC class I data set
The data set of quantitative peptide-MHC class I binding aﬃnity data pub-
lished by Peters et al. [57] contains data from 48 diﬀerent human, mouse,
macaque and chimpanzee alleles. We selected 12 representative human alle-
les, and extracted binding data for 9-mer peptidesmaintaining the subsets of
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the original benchmark. This allows comparing the performance ofNNAlign
to the other methods presented in the paper by Peters et al. .
MHC class II data set
A large set of over 17,000 HLA-peptide binding aﬃnities was published by
Wang et al. [37] containing data from several diﬀerent human alleles in-
cluding HLA DR, DP and DQ alleles. For each allele, the predictive per-
formance of various methods was estimated on the similarity reduced (SR)
data set, where sequence similarity is minimized in order to avoid overlap
between cross-validation subsets. We preserved the same subsets for our
cross-validation, for easy comparison of the results and predictive perfor-
mances.
Peptide arrays
Peptide arrays were synthesized by Schafer-N, Copenhagen, Denmark us-
ing a maskless photolithographic technique [71] in which 365 nm light is
projected onto NPPOC-photoprotected [72, 73] amino groups on a glass sur-
face in patterns corresponding to the synthesis ﬁelds. Details of the tech-
nique will be published elsewhere, but brieﬂy, the patterns were generated
using digital micromirrors and projected onto the synthesis surface using
UV-imaging optics. In each layer of amino acids, the relevant amino acids
were coupled successively to predeﬁned ﬁelds after UV-induced removal of
the photoprotection groups in those ﬁelds. The couplings were made us-
ing standard Fmoc-amino acids activated with HBTU/DIEA in NMP. After
coupling of the last Fmoc-amino acid in each layer, all Fmoc-groups were
removed in 20% piperidine in NMP and replaced by NPPOC groups cou-
pled as the chloroformate in DCM with 0.1 M DIEA. The procedure was
then repeated until all amino acids had been added to the growing peptide
chains. Final cleavage of side protection groups was performed in TFA:1,2-
ethanedithiol:water 94:2:4 v/v/v for 2 h at room temperature.
Trypsin data. Peptide arrays were incubated for 30 min at room tempera-
ture with 0.1 g/L bovine Trypsin (Sigma T9201) dissolved in 0.1 M Tris/Ac-
etate pH 8.0. After washing in the same buﬀer containing 0.1% SDS, the
slides were washed with deionized water and air-dried. Staining of amino
groups exposed by enzyme cleavage wasmade by incubation the slide for 30
min in 0.1 mg/mL Dylight549-NHS (Thermo Scientiﬁc) in 9:1 v/v n-methyl
pyrrolidone:0.1M n-methyl morpholine/HCl pH 8 for 10 minutes.
Chymotrypsin. Peptide arrays were incubated for 30 min at room tem-
perature with 0.1 g/L bovine Chymotrypsin (Sigma C4129) dissolved in 0.1
M Tris/Acetate pH 8.0. After washing in the same buﬀer containing 0.1%
SDS, the slides were washed with deionized water and air-dried. Staining
of amino groups exposed by enzyme cleavage was made by incubation of
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the slides for 10 min in 1 mM 5(6)-TAMRA (carboxytetramethylrhodamine,
Fluka 21953) activated with 1 eq HBTU, 2 eq DIEA in n-methylpyrrolidone.
Recording of signals from peptide arrays. After incubationwith activated
ﬂuorochromes, the peptide array slideswerewashed in the incubation buﬀer
without ﬂuorochrome followed by washings in n-methylpyrrolidone and
dichloromethane and air-dried. Images of the arrays were recorded using a
MVX10microscope equippedwith aMT10_D ﬂuorescence illumination sys-
tem and aXM10CCD camera (all fromOlympus). The excitationwavelength
was 530-550 nm and the emission ﬁlterwas 575-625 nm. The imageswere an-
alyzed using the PepArray analysis program (Schafer-N, Copenhagen Den-
mark).
The NNAlignWeb Server
Data pre-processing. The quantitative peptide data entered by the user is
rescaled to be between 0 and 1 before being fed to the neural network. The
user is also given the option to apply a logarithmic transformation to the
raw data, if its distribution appears to be too squashed towards low values.
Outliers deviating more than 3 standard deviations from the average, which
after rescaling would produce sparse regions in the spectrum with no data,
are set at a value of exactly 3 standard deviations. This procedure produces
ideal data for artiﬁcial neural network (ANN) training, with all values in the
range [0:1] and the bulk of the data in the central region of the spectrum. The
parameters for the rescaling function are deﬁned separately on each of the
training sets used in cross-validation, and then also applied to rescale their
relative test sets.
Subsets for cross-validation. In a n-fold cross-validation, n subsets are cre-
ated from the complete dataset, and at each step n-1 subsets are used for
training and 1 subset for testing. NNAlign oﬀers three alternatives to create
the subsets: i) random, splits the data into n subsets randomly; ii) homology
clustering, uses a Hobohm 1 algorithm [21] to identify sequences that share
an ungapped alignment with more than a speciﬁed fraction of matches; iii)
commonmotif clustering, looks for stretches of identical amino acid between
pairs of sequences as described by Nielsen et al. [53]. For both methods ii)
and iii) similar sequences are grouped together in the same subset, but it
is possible to choose to only include one representative for each group and
disregard the other sequences from training. In this phase, if the input data
contains repeated ﬂanks (as might be the case in peptide array experiments,
where linker sequences can be attached at the extremities of all peptides),
these ﬂanks are discarded, as they would aﬀect the overlap estimation. If
the user reckons that the repeated ﬂanks might contain meaningful biologi-
cal signal, an option allows retaining them in the training data. Note that in
common motif clustering, the motif length is taken as the smallest in the in-
terval of length given by the user. Thus, depending on the selected interval
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the subsets might be constructed in a diﬀerent way and that could inﬂuence
the cross-validated performance.
Neural network training. The neural network training is performed as de-
scribed by Nielsen et al. [36]. Initially, all network weights are assigned ran-
dom values. From the current network conﬁguration, the method selects the
optimal n-mer core (and potential peptide ﬂanking residues) for each of the
peptides within the training set. The network weights are next updated, to
lower the sum of squared errors between the observed and predicted score,
the cores are redeﬁned based on the new network conﬁguration, and the
procedure is iterated.
An ensemble of ANNs is trained on the cross-validation subsets, with
architecture parameters speciﬁed by the user. The motif length, encoding
of ﬂanks and peptide length determine the size of the input layer. If the
motif length is given as an interval of values, multiple runs of ANN train-
ing are performed on the diﬀerent lengths, and the length that produces
the best cross-validated performance in terms of root mean square error
(RMSE) is chosen for the ﬁnal ensemble. The number of hidden neurons
may be speciﬁed as a list of multiple values, so that an ensemble of net-
works is constructed with hidden layers of diﬀerent sizes. Each architecture
is trained multiple times, starting from diﬀerent initial random conﬁgura-
tions, to avoid as much as possible choosing sub-optimal solutions produc-
ing local minima. Sequences can be presented to the network either with
Sparse or Blosum encoding. In Sparse encoding, a vector of length N rep-
resents each amino acid, where all values are identical apart from the one
representing the observed amino acid. Blosum encoding, on the other hand,
takes into account amino acids similarity and partially allows substitutions
of similar amino acids while penalizing very dissimilar ones [22].
Performance measures. Cross-validation allows estimating a method per-
formancewithout the need of external evaluation data. The subsets reserved
as test-sets are run through the network trained in the same cross-validation
step, and Pearson's correlation, RMSE and Spearman correlation are calcu-
lated between observed and predicted values.
It is possible to use the internal subsets to stop the training phase on
the best test set performance in terms of RMSE. In this mode, performance
can be estimated in an exhaustive or in a fast way. Exhaustive n-fold cross-
validation (CV) consists of a nested CV procedure. At each step, 1 subset is
left out as evaluation set, and the remaining subsets are used to generate a
network ensemble in an n-1 CV training. In this CV training, the selected net-
work conﬁguration is the one that gives theminimumRMSE on the stopping
set. Next the predictions for the evaluation data are estimated as a simple av-
erage of the prediction values for each network in the training ensemble. The
exhaustive CVprocedure adds one level to the cross-validation and increases
greatly the running time. In alternative, the fast evaluation skips one nested
level by using the same subset for stopping and evaluating performance, for
a quicker but likely less accurate performance estimation.
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Final network ensemble. With cross-validated ANN training, each net-
work has been evaluated on data not included in the training. The net-
works can then be ranked by performance, and only the topN for each cross-
validation stepwill be included in the ﬁnal ensemble, withN speciﬁed by the
user. The ﬁnal network ensemble can be downloaded to local disk, and used
for predictions on new data by loading it to the NNAlign server submission
page.
Sequence motif logo. A list of 100,000 random naturally occurring pep-
tides with length L = motif length+ 2 ﬂank length, generated from ran-
dom UniProt [19] sequences, is presented to the individual networks in the
ensemble. For each network, the 1% peptides that obtain the highest predic-
tion scores are used to create a position speciﬁc scoring matrix (PSSM) that
represents the motif captured by the neural network. Using a Gibbs sampler
approach, all PSSMs are aligned to maximize the information content of the
combined matrix. This "oﬀset correction" step is obtained by repeatedly at-
tempting to shift the starting position of randomly chosen PSSMs, and ac-
cepting/rejecting the move according to the conventional Metropolis Monte
Carlo probability relation [74]:
Paccept = min(1, e
DI/T ) (2.1)
Where DI is the change in information content between the new and old
oﬀset conﬁguration and T is a scalar that is lowered during the calculation.
The process assigns to each PSSM, and to its relative network, an oﬀset value
that quantiﬁes the shift distance from other networks (see section 2.2 for de-
tails). The re-aligned cores from the 1% scoring of 100,000 peptides are ﬁnally
used to generate a combined sequence logowith theWebLogo program [28].
The oﬀset correction can be skipped if the user chooses to, and in this case
the logo is simply created by presenting the list of random peptides to the
ANN ﬁnal ensemble and selecting the 1% peptides that obtain the overall
best score.
Evaluation data. Additional data not included in the training can be up-
loaded to the NNAlign server as an evaluation set. Evaluation data must
be a list of peptides, with or without associated values, or a ﬁle in FASTA
format. In the ﬁrst case, all peptides are run through the trained network
ensemble, and scored accordingly to their best alignment core. If values
are provided together with peptides, they are assumed to be target val-
ues for validation purposes, and statistical measures between these values
and predictions are calculated. In the case a FASTA ﬁle is loaded as eval-
uation set, the sequences therein contained are cut into peptides of length
L = motif length + 2  ﬂank length, shifting the starting position of one
amino acid at a time. The generated peptides are all fed to the network to
identify those that most closely match the motif learned by the ANNs. The
results are sorted by prediction value, so that the best candidates are dis-
played at the top of the list.
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Making sequence logos
Sequence logos were introduced by Schneider et al. [26] as a way to repre-
sent graphically the pattern in a set of aligned sequences. The height Ri of
each column i in the logo is given as the information content in bits of the
alignment at that particular position, and for a suﬃciently large number of
sequences and a 20-letter alphabet it is calculated as:
Ri = log2 20+å
a
fa,i log2 fa,i (2.2)
where fa,i is the frequency of amino acid a at position i. The relative height
ha,i of amino acid a at position i is:
ha,i = Ri fa,i (2.3)
The value of Ri varies between 0, for a position with maximum entropy,
to log2 20, for a completely conserved position in the alignment. Thus, the
height of a column in the sequence logo indicates the importance of a certain
position in deﬁning the motif, and the height of each letter in the column the
amino acid preference at that position. Amino acid letters are colored ac-
cording to their chemical properties: polar amino acids (C, G, S, T, Y) are
shown in green and (N, Q) pink, basic (K. R, H) in blue, acidic (D, E) in red,
and hydrophobic (A, L, I, V, F, M, P, W) in black.
A C
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2.2 Oﬀset correction for ANN ensembles
Aneural network ensemble is a collection of networks aiming to describe the
sameproblem, butwhich generally diﬀer in their architecture (e.g. number of
hidden neurons or encoding scheme), their initial conﬁguration, or the sub-
set of the data used for training. Ensembles have been shown to be superior
to individual network in generalizing the description of many problems [75,
76]. After training a number of ANNs, their outputsmust be combined into a
single prediction for the ensemble. For regression tasks, predictions are often
combined by simply averaging the individual networks output values. For
classiﬁcation tasks (when examples are to be assigned to a discrete number
of categories), the consensus classiﬁcation is commonly chosen by amajority
vote. Many other methods exists (reviewed in [77]).
The NNAlign method presented in section 2.1 performs two tasks at the
same time: identiﬁcation of the alignment core and prediction of binding
aﬃnity. The ﬁrst is a classiﬁcation task, the second is a regression task. Fol-
lowing the paradigmdiscussed above, the optimal alignment core for a given
sequence is chosen by majority vote. Among all the possible alignment reg-
isters of a peptide, a democratic agreement of the ANNs determines the con-
sensus solution. As for the regression task, the ﬁnal prediction value is the
arithmetic mean of the outputs of all individual networks in the ensemble.
Ensembling networks was shown to give high performance in terms of
peptide-MHC class II binding prediction [36]. However, the identiﬁcation of
a common alignment for all the components in the ensemble presents some
challenges. As a consequence of diﬀerent training conditions (distinct sub-
sets, architecture or initial conﬁguration), distinct networks may disagree on
the precise boundaries of the alignment core. Althoughmost or all networks
may identify the fundamental pattern contained in the data, they may place
the motif anchors in diﬀerent core registers, especially if any of the extreme
positions of the binding motif is weak. This situation is exempliﬁed in ﬁg-
ure 2.3, where panels A to D show the sequence logos of four diﬀerent net-
works trained on HLA*DRB1-04:01 binding data. The salient features of the
peptide-MHC motif were captured by all networks, but were placed in dif-
ferent registers within the 9 amino acid core. Therefore, a direct overlay of
the individual motifs results in a muddled motif (panel E) and fails to create
a consensus motif for the ensemble. The networks, from the point of view of
the binding core, are unaligned.
Here, we describe a simple algorithm to calculate the extent of this net-
works misalignment, which we quantify with an ''oﬀset'' value for each net-
work, and by that construct a consensus motif for the complete network en-
semble.
2.2.1 PSSM representation of a network
The ﬁrst step is to translate the motif captured by each ANN into a position-
speciﬁc scoring matrix (PSSM). A large number of random natural peptides
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Figure 2.6. A schematic of the PSSMalignment algorithm. Eachmatrix, composed of Lc
rows and 20 columns, is elongated with ﬂanks composed of the background frequencies
(BG) of each amino acid. Then, the algorithm attempts to ﬁnd the optimal alignment that
maximizes the information content of the average matrix over a core of Lc positions. The
numerical values quantifying the shift from the original core position of each matrix are
called the oﬀset of each matrix.
(commonly 100,000) are presented separately to each network in the ensem-
ble. For each network, every peptide is assigned a prediction score and an
optimal binding core of length Lc. The core of the top 1% scoring peptides
is used to calculate the frequency of all 20 amino acids in each position of
the core. The result is a collection of frequency matrices, each correspond-
ing to a network, with size Lc  20. Finally, the matrices are all elongated
of Lc positions at both extremes, setting the amino acid frequencies at these
positions to the background frequencies (i.e. the relative occurrence of each
amino acid in natural sequences, see Table 1.1). The function of these ﬂanks
will be clear in the next section. The ﬁnal representation of each network
is thus a matrix composed of 20 columns (one per amino acid), and 3 Lc
rows, containing the frequency of a given amino acid at a given position in
the alignment.
2.2.2 Alignment of PSSMs
The algorithm for PSSM alignment is based on Gibbs sampling. Initially,
all matrices are assigned a random oﬀset between  Lc and +Lc. The oﬀset
value determines from which position, compared to the initial matrix with-
out ﬂanks, the core of the alignment starts for a certain matrix. For instance,
if at a given time a matrix has oﬀset = 2, the ﬁrst position in the alignment
core for this matrix is position 2, and the core extends to position Lc+ 2, thus
including 2 rows composed of background frequencies. The notation and an
example alignment is shown in ﬁgure 2.6.
Then, the algorithm performs a number of iterations to ﬁnd the optimal
alignment (the optimal set of oﬀset values) for the set of matrices. At each
iteration, the algorithm attempts one of two possible moves: i) a single shift
move or ii) a phase shift move. In the single shift move, one PSSM is cho-
sen randomly, and it is shifted to the right or to the left by assigning a new
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random oﬀset value to the matrix. In the phase shift move, the entire align-
ment is shifted a random number of positions to the left or right. A move
therefore produces a new candidate set of oﬀset values. In the new conﬁg-
uration of oﬀsets, a consensus matrix is calculated by averaging the amino
acid frequencies of all matrices on the alignment core. We can then evaluate
the information content of this average matrix using
E =
Lc
å
i=1
20
å
A=1
pi,A log
pi,A
qA
(2.4)
where pi,A is the frequency of amino acid A at position i, and qA is the
background frequency of amino acid A as in table 1.1.
Whether themovewas favorable or not to the energy of the system, can be
estimated by comparing the information content before and after the move,
obtaining
DE = E1   E0 (2.5)
The probability of accepting a move is given by the conventional
Metropolis Monte Carlo relationship
Paccept = min(1, e
DE
T ) (2.6)
where T is a scalar progressively lowered during the iterations, com-
monly called the ''temperature'' of the system. If DE is positive, a move will
always be accepted. Moves that lower the energy of the system (DE < 0)
are only accepted with a certain probability, which depends on the value of
T. Initially when the temperature T is high many moves, also unfavorable
ones, will be accepted. But as T is lowered and the system gets colder, fewer
and fewer moves with DE < 0 are accepted and the system converges to an
energy maximum.
Eventually, when the temperature reaches itsminimumand the iterations
are over, each matrix has assigned an optimal oﬀset value that maximize the
information content of the alignment (Figure 2.6). The oﬀset value quantiﬁes,
for each matrix, the relative distance from the optimal alignment core.
2.2.3 Including oﬀset in ANN predictions
Once the oﬀset values have been calculated using the PSSM alignment dis-
cussed in the previous section, incorporation of the oﬀsets into the neural
networks ensemble is straightforward. Each network inherits the oﬀset val-
ues of its corresponding PSSM. At prediction time, the starting position in
the core for a given query sequence is simply shifted by on positions, with on
being the oﬀset value for network n in the ensemble. In the next chapter we
show how oﬀset correction, by combining signals from distinct neural net-
works, contributed to enhance the characterization of molecules with very
weak binding motifs.

Chapter 3
The binding motifs of HLA-DP
and DQ molecules
I  the previous chapter, we demonstrated the power of artiﬁcial neu-ral networks in identifying weak sequence motifs in unaligned pep-tide data. Here, after discussing brieﬂy the function and current un-
derstanding of HLA class II molecules, we show how the NNAlign method
was applied to characterize, at an unprecedented level of detail, the binding
speciﬁcities of 5 HLA-DP and 6 HLA-DQ molecules among the most com-
mon in the human population.
3.1 HLA class II molecules
Human major histocompatibility complex (MHC) molecules are surface re-
ceptors encoded in a large genomic region of chromosome 6, commonly re-
ferred to as the human leukocyte antigen (HLA) system (Figure 3.1). MHC
class II molecules, in particular, present antigens in form of short peptides
derived from extracellular proteins. Such peptide antigens, potentially orig-
inated from extracellular pathogens, are brought to the cell membrane for
presentation to CD4+ (helper) T-cells. If the antigen is recognized as for-
eign, the helper T-cells contribute in initiating an immune cascade aimed to
destroy the pathogen.
The three HLA class II loci DR, DP and DQ are among the most geneti-
cally variable loci in the human genome, resulting in a very large number of
allelic variations and phenotypes in the world population [78]. In HLA-DR
molecules the polymorphism is limited to the b chain, so that variants are
commonly simply identiﬁed by their DRB genetic locus (e.g. DRB1*01:01).
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Conversely, in HLA-DP and DQ both the a and the b chain are highly poly-
morphic, and both the A1 and B1 loci are used to identify the serotype (e.g.
DQA1*01:01-DQB1*05:01).
The binding speciﬁcity of HLA-DR molecules (i.e. which peptides are
recognized by the MHC molecule) are relatively well studied and charac-
terized. Among hundreds of knownHLA-DR variants, only for a small frac-
tion there is a considerable amount of measured peptide binding aﬃnities.
However, even in absence of experimental data, pan-speciﬁc bioinformatics
methods have successfully been applied to predict the binding speciﬁcity of
most knownHLA-DR alleles [79, 80]. Much less is known about the peptide-
binding repertoire of HLA-DP and DQ molecules. Most studies have tar-
geted only speciﬁc variants suspected to be associatedwith disease, and have
generally been performed on a small scale. Given such scarcity of data, a de-
tailed characterization of the binding speciﬁcity of these molecules has not
been thus far possible. Only recently larger data sets of binding data for
HLA-DP and DQ molecules have been published. In particular, Wang et al.
[37] released an unprecedentedly large set of measured MHC class II aﬃni-
ties covering 26 allelic variants, including a total of about 17,000 aﬃnitymea-
surements for 5 DP and 6 DQ molecules. In the following section, we show
how the NNAlign method was employed to ﬁnely characterize the binding
speciﬁcities of these molecules, and display them as sequence logos. To the
best of our knowledge, no previous studies could provide such a quantita-
tive measure of the importance of each position, and relative importance of
diﬀerent amino acids, in the binding core of the HLA molecules.
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Figure 1. Gene map of the human leukocyte antigen (HLA) region. The HLA region spans 4 ! 106 nucleotides
on chromosome 6p21.1 to p21.3, with class II, class III and class I genes located from the centromeric (Cen) to
the telomeric (Tel) end. HLA class I molecules restrict CD8+ cytotoxic T lymphocyte function and mediate
immune responses against ‘endogenous’ antigens and virally infected targets, whereas HLA class II molecules
are involved in the presentation of ‘exogenous’ antigens to T helper cells. The HLA class III region contains
many genes encoding proteins that are unrelated to cell-mediated immunity but that nevertheless modulate or
regulate immune responses in some way, including tumour necrosis factor (TNF), heat shock proteins (Hsps)
and complement proteins (C2, C4) (fig001nmn).
the " and # chains (encoded by the respective
second exons).
Function
The MHC class I and class II antigens are cell-
surface glycoproteins that dictate the T-cell-
mediated immune response and their prime
function is antigen presentation to effector cells
(reviewed in Ref. 15). HLA molecules interact with
the antigen-specific TCR to provide a context for
the recognition of antigens by T cells, thereby
bringing about T-cell activation and resulting in
an immune response. HLA class I-encoded
molecules restrict CD8+ CTL function and mediate
immune responses against ‘endogenous’ antigens
and virally infected targets, and are present on
the surface of almost all nucleated cells. By
contrast, HLA class II molecules are involved in
the presentation of ‘exogenous’ antigens to CD4+
T helper (Th) cells and are present on the
surface of special immunocompetent cells
called the antigen-presenting cells (APCs) such
as macrophages/monocytes, dendritic cells,
activated T cells and B cells. The HLA class III
region contains more than 75 genes encoding
proteins that are unrelated to cell-mediated
immunity but that nevertheless modulate or
regulate immune responses in some way. These
include tumour necrosis factor (TNF), heat shock
proteins (Hsps) and complement proteins (Ref.
16). Since HLA molecules play a central role in
mounting and regulating the immune response,
they also play an important role in influencing
resistance (protection) and susceptibility to
disease.
MHC–peptide interactions: implications
of genetic polymorphism
X-ray crystallography studies (Refs 17, 18) have
helped significantly in understanding how
peptides interact with, and anchor to, the
peptide-binding pockets of MHC proteins (Fig.
2). All stable HLA molecules on the cell surface
contain a tightly bound peptide 8–10 amino acids
in length for class I molecules and 12–24 amino
acids in length for class II molecules. The peptide
Gene map of the human leukocyte antigen (HLA) region
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Figu e 3.1. Gene ma of the human leukocyte antigen (HLA) region. HLA lass I
molecules present peptides derived from cytosolic proteins; HLA class II molecules sam-
ple peptides from extracelllular proteins; HLAs corresponding to MHC class III mainly
encode components of the complement system. Adapted fromMehra & Kaur [81]
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Abstract
ComparedwithHLA-DRmolecules, the speciﬁcities ofHLA-DP and
HLA-DQ molecules have only been studied to a limited extent. The de-
scription of the binding motifs has been mostly anecdotal and does not
provide a quantitative measure of the importance of each position in
the binding core and the relative weight of diﬀerent amino acids at a
given position. The recent publication of larger data sets of peptide-
binding to DP and DQ molecules opens the possibility of using data-
driven bioinformatics methods to accurately deﬁne the binding motifs
of these molecules. Using the neural network-based method NNAlign,
we characterized the binding speciﬁcities of ﬁve HLA-DP and six HLA-
DQ among the most frequent in the human population. The identiﬁed
binding motifs showed an overall concurrence with earlier studies but
revealed subtle diﬀerences. The DP molecules revealed a large over-
lap in the pattern of amino acid preferences at core positions, with con-
served hydrophobic/aromatic anchors at P1 and P6, and an additional
hydrophobic anchor at P9 in some variants. These results conﬁrm the ex-
istence of a previously hypothesized supertype encompassing the most
common DP alleles. Conversely, the binding motifs for DQ molecules
appearmore divergent, displaying unconventional anchor positions and
in some cases rather unspeciﬁc amino acid preferences.
3.2.1 I
TheMHCperforms an essential role in the cellular immune system, and reg-
ulates immune responses through presentation of processed antigens to T
lymphocytes. The MHC is also widely studied because of its association
with many autoimmune and inﬂammatory diseases, including type I dia-
betes, rheumatoid arthritis, multiple sclerosis and Crohn's disease, and cer-
tain MHC alleles have been linked to susceptibility to infectious diseases
such as malaria and HIV (reviewed in [82]).
Unlike MHC class I, which samples peptides from cytosolic proteins,
MHC class II molecules present short peptide sequences derived from ex-
tracellular proteins. Human MHC class II molecules are heterodimers con-
sisting of an a-chain and a b-chain encoded on chromosome 6 in one of three
HLA loci: DR, DP and DQ. Compared with DR molecules, the speciﬁcities
of DP and DQ molecules have only been studied to a limited extent, and
their binding motifs are poorly characterized and understood. The scarcity
of binding data for DP and DQ molecules is mainly the result of the rela-
tive diﬃculty, compared with HLA-DR, of obtaining experimental binding
data for thesemolecules, but the common assumption that DRmolecules are
more important in mediating immune responses has exacerbated the lack of
information on DP and DQ. However, a growing number of reports asso-
ciate certain DP and DQ alleles with several diseases, such as type I diabetes
and coeliac disease [82, 83, 84], as well as in cancer [85, 86, 87].
This gap in knowledge between DR and the other class II molecules has
only recently begun to be ﬁlled, with the publication of larger sets of binding
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data for HLA DP and DQ molecules. In particular, a recent study by Wang
et al. [37] describes the release of an unprecedentedly large set of measured
MHC class II binding aﬃnities covering 26 allelic variants, including a total
of about 17 000 aﬃnitymeasurements for ﬁve DP and six DQmolecules. The
same study also compared the predictive performance of some of the best
available bioinformatics methods on these data, and found that it was possi-
ble to obtain reliable binding predictions for DP andDQ at levels comparable
to those for DR molecules. The same group, in two additional publications
[88, 89] attempted to characterize the binding speciﬁcities of a number of DP
and DQmolecules using amatrix method called ARB (average relative bind-
ing) [90]. However, this method has been shown to perform signiﬁcantly
worse than other comparable approaches for MHC class II binding predic-
tion, such as the NN-align method [36]. In this report, we applied the latest
version of the NN-align algorithm, implemented as the NNAlignweb-server
[91], to exploit the newly available large data sets of peptide binding aﬃnity
to DP and DQ molecules and ﬁnely characterize the binding speciﬁcities of
11 DP and DQ molecules.
3.2.2 M  M
NNAlign is a neural network-based method speciﬁcally designed to iden-
tify short linear motifs contained in large peptide data sets. As a direct re-
sult of the method, it identiﬁes a core of consecutive amino acids within the
peptide sequences that constitutes an informative motif. The method has
been shown to perform signiﬁcantly better than any other publicly avail-
able method for MHC class II binding prediction, including HLA-DP and
HLA-DQ molecules [37]. One of the strengths of this approach is the use
of multiple neural networks, trained with diﬀerent architectures and initial
conditions, to reduce stochastic factors and at the same time combine infor-
mation from the diﬀerent networks in the ensemble to obtain a prediction
that is better than what can be obtained from the individual networks. Al-
though this ensemble approach has earlier proved to be highly eﬀective in
terms of improving the accuracy for binding aﬃnity predictions [36], it has
been demonstrated that the use of network ensembles could lead to a loss
in accuracy when it comes to identiﬁcation of the motif binding core [91].
However, using an oﬀset correction algorithm implemented inNNAlign, this
problem is resolved allowing not only improved predictive performance for
network ensembles but also a more accurate representation of the identiﬁed
sequence motif.
In this report, we applied NNAlign to peptide￿MHC class II binding data
for ﬁveHLA-DP and sixHLA-DQmolecules to characterize their speciﬁcities
and bindingmotifs. The binding data were obtained from the publication by
Wang et al. [37]. They comprise a total of 17092 measured peptide￿MHC
aﬃnities, with an average of over 1500 measurements per allelic variant.
Each data set was split in ﬁve random subsets and, each time excluding one
subset, a network was trained on the remaining four subsets. We set the mo-
tif length to nine amino acids, and for all the remaining parameters we used
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the default values of the NNAlign web server: sequences were presented to
the networks using Blosum encoding [22], hidden layers were composed of
three neurons, training lasted 500 iterations per training example, starting
from ﬁve diﬀerent initial conﬁgurations for each cross-validation fold, sub-
sets for cross-validation were created using a homology clustering at 80%
to reduce similarity between subsets, using the best four networks for each
cross-validation step.
The resulting 20 networks in each ensemble, trained on diﬀerent subsets
of the data and from alternative initial conditions, capture motifs that can
be diﬀerent from each other to some extent. They often place the alignment
core in a diﬀerent register, and might disagree on the exact boundaries of
the motif. The oﬀset correction algorithm described by Andreatta et al. [91]
proved extremely eﬃcient in correcting for this disagreement, allowing re-
alignment of diﬀerent networks to a common core. This alignment proce-
dure creates a position-speciﬁc scoring matrix (PSSM) representation of the
motif of each network, and then aligns the matrices to maximize the infor-
mation content of the combined core. We used a slightly modiﬁed version
of the algorithm described in detail in a previous publication [91], where
PSSMs are extended at both ends with background frequencies before align-
ment, so allowing the PSSMs to be aligned on awindowof the same length as
the matrices. This process assigns to each PSSM, and its relative network, an
oﬀset value that quantiﬁes the shift distance from other networks. Note that
the alignment procedure does not guarantee that the ﬁnal combined register
corresponds to the biologically correct register (in the case of peptide￿MHC
binding, the nine-amino-acid stretch bound in the MHC binding cleft), but
rather to the window with the maximum information content. In most of
the cases informative positions are also biologically important positions, so
the core register would be in the correct place. However, if either terminal
of the core has very weak information content (i.e. no particular amino acid
preference at terminal positions), the sequences might possibly, although
aligned correctly, all be shifted by one or more positions with respect to the
biologically correct core register. This is an aspect to keep in mind when
interpreting the results, and possibly adjust the register based on previous
knowledge about the location of the motif anchors.
An eﬀective way of visualizing the receptor-binding motif is by using se-
quence logos. Sequence logos were introduced by Schneider and Stephens
[26] to graphically represent the sequence motif contained in a set of aligned
sequences, where at each position, the frequency of all amino acids is dis-
played as a stack of letters. The height of a column in the logo is given as
the information content in bits of the alignment at that particular position,
and the relative height of individual letters is proportional to the frequency
of the corresponding amino acid at that position. In this paper, we use such
sequence logos to display the HLA-DP and HLA-DQ binding speciﬁcities
identiﬁed by NNAlign.
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3.2.3 R  D
HLA-DP
The ﬁve HLA-DP allelic variants were chosen by Wang et al. [37] to cover
a high percentage of the human population. Only considering the b-chain,
more polymorphic than the a-chain and the main determinant for HLA-DP
binding [92, 93], the allele choice provides coverage of about 92% of the av-
erage population at the DPB1 locus [89].
The sequence motifs identiﬁed by NNAlign for the ﬁve HLA-DP
molecules are shown in Figure 3.2. In general, all variants share a com-
mon pattern characterized by anchors at positions P1 and P6, with strong
preferences for phenylalanine (F) and other aromatic or hydrophobic amino
acids. Additionally, some molecules appear to have a hydrophobic pref-
erence at P9 especially for leucine (L). This P9 anchor was previously de-
scribed for DPB1*04:02 [94], but here we observe it also for other variants
such as DPA1*02:01-DPB1*01:01 and DPA1*02:01-DPB1*05:01. In some in-
stances, and notably for DPA1*03:01-DPB1*04:02, the residues at position P7
appear to have inﬂuence on the binding speciﬁcity of the molecule. This has
not been described in previous reports. Another small exception to the P1-P6
hydrophobic/aromatic pattern is observed in the allelic variant DPA1*02:01-
DPB1*05:01, where the positively charged amino acids R and K are moder-
ately preferred at P1 together with hydrophobic ones, as was also previously
noted [89].
Taken as a whole, there appears to be a large overlap in the peptide-
binding speciﬁcities of the ﬁve DP molecules, characterized by strong hy-
drophobic/aromatic anchors at P1 and P6, with the few exceptions noted
above. Consistent with these observations, previous studies have found con-
siderable overlaps in the peptide repertoires that can bind diﬀerent DP alle-
les, and suggested the existence of a DP supertype encompassing the most
common variants [89, 94]. Greenbaum et al. [95] on the basis of shared bind-
ing repertoires, suggested the presence of two DP supertypes: a ￿main DP￿
supertype (composed of DPB1*01:01, 05:01 and 04:02) and a DP2 supertype
(DPB1*02:01 and 04:01). These two subgroups correspond, in our analysis, to
molecules with a strong P9 anchor (main DP) as opposed to molecules with
weak or no P9 hydrophobic preference (DP2).
HLA-DQ
Most eﬀorts in characterizing HLA-DQ binding speciﬁcities have been di-
rected towards a few selected molecules, such as DQA1*05:01-DQB1*02:01
(also known as DQ2) or DQA1*03:01-DQB1*03:02 (DQ8) because of their as-
sociation with disease [96, 97, 98]. The data published by Wang et al. [37]
aim to be more comprehensive in terms of human population coverage, and
they include binding data for the six most common allelic variants across
diﬀerent ethnicities.
The HLA-DQ sequence motifs identiﬁed by NNAlign are shown in Fig-
ure 3.3. In contrast to the DP variants, which appear to share a common
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position. In this paper, we use such sequence logos to dis-
play the HLA-DP and HLA-DQ binding specificities iden-
tified by NNAlign.
Results and discussion
HLA-DP
The five HLA-DP allelic variants were chosen by Wang
et al.7 to cover a high percentage of the human popula-
tion. Only considering the b-chain, more polymorphic
than the a-chain and the main determinant for HLA-DP
binding,15,16 the allele choice provides coverage of about
92% of the average population at the DPB1 locus.9
The sequence motifs identified by NNAlign for the five
HLA-DP molecules are shown in Fig. 1. In general, all vari-
ants share a common pattern characterized by anchors at
positions P1 and P6, with strong preferences for phenylala-
nine (F) and other aromatic or hydrophobic amino acids.
Additionally, some molecules appear to have a hydropho-
bic preference at P9 especially for leucine (L). This P9
anchor was previously described for DPB1*04:02,17 but
here we observe it also for other variants such as
DPA1*02:01-DPB1*01:01 and DPA1*02:01-DPB1*05:01.
In some instances, and notably for DPA1*03:01-
DPB1*04:02, the residues at position P7 appear to have
influence on the binding specificity of the molecule. This
has not been described in previous reports. Another small
exception to the P1–P6 hydrophobic/aromatic pattern is
observed in the allelic variant DPA1*02:01-DPB1*05:01,
where the positively charged amino acids R and K are
moderately preferred at P1 together with hydrophobic
ones, as was also previously noted.9
Taken as a whole, there appears to be a large overlap in
the peptide-binding specificities of the five DP molecules,
characterized by strong hydrophobic/aromatic anchors at
P1 and P6, with the few exceptions noted above. Consis-
tent with these observations, previous studies have found
considerable overlaps in the peptide repertoires that can
bind different DP alleles, and suggested the existence of a
Figure 1. Sequence logos for five HLA-DP molecules. Hydrophobic amino acids are shown as black, acidic amino acids as red, basic amino acids
as blue, neutral and polar amino acids as green and pink. All variants appear to share two main hydrophobic/aromatic anchors at P1 and P6,
with an additional P9 anchor for some variants.
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Figure 3.2. Sequence logos for ﬁve HLA-DP molecules. Hydrophobic amino acids are
shown s black, acidic amino acids as red, basic amino acids as blue, neutral and polar
amino acids as green and pink. All variants appear to share two main hydrophobic/aro-
matic anchors at P1 and P6, with an additional P9 anchor for some variants.
supertypical pattern, the DQ molecules show very little overlap in speci-
ﬁcity. There do not appear to be common amino acid preferences, and the
anchors are found at diﬀerent positions within the 9-mer core. In particular,
DQA1*01:01-DQB1*05:01 shows a strong preference for aromatic residues (F,
W, Y) at P5, and secondary anchors at P6 and P7. The only previous report
addressing the binding motif of this molecule [88] also found a dominant
anchor characterized by a preference for W and F, but placed this anchor at
P4, and is generally in disagreement with our ﬁndings on other positions.
The binding motif for DQA1*01:02-DQB1*06:02 appears loose, with several
amino acids allowed at most positions. Previous reports [99, 100] identiﬁed
mainly a P4-P6-P9 anchor spacing, with small and hydrophobic residues at
P4, hydrophobic/aliphatic amino acids such as I, L, M, V at P6, and small
residues like A and S at P9. Similar amino acid preferences are reﬂected
in the binding motif detected by NNAlign, with additional anchors at P3
and P7. The only pair of molecules that appear to have a somewhat sim-
ilar speciﬁcity is composed of DQA1*03:01-DQB1*03:02 and DQA1*04:01-
DQB1*04:02. Both show a dominant anchor at P9, with preference for the
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DP supertype encompassing the most common vari-
ants.9,17 Greenbaum et al.,18 on the basis of shared binding
repertoires, suggested the presence of two DP supertypes:
a ‘main DP’ supertype (composed of DPB1*01:01,
05:01 and 04:02) and a DP2 supertype (DPB1*02:01 and
04:01). These two subgroups correspond, in our analysis,
to molecules with a strong P9 anchor (main DP) as
opposed to molecules with weak or no P9 hydrophobic
preference (DP2).
HLA-DQ
Most efforts in characterizing HLA-DQ binding specifici-
ties have been directed towards a few selected molecules,
such as DQA1*05:01-DQB1*02:01 (also known as DQ2) or
DQA1*03:01-DQB1*03:02 (DQ8) because of their associa-
tion with disease.19–21 The data published by Wang et al.7
aim to be more comprehensive in terms of human popula-
tion coverage, and they include binding data for the six
most common allelic variants across different ethnicities.
The HLA-DQ sequence motifs identified by NNAlign
are shown in Fig. 2. In contrast to the DP variants, which
appear to share a common supertypical pattern, the DQ
molecules show very little overlap in specificity. There do
not appear to be common amino acid preferences, and the
anchors are found at different positions within the 9-mer
core. In particular, DQA1*01:01-DQB1*05:01 shows a
strong preference for aromatic residues (F, W, Y) at P5,
and secondary anchors at P6 and P7. The only previous
report addressing the binding motif of this molecule8 also
found a dominant anchor characterized by a preference
for W and F, but placed this anchor at P4, and is gener-
ally in disagreement with our findings on other positions.
The binding motif for DQA1*01:02-DQB1*06:02 appears
loose, with several amino acids allowed at most positions.
Previous reports22,23 identified mainly a P4–P6–P9 anchor
spacing, with small and hydrophobic residues at P4,
hydrophobic/aliphatic amino acids such as I, L, M, V at
P6, and small residues like A and S at P9. Similar amino
acid preferences are reflected in the binding motif
detected by NNAlign, with additional anchors at P3 and
P7. The only pair of molecules that appear to have a
somewhat similar specificity is composed of DQA1*03:01-
DQB1*03:02 and DQA1*04:01-DQB1*04:02. Both show a
Figure 2. Sequence logos for six HLA-DQ molecules. Most of the variants display unique anchor positions and spacing, and very diverse amino
acid preferences.
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Figure 3.3. Sequence logos for six HLA-DQ molecules. Most of the variants display
unique anchor positions and spacing, and very diverse amino acid preferences.
acidic residues E and D. Additionally, they both show a preference for hy-
drophobic amino acids at P6, and mainly for A or E at P8. The strong acidic
anchor at P9 was observed before [96, 101]. In the case of DQA1*05:01-
DQB1*02:01, previous studies describe a motif with P1 and P9 binding pock-
ets with hydrophobic/aromatic preferences, and acidic residues in the cen-
tre of the core, particularly at P4, P6 and P7 [88, 101, 102, 103, 104, 105]. Be-
sides the hydrophobic/aromatic P1-P9,NNAlign places the strongest anchor
at P7, but with preferences for glutamic acid (E) also at P6 and P8. Finally,
the somewhat peculiar sequence motif of DQA1*05:01-DQB1*03:01 seems to
just prefer small amino acids such as A, G and S, especially on the central
positions of the core, in agreement with the motif previously suggested for
this molecule [88].
It is evident that the peptide-binding speciﬁcities for HLA-DQ variants
are much more diverse than for HLA-DP variants. In particular, the strong
hydrophobic/aromatic P1 anchor that generally characterizes all known
HLA-DR andDPmolecules is not observed here. There appears to be no gen-
eral pattern in the spacing of the anchors, as well as in the kinds of permitted
amino acids. In particular, we ﬁnd a preference for acidic amino acids close
to or at the C-terminal of the binding motif for three of the six molecules,
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and generally, the motifs seem rather promiscuous, with several residues
allowed in the binding groove of the MHC.
3.2.4 C
In this report, we applied a state-of-the-art neural network-based method,
NNAlign, to characterize the binding speciﬁcities of ﬁve HLA-DP and six
HLA-DQ molecules. The allelic variants are among the most common hu-
man MHC class II molecules at the two HLA loci DP and DQ, covering a
large percentage of the human population [88, 89].
For what concerns HLA-DP, there appears to be a common pattern in
all the ﬁve variants under consideration, with primary anchor positions at
P1 and P6 with preference for hydrophobic and aromatic residues. Some
variants show an additional hydrophobic anchor at P9 and other minor dif-
ferences, but in general there appears to be a consistent overlap in the bind-
ing speciﬁcities of all ﬁve molecules. The same cannot be said for HLA-DQ,
where most of the molecules have very diﬀerent anchor positions, anchor
spacing and amino acid preferences. Hence, there does not seem to be a
supertypical mode of binding for DQ, and each variant appears to be char-
acterized by a distinct binding speciﬁcity. The most striking observation for
the DQ loci bindingmotifs is the preference for acidic amino acids close to or
at the C-terminal of the binding groove. Such an amino acid preference has
not, to the best of our knowledge, previously been described for any HLA
class I molecules, and has only sporadically been reported for HLA class II
molecules. Binding predictions (including identiﬁcation of the binding core)
for any peptide sequence to all the alleles described in this report can be ob-
tained at the NetMHCII server (http://www.cbs.dtu.dk/services/NetMHCII).
The binding motifs described in this work conﬁrm most of the obser-
vations brought up by previous studies, but also highlight some interest-
ing diﬀerences. Importantly, the sequence logo representation provides a
quantitative measure of the relevance of each position in the binding core,
and the relative importance of each amino acid, in determining the speci-
ﬁcities of a given molecule, a diﬀerentiation that was not obtained in pre-
vious studies. The study ﬁrst and foremost demonstrates the power of the
NNalign method to, in a fully automated manner, identify and character-
ize the receptor-binding motif from a set of peptide-binding data. Secondly,
it underlines the importance of generating such peptide data sets to carry
out receptor-binding motif characterizations, gain insights into the peptide-
binding repertoire of MHCmolecules and reveal details about which amino
acids and amino acid positions are critical for binding and, potentially, for
peptide immunity.
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Chapter 4
Identifying multiple speciﬁcities
in peptide data
C  2 and 3 addressed the problem of identifying sequence mo-tifs in unaligned peptide data. In these chapters, it was shown howartiﬁcial neural networks could be used to ﬁnd the optimal local
alignment in sets of peptide data and at the same time produce quantitative
predictions for new occurrences of the identiﬁed sequence motif. As dis-
cussed in section 1.4, ANNs have the power of capturing higher-order cor-
relations between positions in a motif. Thus, if presence of a given residue
at some position inﬂuences the amino acid preference at another position,
such correlation can be eﬀectively captured by ANNs with hidden neurons.
Non-linearmodels such as ANNs are very powerful for learning and pre-
dicting patterns. However, in presence of positional correlations this non-
linearity poses some diﬃculties when it comes to visualizing and interpret-
ing the identiﬁed sequence motifs. A sequence logo can only show amino
acid preferences in a linear fashion and assumes that positions are indepen-
dent from each other. For example, imagine that a certain receptor displays
a preference for ligands with a charged residue at one of two adjacent posi-
tions, but not at both positions at the same time. The relationship regulating
this interaction is a XOR (or "exclusive disjunction"), where the binding event
occurs only if exactly one of the two positions presents a charged amino acid.
This relationship, though rather simple, is not linear and cannot be repre-
sented by a sequence logo. Attempting to plot instances of the binding motif
with a linear device such as a sequence logo would give the erroneous im-
pression that charged residues are allowed simultaneously at both positions,
while they should be mutually exclusive.
The problem can be made linear by considering the two mutually exclu-
sive conditions as two separate "classes" of binders. That is, creating two
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separate clusters containing peptides with one or the other mode of bind-
ing. The logo representation of the two clusters would now truthfully spec-
ify the preference for a charged residue at one of the two positions, but not
at both positions. Generalizing from this simple example, we can imagine
representing a binding motif that contains positional correlations by subdi-
viding its positive instances into a number of clusters devoid of positional
correlations.
In a recent study Gfeller et al. [24] showed that positional correlations are
widespread in peptide recognition domains, and that such positional corre-
lations originate from the multiple speciﬁcity of the receptors. The speci-
ﬁcities of these domains can be represented by multiple PSSMs, allowing
the visualization of the diﬀerent binding modes by multiple sequence logos
[24, 106]. Signals of higher order correlation between diﬀerent amino acids
have been found in MHC binding peptides [25], and in these cases the in-
vestigation of sub-speciﬁcities for individual molecules may elucidate their
mechanism of binding.
In the following paper, we propose amethod for the identiﬁcation ofmul-
tiple speciﬁcities in peptide data sets. The novelty of the Gibbs clustering
algorithm lies in its ability to simultaneously align and cluster peptide data.
Other available methods are limited to one of these aspects at a time, dealing
only with single speciﬁcities or requiring the data to be pre-aligned prior to
clustering [33, 91, 24, 69, 107]. We show applications of themethod to a range
of diﬀerent benchmark data sets, including pre-aligned and unaligned pep-
tide data covering the MHC class I, MHC class II and SH3 domain systems.
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Abstract
Motivation: Proteins recognizing short peptide fragments play a
central role in cellular signaling. As a result of high-throughput tech-
nologies, peptide-binding protein speciﬁcities can be studied using large
peptide libraries at dramatically lower cost and time. Interpretation of
such large peptide data sets however is a complex task, especially when
the data contain multiple receptor binding motifs, and/or the motifs are
found at diﬀerent locations within distinct peptides.
Results: The algorithm presented in this paper, based on Gibbs sam-
pling, identiﬁes multiple speciﬁcities in peptide data by performing
two essential tasks simultaneously: alignment and clustering of peptide
data. We apply the method to de-convolute binding motifs in a panel
of peptide data sets with diﬀerent degrees of complexity spanning from
the simplest case of pre-aligned ﬁxed-length peptides, to cases of un-
aligned peptide data sets of variable length. Example applications de-
scribed in this paper include mixtures of binders to diﬀerent MHC class
I and class II alleles, distinct classes of ligands for SH3 domains, and
sub-speciﬁcities of the HLA-A*02:01 molecule.
Availability: The Gibbs clustering method is available online as a web
server at http://www.cbs.dtu.dk/services/GibbsCluster
Contact: mniel@cbs.dtu.dk
Supplementary information: Supplementary Data are available at
Bioinformatics online.
4.1.1 I
Peptides are short amino acid sequences occurring ubiquitously in biological
processes, such as metabolism, signal transduction and immune response.
They are also extensively used in research to mimic functional or (linear)
structural aspects of proteins and protein interactions. The advantage of us-
ing peptides lies in the relative ease in generating large libraries of sequences,
such as in phage display technologies [3, 108]. More recently, developments
in high-throughput peptide microarrays have allowed producing large-scale
data sets of peptide-ligand interactions, and have been applied to various
problems including antibody-antigen interactions, peptide-MHC binding,
kinase binding motifs and other receptor-ligand interactions [4, 13, 42, 109].
Identifying receptor-ligand binding motifs within peptide data sets is a
highly challenging task for at least two major reasons which we term align-
ment and poly-speciﬁcity. The alignment problem arises because most re-
ceptor motifs are weak and short making identiﬁcation of the binding reg-
ister within the ligands not trivial [33]. The poly-speciﬁcity problem arises
because receptor-ligand data sets often contain multiple motifs either due
to the experimental setup or to the actual poly-speciﬁcity of the receptor
[110]. Several bioinformatics methods have been developed attempting to
deal with these challenges and detect subtle sequence signals in peptide data
sets, including motif alignment [69], Gibbs sampling [34], Hidden Markov
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Models [35] and artiﬁcial neural networks [36]. In particular, artiﬁcial neu-
ral networks (ANNs) have shown a high performance on this kind of data
[37, 91]. Signiﬁcant correlations between residues have been found in pep-
tide interaction domains [24]. Although positional correlations can be accu-
rately captured byANNs, the speciﬁcities of such domains can inmany cases
more intuitively be represented by multiple position-speciﬁc scoring matri-
ces (PSSM) [24, 106, 107]. Multiple PSSMs allowvisualizing poly-speciﬁcities
as sequence logos of the diﬀerent binding modes.
While the above methods attempt to deal with the challenges involved in
motif identiﬁcation in peptide data sets, they all suﬀer from the limitations
of only dealing with single speciﬁcities or requiring the input data to be pre-
aligned to a common motif. In this paper, we describe a novel approach for
eﬀective alignment and clustering of peptide data going beyond these limi-
tations. In the Gibbs clustering method, alignment and speciﬁcity clustering
are performed simultaneously by sampling the space of possible solutions
using a Gibbs sampling strategy. Each cluster is represented by a PSSM, and
the method aims at maximizing the information content of individual ma-
trices while minimizing the overlap between distinct clusters.
4.1.2 D 
MHC class I data
The MHC class I data set was extracted from the Immune Epitope Database
[111]. We selected representative alleles for each of the 12 HLA supertypes
identiﬁed by Lund et al. [8], and considered as binders all peptides with
aﬃnity < 500nM. The representative alleles for each supertype are: HLA-
A0101 (A1); HLA-A0201 (A2); HLA-A0301 (A3); HLA-A2403 (A24); HLA-
A2601 (A26); HLA-B0702 (B7); HLA-B0801 (B8); HLA-B2705 (B27); HLA-
B3901 (B39); HLA-B4001 (B44); HLA-B5801 (B58); HLA-B1501 (B62). The
12 MHC class I molecules have rather divergent binding motifs, and cross-
binding across alleles is limited, with90% of themeasured binders in IEDB
being exclusive binders of a single molecule. This should ensure a data set
where the actual number of speciﬁcities is known, making it ideal to bench-
mark the method with respect to the real number of clusters.
MHC class II data
HLA-DR binding data for the two molecules HLA-DRB1*03:01 and HLA-
DRB1*04:01 was taken from the large data set published by Wang et al. [37].
As in the case of MHC class I, we selected peptides with aﬃnity < 500nM as
binders. HLA-DR alleles are highly promiscuous, and often the same pep-
tide cross-binds to several alleles. In order to reduce this promiscuity and
obtain an orthogonal data set we excluded, for each allele, peptideswith pre-
dicted cross-binding. Cross-binding was predicted using the NetMHCIIpan
method [79] with a strict binding threshold of 50% rank score (that is a pep-
tide with a predicted binding aﬃnity equal to or higher than 50% rank score
54 CHAPTER 4. MULTIPLE SPECIFICITIES
is assumed to cross-bind). The data set was composed of respectively 202
and 201 binders to the molecules HLA-DRB1*03:01 and HLA-DRB1*04:01.
SH3 domain binding data
We used the phage display data for the Src SH3 domain from the recent pub-
lication by Kim et al. [107]. The raw data set consists of 2,457 unique peptide
sequences identiﬁed to bind to the Src SH3 domain. All the peptides are 12
amino acids long and are unaligned with respect to the binding motif to the
SH3 domain. We extended all sequences with artiﬁcial ﬂanks composed of X
(any amino acid) to both extremes, to give the alignment algorithm freedom
of movement in the search of the optimal alignment window.
HLA-A*02:01 aﬃnity and stability data
In a recent study, Harndahl et al. [112] published a data set of measurements
of binding aﬃnity and stability to HLA-A*02:01 for 739 peptides. We limited
the data set to peptides with binding aﬃnity stronger than the conventional
500nM, resulting in 650 peptides with measured aﬃnity and stability.
4.1.3 M
TheGibbs clustering algorithm attempts to group the input peptide data into
a number of clusters and for each cluster identify the optimal local sequence
alignment based on the optimization of the ﬁtness of the system in terms
of Kullback-Leibler distance (KLD) sum of the alignments. The KLD allows
measuring the information gain of an observed amino acid distribution com-
pared to a background distribution (the frequency of each amino acid in ran-
domprotein sequences). A given alignment can be represented by a log-odds
(LO) weight matrix, which summarizes the amino acid preferences for each
column of the alignment. Throughout the paper, we graphically represent
LO matrices using the sequence logo visualization tool Seq2Logo [32].
Log-odds matrices
A log-odds weight matrix is calculated as log(pA,j/qA), where pA,j is the fre-
quency of amino acid A at position j, and qA is the background frequency of
A. These frequencies are calculated as described inNielsen et al. [33], includ-
ing heuristic sequence weighting and pseudo-count correction. To avoid the
creation of small highly specialized clusters, we introduce an additional term
to the log-odds matrix calculation to account for the size of the alignment.
In our scheme, terms in the PSSM are calculated using:
LOA,j =
n
n+ s
log
p0A,j
qA
(4.1)
where n is the number of peptides in the alignment, s is aweight on small
clusters, and p0A,j is the pseudo-count corrected frequency. The function of
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s is to ﬂatten the log-odds matrix when the alignment is composed of few
sequences (n small), but its eﬀect is minor when the matrix is constructed
on many data points (n large). Practically, it avoids the creation of small and
specialized alignments, favoring instead larger and more general ones.
A peptide x can be scored simply by adding the LO values for the amino
acid found at each position in x:
S =å
j
LO0A,j (4.2)
where j is the index over the positions in the alignment core, and A is the
amino acid found at position j in x. However, when evaluating the ﬁtness of a
given sequence x in an alignment (where x is part of the alignment), wemust
take the precaution of excluding x from the matrix calculation before doing
the evaluation. We call LO0A,j the log-odds matrix made without sequence x.
Scoring function
In the general case, a Gibbs clustering solution is composed of g clusters,
each with a corresponding alignment and LO matrix. When evaluating a
clustering solution, we aim to maximize the intra-cluster ﬁtness of the align-
ment while minimizing the similarity between diﬀerent clusters. In other
words, the distance between points in the same cluster should be as small
as possible, whilst the distance between points in diﬀerent groups should be
maximal. In the Gibbs clustering algorithm, we implement this maximiza-
tion using the relationship:
Si = Si   l max1ng
n 6=i
(Sn, 0) (4.3)
where Si is the score of a given peptide to the log-odds matrix LOA,j of
cluster i. Note that, as discussed above, the log-odds matrix of group i is
calculated excluding the peptide to be scored. The max() part of the equa-
tion determines the inter-cluster similarity, i.e. which cluster is the closest to
cluster i. If we imagine to have, besides the g clusters given by the data, and
additional cluster composed of the universe of natural peptides, the amino
acid frequencies pA,j in this extra group would be equal to the background
frequencies qA for any amino acid A. Thus log(qA/qA) = 0 in equation 4.1,
leading to a LOA,j matrix composed of zeros which gives scores SBG = 0 for
all sequences. This justiﬁes the zero in equation 4.3, and provides a general-
ization for the case where there is only one cluster, with Si = Si .
The parameter l modulates the weight of inter-cluster similarity on the
ﬁnal sequence score. For l = 0 overlap between clusters is not penalized,
leading to tight but promiscuous clusters. Large l values put emphasis on
inter-cluster similarity, at the expense of consistency within the same group.
Equation 4.3 deﬁnes the energy function of a single sequence in the align-
ment. The overall score of the alignment/clustering is given by the average
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score of all sequences in the data set. The ﬁtness of the system can be thought
of as the relative entropy or Kullback-Leibler distance (KLD) from the back-
ground model made on random peptides.
Moves of the algorithm
Initially, peptides are distributed randomly in g clusters. Then the algorithm
proceeds with a number of ￿moves￿ to align and cluster the sequences and
optimize the KLD of the alignment/clustering. The probability of accepting
a move is given by:
P = min(1, e
dE/T ) (4.4)
where dE is the energy change as a result of the move, and T is a scalar
commonly known as the temperature of the system, lowered by discrete
steps during the iterations.
The algorithm consists of 3 diﬀerentmoves: i) Single sequence move: in this
move, we attempt to transfer a peptide x from one group Go to a destination
group Gd chosen at random. The score So of x in its original cluster is cal-
culated using equation 4.3, selecting the core register that gives the highest
score. In the same way, Sd is obtained for the destination group. The move
is then accepted or rejected following equation 4.4, where dE = Sd   So . ii)
Simple shift: this move attempts to move a peptide x within a group, by ap-
plying a random shift to the alignment core of x. The score of x is calculated
before and after the shift, and the dE between the two conﬁgurations deter-
mineswhether themove is accepted or rejected according to equation 4.4. iii)
Phase shift: the entire alignment of a group Go is shifted a random number of
positions to the left or to the right. This move may be important if the align-
ment reaches a local minimum where the sequences are optimally aligned
to each other but the core window is not centered on the most informative
motif. As in the other moves, the conﬁgurations before and after the move
are compared to calculate whether the move is favorable or unfavorable, and
accepted/rejected following equation 4.4.
The simple shift and phase shiftmoves have been described before for mul-
tiple sequence alignment [33, 34]. The new feature of the Gibbs cluster-
ing method is the additional single sequencemove, which allows transferring
sequences between diﬀerent clusters. The three moves are generally per-
formed with diﬀerent frequency. The simple shift move, with the lowest im-
pact among the three moves, is attempted at each iteration. Single sequence
moves are performed every Fr iterations. Phase shifts, which aﬀect at the same
time all peptides in a given clusters, would generally be the least frequent
and occur every Fs iterations, with Fs > Fr > 1. Throughout the paper these
parameters are ﬁxed to Fr = 10 and Fs = 1, 000. The default cooling sched-
ule uses 20 linear temperature steps starting from an initial T of 0.8 down to
10 5.
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Trash cluster to collect spurious sequences
The algorithm allows including an additional cluster, called "trash-cluster",
to collect the peptides that appear not tomatch any of themotifs being identi-
ﬁed. The behavior of the trash-cluster is identical to any of the other clusters,
with the diﬀerence that sequences in the trash cluster do not contribute to the
overall score of the system. The trash-cluster can be thought of as the uni-
verse of all natural peptides (i.e. the background model) and peptides can
be moved in and out from the trash-cluster with probability deﬁned by the
Monte Carlo relationship (equation 4.4), where the score to the trash-clusters
is always equal to the background baseline (zero by default, but can be set to
diﬀerent values to adjust the levels of sensitivity and speciﬁcity).
Measures of clustering quality
As a measure of clustering quality, we used the Adjusted Rand Index (ARI).
This measure is based on the well-known Rand index [113], but corrected for
chance and class size. We implemented the ARI corrected for chance as in
Hubert and Arabie [114]. As a term of comparison, we also used a modiﬁed
version of theMatthews correlation coeﬃcient (MCC) extended tomore than
the conventional two classes (positives and negatives). In the general case
where A mixed speciﬁcities are grouped in C clusters, a MCC is initially
calculated for each cluster. The true positives (TP) for group Ci are given by
the class Ai with highest number of sequences in Ci, the false positives (FP)
by the number of sequences inCi not belonging to Ai, the false negatives (FN)
by the number of sequences labeled Ai not found inCi, and the true negatives
(TN) are all the remaining sequences. The MCC for the entire matrix is then
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Figure 4.1. Confusion matrix and notation for calculation of ARI andMCC. In the case
of a clustering problem, the two partitions being compared are the predicted clusters
(rows) and the labels for the actual classes (columns). Row sums and column sums are
used in the calculation of the ARI. TheMCC for the entire matrix is calculated as the aver-
age of theMCC of each row. Highlighted in diﬀerent colors are the 4 classes of prediction
for cluster R2, assuming that n2,2 is the highest value in R2: yellow - true positives; blue ￿
false negatives; green ￿ false positives; red ￿ true negatives.
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calculated as the average MCC of each cluster. The notation for ARI and
MCC calculation is also illustrated in Figure 4.1.
Training from multiple initial seeds
Gibbs sampling is a heuristic rather than a rigorous optimization proce-
dure. Therefore, it cannot guarantee that themost optimal solution is always
reached from any starting conﬁguration. A common procedure to boost per-
formance is to repeat the sampling from a number of initial random conﬁg-
urations, and select the solution that appears to be optimal in terms of the
ﬁtness function that governs the system. Clearly, this is a sound procedure
only if optimal ﬁtness (KLD) corresponds to optimal clustering of the data.
We investigated the correlation between ﬁtness and quality of the cluster-
ing on MHC class I data sets containing diﬀerent number of speciﬁcities.
Binders to diﬀerent alleles were combined to obtain mixtures of 5 to 8 alle-
les, and then the Gibbs clustering algorithm was used to recover the distinct
motifs. For each allele combination, we ran the algorithm from 40 random
initial conﬁgurations, measuring for each the ﬁtness in terms of KLD and the
clustering quality in terms of ARI.
In general, we observe that both KLD and ARI tend to decrease as the
number of alleles in the mixture increases (Figure 4.2). Yet, in the case of
MHC class I where motifs are very strong and distinct from each other, it is
possible to reconstruct with high accuracy even up to 8 diﬀerent speciﬁci-
ties. The same considerations can be made if we measure clustering qual-
ity in terms of MCC instead of ARI, which correlates in very similar fash-
ion to KLD (Figure 4.3). These results show that, only based on the KLD,
it is possible to ﬁlter out sub-optimal solutions. By running the algorithm
from diﬀerent starting conditions, and selecting solutions with high KLD,
the method achieves a higher classiﬁcation performance. Multiple seeding
and automatic selection of the optimal solution are integrated in the Gibbs
clustering algorithm.
4.1.4 R
TheGibbs clustering algorithmperforms two essential tasks simultaneously:
alignment and clustering of peptide data. Here, we use the method to de-
convolute binding motifs in a panel of diﬀerent peptide data sets with dif-
ferent degrees of complexity spanning from the simplest case of pre-aligned
ﬁxed-length peptides, to cases of unaligned peptide data sets of variable
length.
Pre-aligned data - Mixtures of binders to MHC class I alleles
In order to benchmark the clustering aspect of the Gibbs algorithm, we used
a set of pre-aligned ﬁxed-length peptides with experimentally conﬁrmed
binding to representatives of the 12 MHC class I supertypes (see Data sets
section). These 12 MHC molecules all have highly speciﬁc binding motifs
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Figure 4.2. Correlation between KLD and quality of clustering (in ARI) for mixtures of
5, 6, 7 and 8 MHC class I alleles. The ARI is a measure of how well the algorithm recon-
structed the original classes, the KLD represents the energy of the alignments including
distance within and between clusters. The individual data points were collected by start-
ing the algorithm from 40 random initial conditions. The plots show that, only based on
the KLD, it is possible to ﬁlter out most of the sub-optimal solutions and achieve higher
performances by selecting solutions with high KLD.
with limited mutual overlap [8]. For each number of alleles n = {1,2,. . . ,8},
10 diﬀerent combinations of n alleles were constructed randomly from the
pool of the 12 MHC molecules. For each data set, the algorithm was used
to cluster the peptides into c = {1, 2,. . . , 12} groups and the c with optimal
KLD score was recorded. Figure 4.4 shows the results of this calculation. For
l = 0.5, the number of predicted motifs correlates well with the actual num-
ber of alleles in the data set. With smaller values of l, the method tends to
over-estimate the number of motifs, while for larger l clusters with shared
similarities are more heavily penalized and are merged into fewer clusters.
The predictions are most consistent (lowest variations in the optimal num-
ber of clusters) on mixtures of few alleles. This is a natural consequence of
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Figure 4.3. Correlation between KLD and two measures of clustering quality (MCC
and ARI).MCC and ARI are measures of how well the algorithm reconstructed the ori-
ginal classes, the KLD represents the energy of the alignments including distance within
and between clusters. The left panel shows that most of the best solutions (high MCC)
have the highest values of KLD. ARI and MCC correlate very strongly (right panel) and
appear to be equally good measures for cluster quality.
both the increased complexity of the search space as the number of alleles is
increased, and the promiscuity of MHC binding peptides. Although the 12
MHC class I molecules share very limited overlap in speciﬁcity, a larger col-
lection of alleles increases inevitably the chance of including cross-binding
peptides in the data set.
Unaligned data - Mixtures of binders to MHC class II alleles
To demonstrate the performance of the Gibbs clusteringmethod on data sets
of unaligned peptides of variable length, we turned to the MHC class II sys-
tem. As opposed to MHC class I molecules, which in the vast majority of
cases interact only with peptides of length between 8 and 10 amino acids,
MHC class II molecules can bind peptides of highly variable length [60].
Binding of a peptide to a MHC class II molecule is primarily determined
by a core of 9 amino acids, but the location of the 9-mer core within the pep-
tide is not known a priori. Therefore, MHC class II binding data is by nature
unaligned with respect to the binding core.
The Gibbs clustering algorithm was applied to identify motifs in a set
of binders to the MHC class II HLA-DRB1*03:01 and HLA-DRB1*04:01
molecules. Compared to MHC class I, class II alleles share a high degree
of overlap in their binding speciﬁcities. This promiscuity between diﬀerent
MHC class II molecules complicates the performance evaluation of the clus-
tering algorithm, as a peptide may match the motif of multiple alleles, in
which case it is not clear in what cluster the sequence should be rightfully
placed. To lower this potential degree of cross-binding, the data set was con-
structed to include experimentally conﬁrmed binders with weak predicted
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Figure 4.4. Box-and-whisker plot showing the optimal number of clusters on mixtures
of diﬀerentMHC class I alleles. The algorithmwas run on 10 diﬀerent random combina-
tions of n alleles, where n = {1…8}, startingwith c = {1…12 } clusters for each combination.
The optimal number of clusters of each of the 10 combinations is the c with highest KLD
of the system. The four panels show the predicted number of clusters for four diﬀerent
values of l for a ﬁxed value of s = 10. With l = 0.5 the correlation between number of
alleles in the data set and predicted number of clusters falls approximately on a straight
line with slope = 1.
cross-binding potential (for details refer to Data sets section). Wemaintained
the same parameters used for theMHC class I benchmark, except for lwhich
was increased to 0.8 to avoid the creation of excessively small and specialized
clusters (running the algorithm with l = 0.5 resulted, in particular, in the
DRB1*03:01 peptides being subdivided into several small and highly special-
ized clusters). Additionally, since HLA-DR molecules are known to prefer
hydrophobic amino acids at position P1, we imposed a preference for this
kind of amino acids in the Gibbs sampling moves as proposed by Nielsen
et al. [33]. The algorithm was run multiple times to create 1-4 clusters, each
started from 5 diﬀerent random conﬁgurations. For each cluster size, the
solution with the highest KLD score was recorded. The optimal solution
indicated the presence of two clusters (Figure 4.5), and the corresponding
motifs are shown in Figure 4.6. The main distinctive feature in the logos of
Figure 4.6 is the acidic (D) anchor at position P4 and a basic (K/R) anchor
at position 6 of the ﬁrst motif, which are absent in the second logo. These
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Figure 4.5. KLD of the alignment/clustering on a mixture of 2 MHC class II molecules
depending on the initial number of clusters. Each block represents a cluster, and its size
is proportional to the number of sequences in the cluster. The global optimal solution
(highest KLD) was found with 2 clusters, and the corresponding sequence motifs are
shown in Figure 4.6.
!
"
#
$
%
&
'
(&
$
))
!
"
#
$
%
&
*
(&
$
))
+$! $,&) -')
+.! '$) $*/)
01) 21) 31)Group 1 of 2
created by Seq2Logo
0.0
0.5
1.0
1.5
H
a
lf
b
it
s
1
M
I
L
V
W
C
Q
N
D
E
G
R
K
S
Y
H
A
P
F
T
2
W
Q
G
I
K
T
R
V
S
C
Y
F
N
H
M
P
L
D
E
A
3
H
Y
W
V
A
R
G
N
C
M
F
Q
T
D
S
P
K
I
E
L
4
H
W
R
I
T
A
D
Y
C
M
F
P
Q
N
S
K
V
G
E
L
5
C
W
M
N
D
Q
P
A
L
G
Y
H
T
K
F
R
S
E
I
V
6
W
H
N
D
V
P
R
K
Y
C
T
Q
M
F
G
I
E
S
A
L
7
H
F
Q
Y
M
D
I
K
W
C
N
P
T
E
R
S
V
A
G
L
8
Y
T
F
I
A
L
R
V
W
C
S
H
M
Q
N
P
E
G
D
K
9
P
Y
T
I
R
V
F
L
WC
Q
M
N
H
E
D
S
K
A
G
Group 2 of 2
created by Seq2Logo
0.0
1.0
2.0
H
a
lf
b
it
s
1
W
I
F
Y
C
Q
D
N
M
E
R
H
P
A
K
S
T
G
V
L
2
N
Q
H
R
P
E
C
G
K
T
WY
I
M
F
V
D
L
S
A
3
P
N
K
S
A
T
WM
C
Y
F
Q
H
G
R
D
I
E
V
L
4
W
I
Y
F
A
L
G
M
CH
R
N
D
Q
E
K
P
T
V
S
5
W
H
Y
D
T
K
I
S
V
G
A
CMF
R
N
E
Q
P
L
6
W
C
F
V
A
T
G
S
Y
H
M
D
E
Q
I
N
R
K
L
P
7
Q
P
K
N
I
T
V
A
S
WC
H
M
Y
F
R
D
G
E
L
8
W
H
P
A
K
T
Y
C
M
Q
F
R
I
L
N
G
D
E
V
S
9
N
V
S
I
P
G
A
W
C
M
H
K
Y
F
R
Q
E
D
L
T
Figure 4.6. Reconstructed binding motifs from a mixture of binders to 2 MHC class II
alleles. The data set was composed of respectively 202 and 201 binders to the molecules
HLA-DRB1*03:01 and HLA-DRB1*04:01. In a) and b) are shown the logos of the two
motifs identiﬁed by the algorithm, with the ﬁrst cluster predominantly composed of
DRB1*03:01 binders and the second of DRB1*04:01 binders. c) confusion matrix for the
two classes of binders, the correlation coeﬃcient is MCC = 0.59.
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preferences characterize the binding motif of HLA-DRB1*03:01. The classiﬁ-
cation of the peptides in the two groups (Figure 4.6c) demonstrates that most
peptides are clustered correctly, with an accuracy of 79% and MCC of 0.59.
Gibbs clustering as a tool to remove noise from data
In the previous examples, we assumed that all sequences belong to one clus-
ter or another. However, experimental data often contain some level of noise
and hence peptides which may not ﬁt in any of the motifs. The Gibbs clus-
tering algorithm allows, by the inclusion of a trash-cluster, a very simple yet
highly eﬀective manner to detect such spurious peptides and remove them
from the motif identiﬁcation (see Methods for the implementation).
In Figure 4.7 is shown the eﬀect of the trash cluster on mixtures of 1,
2, 3 and 4 MHC class I alleles polluted with 50 random peptides. We ob-
served that the majority of the random peptides were placed into the trash-
cluster, but that an average of about 5 peptides were assigned to one of the
clusters. This ﬁts the overall expectation as 1-5% of random natural pep-
tides are estimated to bind to a given MHC class I molecules [5, 115]. Fur-
thermore, most of the random peptides that were inserted into one of the
clusters had consistently lower scores than the actual binders (Figure 4.8).
The Gibbs clustering algorithm allows obtaining diﬀerent levels of sensitiv-
ity and speciﬁcity by varying the threshold to assign a peptide to the trash
cluster. Increasing this threshold would remove more noise (peptides with
low cluster score) from the data set, but at the same time would increase the
number of binders placed in the trash. In the experiments with noisy data
(Figure 4.7), a few sequences measured to be binders to a given allele are as-
signed to the trash (2 for the 1 clusters case, 2 for 2 clusters, 2 for 3 clusters,
4 for 4 clusters). Interestingly, none of these peptides appear to match the
binding motifs of the alleles they were measured to bind to. Using the state-
of-the-art MHC class I binding prediction method NetMHCcons [116], these
Table 4.1. Measured, predicted and re-tested binding aﬃnities (in nM) for peptides as-
signed to the trash cluster.
Peptide HLA IEDBa Predictedb Validatedc
DHHFTPQII A*01:01 62 28485 24822
SQTSYQYLI B*07:02 248 24349 49928
NAFGWENAY B*07:02 350 24481 -
TVFKGFVNK B*27:05 235 13723 -
ELPIVTPAL B*40:01 314 15208 -
ADKNLIKCS B*40:01 316 33324 76190
a Binding aﬃnity deposited in the Immune Epitope Database.
b Predicted binding aﬃnities using NetMHCcons.
c Re-tested binding aﬃnities after detection as outliers.
As a rule of thumb, generally aﬃnity<50nM identiﬁes a strong binder,
50nM<aﬃnity<500nM a weak binder, aﬃnity>500nM non-binders.
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Figure 4.7. Clustering of MHC class I data polluted with 50 random sequences using a
trash-cluster. In the 4 examples 200 binders for respectively 1, 2, 3 and 4 alleles are mixed
together and then reconstructedusing theGibbs clustering. Clusteringwas repeated from
10 initial random seeds, choosing the solution with highest KLD. Despite the noise nearly
all sequences are clustered correctly. Most random sequences are collected by the trash-
cluster, although a few obtain scores > 0 to some cluster and are retained in the main
groups.
peptides all show extremely low predicted binding aﬃnity to their respec-
tive HLA restriction element (>10,000 nM, see Table 4.1). Furthermore, an
experimental re-examination of three of these peptides conﬁrmed that they
are indeed non-binders to their respectiveHLAmolecule (J. Sidney, personal
communication). The method was thus able, whilst grouping distinct speci-
ﬁcities into diﬀerent clusters, to also identify false positives that most likely
correspond to erroneousmeasurements in the experimental assay. Introduc-
ing the trash-bin for the MHC class II benchmark also led to an improved
clustering performance, removing two outlier peptides, maintaining the op-
timal solution to consist of two clusters and enhancing the performance to
MCC=0.62 (data not shown).
SH3 domains
The Src Homology 3 domain (SH3 domain) is a small protein interaction
module abundantly found in eukaryotes. SH3 domains consist of about 60
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Figure 4.8. Scores of binders and random sequences in clustering 1 to 4 alleles polluted
with random peptides. The 4 N.x and S.x columns refer to the 4 clustering solutions in
Figure 4.7, where x is the number of alleles in the mixture. N (red) columns show the
KLD scores for random peptides assigned non-trash clusters, S (yellow) columns depict
the scores for binding peptides in non-trash clusters. TheKLD scores for binding peptides
(yellow) are consistently higher than the scores of random peptides (red). By increasing
the threshold for the trash cluster more noise can be removed from the data set, but at the
same time an increasing number of binders would be placed in the trash. The width of
the boxes in the boxplot is proportional to the square root of the number of sequences in
a given group.
amino acids and have been shown to mediate protein-protein interactions
by preferentially binding to short proline-rich sequences [117]. The minimal
consensus sequence for SH3 domain binding is composed of two prolines lo-
cated two amino acids apart (PxxP), but it is commonly recognized that there
exist two main classes of binders: class I ligands having a general consensus
sequence +xFPxFP and class II ligands with consensus sequence FPxFPx+
(where + is a positively charged amino acid, usually R, F is a hydrophobic
amino acid, and x any amino acid) [118]. However, there are a few excep-
tions to the these predominant motifs, and a number of non-consensus lig-
ands have been identiﬁed (reviewed in [119, 120]).
The Gibbs clustering algorithm was run on a large data set of 2,457 pep-
tides binding to the Src SH3 domain. The peptides are 12 amino acids long
and unaligned with respect to the binding motif(s) to the SH3 domain. As
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the data set may contain non-consensus ligands as well as noise, we per-
formed the alignment/clustering with the addition of a trash-cluster, which
collects peptides that do not match any of the main motifs. To ensure the
removal of non-consensus sequences that may only partially match the ma-
jor motifs, the baseline for the trash cluster was set to a relatively high value
of 10. The sequence motifs identiﬁed by the Gibbs clustering are shown in
Figure 4.9. Aligning all sequences into a single cluster (Figure 4.9a) showed
the characteristic PxxP pattern, in this case preceded by a leucine (L) and
arginine/proline (R/P) three positions back. Clustering the peptides into
two groups revealed the two sequencemotifs shown in Figure 4.9b. They cor-
respond very well to the two known classes of SH3 domain ligand, one with
the PxFPxRN pattern (class II) and the other with pattern RxFPxFP (class
I). Dividing further the data set and creating 3 clusters led to the emergence
of a new subset of speciﬁcity (panel c) besides the two described in the 2-
clusters case. Although several exceptions to the twomain classes have been
!"#$%&'()&"
*"#$%&'()&"+"#$%&'()"
,-" .-"
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Figure 4.9. Sequence motifs on SH3 domain binding data clustered in 1 to 3 clusters.
a) Sequence motif of the data set aligned in one single cluster. The cluster contains 2,360
peptides, 97 peptides were discarded to the trash cluster. b) Sequence motifs for SH3 do-
main data split in two clusters. The twogroups are in strong agreementwith the canonical
class I (right, 1,892 peptides) and class II (left, 498 peptides) types of SH3 domain ligands.
67 peptides were moved to the trash cluster. c) Sequence motifs when the data is split
in 3 clusters. The clusters have sizes of respectively 1,606, 490 and 305 peptides, with 56
peptides discarded to the trash cluster.
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discovered [120], this RxRPFP pattern has not, to the best of our knowledge,
been described before. Splitting the data set further to more than 3 clusters
does not show new speciﬁcities besides those described here.
The two motifs displayed in Figure 4.9b agree strongly with the results
obtained in a previous study [107], where the MUSI method was applied to
the same phage display data set. The Gibbs clustering method however has
the strong advantage, compared to MUSI, in that the data do not need to be
aligned prior to clustering. Instead, in the Gibbs clustering method align-
ment and clustering are performed simultaneously. In the speciﬁc case of
SH3 domain binding, where both motifs share a strong common PxxP pat-
tern, a pre-alignment strategy to a common motif like the one implemented
in MUSI can be successful. However, in the general case, the diﬀerent motifs
will be weak and will not share a common pattern. On such data, it becomes
diﬃcult if not impossible to accurately identify the binding core within the
peptide data set using alignment techniques [33]. For instance, by applying
the MUSI method on the MHC class II data set from above, we found the so-
lutionwith twomotifs being suboptimal compared to a solutionwith a single
motif. Forcing MUSI to generate two clusters, the overall performance was
MCC=0.21, which is signiﬁcantly lower than what was obtained using the
Gibbs clustering method (p<0.01, bootstrap test).
Sub-speciﬁcities of MHC class I molecules
Peptide binding to MHC molecules is one of the most selective steps in de-
termining MHC class I-restricted CTL responses. The strength of this in-
teraction is commonly measured in terms of binding aﬃnity between pep-
tide and MHC complex. However, not all peptides with high aﬃnity are
immunogenic, indicating the presence of other factors determining an eﬀec-
tive response [121]. Some studies have suggested that the stability of the
MHC-peptide complex is a major player in determining immunogenicity
[122, 123, 112].
By means of the Gibbs clustering algorithm, we investigated if there exist
sub-speciﬁcities forMHC class I binding, andwhether these sub-speciﬁcities
correlated with diﬀerent levels of aﬃnity and/or stability. For this purpose,
we used a data set recently published by Harndahl et al. [112] consisting of
650 peptides binding with aﬃnity stronger than 500nM to HLA-A*02:01 for
which also the peptide stability had been measured. We applied the Gibbs
clustering algorithm to split the data set in two clusters using default param-
eters and investigated the properties of the sequences in the two groups.
The sequence motifs for the resulting clusters are shown in Figure 4.10.
The ﬁrst cluster (G1), composed of 441 sequences, was highly speciﬁc in
terms of amino acid preference, with [LIM] at P2 and [VLI] at P9. The con-
tribution from other positions is secondary. The second cluster (G2) is more
promiscuous at both anchor positions P2 and P9, especially at P2 where sev-
eral amino acids other than L, I and M are allowed. The peptides in the
two groups had a median binding aﬃnity of 6 nM and 9 nM, for G1 and G2
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Figure 4.10. Sub-motifs of HLA-A*02:01 binding speciﬁcity. The peptides in the two
clusters have similar aﬃnity but diﬀer signiﬁcantly in stability. The sequence logo in the
left panel is composedmainly of stable peptides (Th  5.7 hours) whereas peptides in the
second group have lower stability (Th  2.1 hours).
respectively. This diﬀerence is not signiﬁcant (p=0.095, Wilcoxon rank-sum
test). In contrast, we observed that peptides in G1 have a signiﬁcantly higher
stability compared to G2 (p<10 6, Wilcoxon rank-sum test): themedian half-
life of the MHC-peptide complex in G1 is Th  5.7 hours, whereas in G2 it is
only Th  2.1 hours.
From these results, we can conclude that the method identiﬁed subtle
diﬀerences between the binders to HLA-A*02:01 that appear to diﬀerenti-
ate stable binders from unstable binders. In particular, as previously noted
peptide-HLA-A*02:01 complexes appear to be destabilized by a suboptimal
amino acid in just one of the two anchor positions and in particular position
P2 [112].
4.1.5 D
We proposed an eﬃcient algorithm to identify multiple speciﬁcities in pep-
tide data sets. The applications of the method are numerous, ranging from
the deconvolution of poly-speciﬁcities contained in a data set, to the analy-
sis of sub-speciﬁcities within a known binding motif. The algorithm aims at
identifying the solution (the set of clusters and corresponding alignments)
that optimally ﬁts the peptide data set. The optimal solution is automatically
selected and the identiﬁed binding motifs are visualized as individual se-
quence logos. Using a panel of benchmark data sets, we have demonstrated
the power of the Gibbs clusteringmethod in deconvoluting poly-speciﬁcities
contained both in pre-aligned and unaligned peptide data sets covering the
MHC class I, MHC class II and human SH3 domain systems.
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Gibbs sampling is a powerful approach to explore large spaces of possible
solutions. In the case of amino acid sequences, there are immense possible
ways of aligning and clustering them as soon as the number of sequences
becomes bigger than a handful. The probabilistic nature of Gibbs sampling
allows eﬃcient sampling of the search space and convergence towards a state
of high ﬁtness of the system. Compared to other motif identiﬁcation meth-
ods, Gibbs clustering is unique in that it incorporates alignment and cluster-
ing in a set of alternative sampling moves, allowing for simultaneous iden-
tiﬁcation of clusters and optimal sequence alignment. This property makes
the method capable of identifying subtle and relatively weak binding motifs
(as demonstrated for the case of MHC class II binding motifs) but it comes at
the price of computational speed. Analyzing the 400 peptides in the MHC
class II binding data set takes a little more than 5 minutes using Gibbs clus-
tering. This running time is reduced to 15 seconds using theMUSI algorithm
[107] yet at the cost a of dramatic and signiﬁcant drop in accuracy.
In a general situation, it is not known a priori how many motifs are con-
tained in a data set. When presented with a set of experimental data, the
investigator ideally wants a deﬁnitive answer to the question: ￿How many
motifs are contained in my data?￿ Unfortunately the answer is not unam-
biguous, not so much for a fault of mathematical and computational meth-
ods, rather for the ambiguity of the question. The answer depends on the
level of resolution that is expected for the particular problem at hand. If the
goal is a rough classiﬁcation of sequences based on global diﬀerences then
the resulting number of clusters will be small. Conversely, more partitions
would be produced if wewere searching for subtler distinguishing sequence
characteristics. The ￿true￿ number of clusters is therefore not an objective
answer but depends on the kind of biological question that is being asked.
In the Gibbs clustering algorithm, we introduce a parameter l that aims to
modulate the degree of resolution required by the user. High l penalizes
overlap between clusters, and tends to create coarser clusters, whereas low
l results in smaller and specialized clusters. For example, we showed that for
a certain value of l, we could accurately identify the number of MHC class
I molecules contained in a data set of mixed speciﬁcities. In another exam-
ple, we split one of these very same speciﬁcities into sub-motifs, and looked
for subtle diﬀerences in a rather homogenous population of peptides. And
these are not the extremes: one could conceive partitioning the data further
into more specialized sub-populations, as well as obtaining a coarser picture
of similarities between alleles. The same data may have diﬀerent levels of
resolution depending on the aim of the analysis, and the investigator should
keep this in mind when using a classiﬁcation method like the one presented
here. TheGibbs clusteringmethod in its current form is limited to handle sit-
uations where motifs are of uniform length. Likewise, the method can only
handle amino acid input data. The reason for this limitation is that most
of its unique features like pseudo-count estimates from Blosum substitution
matrices and sequence weighting of are speciﬁc for amino acid data.
In conclusion, we believe the Gibbs clusteringmethod to be both a highly
accurate and very user-friendly tool that will allow researchers to interpret
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peptide data sets in terms of receptor speciﬁcities in a highly intuitive man-
ner. Therefore, we expect it to become an important tool as large-scale pep-
tide chip technologies grow to be a cost-eﬀective and accessible platform for
investigation of protein-ligand interactions. The method is highly customiz-
able and publicly available as an online web-server at http://www.cbs.dtu.
dk/services/GibbsCluster.
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Chapter 5
String kernels for binding aﬃnity
prediction
I  a recent publication, Smale and coworkers [124] proposed a kernelfunction to measure distances between amino acid sequences, and ap-plied themethod to the prediction of peptide-MHC class II binding aﬃn-
ity. Themethodwas shown to achieve performances comparable toNNAlign
(described in chapter 2) on a benchmark of HLA-DR molecules. We im-
plemented the kernel method according to the manuscript to investigate
its strengths and weaknesses compared to other available methods. After
brieﬂy introducing the kernel functions and the RLS algorithm, we show
its application for the prediction of peptide binding aﬃnity to HLA class I
molecules, and particularly how the method can beneﬁt by training on pep-
tides of multiple lengths.
5.1 Kernel functions
The kernel function for peptide-peptide distances is constructed by deﬁning
three functions of increasing complexity:
• K1, deﬁning similarities between pairs of amino acids, based on BLO-
SUM scores;
• K2, between amino acid stretches of equal length, based on kernel K1;
• K3, between pairs of amino acid chains of any length, based on K2.
The construction of the kernels starts from the BLOSUM substitution fre-
quencies between amino acids [22]. The BLOSUM odds matrix B can be cal-
71
72 CHAPTER 5. STRING KERNELS
culated for each pair of amino acids using:
Bxy =
pxy
qxqy
(5.1)
where pxy is the substitution frequency between amino acids x and y,
and qa is the background frequency of amino acid a in naturally occurring
proteins. The BLOSUMmatrices commonly used for sequence alignment are
obtained taking the logarithm of the odds matrix B, then rounding the score
to the closest integer.
The basic kernelK1 between a pair of amino acids (x, y) is deriveddirectly
from the BLOSUM62 odds matrix B using:
K1(x, y) = (Bxy)b (5.2)
where b is the Hadamard power (power of single entries) of the matrix.
b is one of the parameters of the method to be optimized.
The kernel K2 between a pair of k-mers (u, v) follows by multiplication
of the K1 on all amino acid pairs composing the two k-mers:
K2k(u, v) =
k
Õ
i=1
K1(ui, vi) (5.3)
where ui denotes the amino acid found at position i in the k-mer u.
Finally, the similarity between a pair of amino acid sequences ( f , g) is
calculated by combining the K2 between any pair of substrings u and v of
respectively f and g:
K3( f , g) = å
u f ,vg
juj=jvj=k
all k=1,2,...
K2k(u, v) (5.4)
A normalized version of the K3 kernel, which returns a value of 1 for any
pair of identical sequences, can be obtained using:
Kˆ3( f , g) =
K3( f , g)p
K3( f , f )K3(g, g)
(5.5)
Examples Calculation of K1 between pairs of amino acids is trivial: it cor-
responds to the BLOSUM odds score for the two amino acids, to the power
of b. For example, assuming b = 0.1, one obtains K1(R,G) = 0.922 and
K1(R,K) = 1.076, indicating that substitutions between R and K are more
frequent than between R and G.
Pairwise K2k entries are calculated bymultiplication of K1 on all the amino
acid pairs composing the k-mers. For example, for the pair of 3-mers TQA
and WQP, we obtain:
K23(TQA,WQP) = K1(T,W) K1(Q,Q) K1(A, P) = 1.081
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On full sequence level, K3 combines in a sum the K2k on all possible k-
mer pairs contained in the two sequences to be compared. Suppose we want
to calculate the similarity based on K3 between the short peptides FFTQA
and WQPE. First we have to calculate K21 an all 1-mer pairs f(F,W), (F,Q),
(F,P), …g, then K22 on all 2-mers f(FF,WQ), (FF,QP), …g, then K23 on all 3-
mers f(FFT,WQP), (FFT,QPE), …g, and ﬁnally K24 on the two possible 4-mer
pairs f(FFTQ,WQPE), (FTQA,WQPE)g. Summing all the contributions one
obtains K3(FFTQA,WQPE) = 37.826. Normalizing this score with equation
5.5 one obtains:
Kˆ3(FFTQA,WQPE) = K
3(FFTQA,WQPE)p
K3(FFTQA,FFTQA)K3(WQPE,WQPE)
= 0.813
For a more thorough and detailed description of the kernel and its prop-
erties refer to the original publication by Smale and coworkers [124].
5.2 Regularized Least Squares (RLS) learning
Given a data set of n peptide sequences, the kernel function Kˆ3 allows cal-
culating pairwise distances between all pairs of peptides. We can deﬁne a
function f to combine the elements of the kernel as a system of linear equa-
tions:
f () =
n
å
i=1
wiKˆ3(xi, ) (5.6)
where x is the vector of n peptide sequences in the training set, and wi
the ith coeﬃcient (or weight) in the linear equations of the system. The RLS
algorithm aims at ﬁnding the optimal set of weights w that minimize the
error between the outcome of the f function and the desired output y for
each data point (the vector ymay be for example the set ofmeasured peptide-
MHC binding aﬃnities):
f = arg min
 
1
n
n
å
i=1
( f (xi)  yi)2 + lk f k2
!
(5.7)
where l is a regularization parameter that controls the absolute value of
the coeﬃcients w and by that avoids over ﬁtting on the training data.
By combining equation 5.6 and 5.7 and imposing ¶ f¶w = 0, one obtains:
(Kˆ3 + nlI)w = Gw = y (5.8)
whereG is simply the kernel on peptides Kˆ3with a constant additive term
nl on the diagonal. The optimization problem is now expressed in terms of
the system of linear equations Gw = y which can be solved to ﬁnd the set of
weights w as follows.
The properties of Kˆ3 (and consequently G) guarantee that G can be de-
composed into a product of a lower and an upper triangular matrix G = LLT
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where L is a lower triangular matrix and LT its transposed version. We im-
plemented the decomposition using the Cholesky￿Banachiewicz algorithm,
with a computational complexity ofO(n3). After calculating L, we can solve
Lb = y for the vector b, and ﬁnally obtain the set of coeﬃcients by solving
LTw = b for w. These solutions are trivial to calculate, as on the triangular
matriceswe can iteratively descend the diagonal and calculate one coeﬃcient
of b (and then w) at a time.
The trained model based on the kernel Kˆ3 and its associated weights w
can be used to predict any new data point x using equation 5.6, or explicitly:
f (x) =
n
å
i=1
wiKˆ3(xi, x) (5.9)
5.3 Predicting MHC class I binding aﬃnity
After conﬁrming the correctness of our algorithm implementation by repro-
ducing the results of the original publication [124] for MHC class II binding
prediction (data not shown), we applied the method to a new problem: pre-
diction of MHC class I binding aﬃnity.
As discussed in section 1.1.1, MHC class I molecules can accommodate
in their binding groove peptide of lengths between 8 and 11 amino acids.
Most prediction methods, including NN-align [36] and the stabilized matrix
method (SMM) [125] require that a separate model is trained for each diﬀer-
ent peptide length. We found particularly interesting that the Kernelmethod
does not suﬀer from this limitation, and can be trained on multiple peptide
lengths at the same time. Here, we investigate whether such property can be
Table 5.1. The human MHC class I 12 alleles used in the benchmark, and number of
peptides with measured binding aﬃnity for each allele.
Allele #9 #9bind #10 #10bind
HLA-A*01:01 1157 103 56 18
HLA-A*02:01 3089 1181 1316 526
HLA-A*02:03 1443 639 1055 470
HLA-A*03:01 2094 517 1082 410
HLA-A*11:01 1985 693 1093 471
HLA-A*24:02 197 99 78 28
HLA-A*29:02 160 68 55 8
HLA-A*31:01 1869 427 1057 315
HLA-A*68:01 1141 498 1055 440
HLA-B*07:02 1262 208 205 78
HLA-B*35:01 736 211 177 46
HLA-B*53:01 254 106 177 47
#9 and #10 refer to the number of 9-mer and 10-mer peptides with measured binding
aﬃnity, #9bind and #10bind to the number of peptides with binding aﬃnity < 500nM.
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an advantage in terms of predictive performance, especially in cases where
training data for a particular peptide length are scarce.
For this benchmark, we used 12 HLA class I alleles from the data set
published by Peters et al. [57], which contains binding data for 9-mer and
10-mer peptides. The size of the data sets and relative number of binding
peptides vary greatly among the diﬀerent alleles, and are listed in Table 5.1.
We train and evaluate predictive performance using a 5-fold cross-validation,
preserving the same partitions as in Peters et al. [57].
First, we estimated an optimal value for the regularization parameter l.
On a cross-validation experiment on the 9-mer training sets, l was found
to give highest performance around l = e 10. We ﬁxed the value of the
parameter b (see equation 5.2) to b = 0.11387, found to be optimal for class
II prediction in the paper by Smale et al. [124].
5.3.1 Enriching 9-mer data with 10-mers
We investigated whether training a method on 9-mer and 10-mer peptides
leads to improved predictions for 9-mer peptides. For this purpose, we en-
riched the 9-mer training sets (still preserving the partitions deﬁned in Peters
et al. [57]) with 10-mer sequences. In order to ensure that the 10-mers have
informative value and are not merely an elongation of existing 9-mers, we
excluded 10-mers that are identical to some 9-mer after removing any of the
amino acids between P3 and P9 in the 10-mers (for most alleles the anchors
are at P2 and P9 for 9-mers, and P2 and P10 for 10-mers).
Table 5.2. Prediction performance of the kernel method for prediction of binding aﬃnity
of 9-mer peptides
Allele AUC RMSEK9 K9/10 K9 K9/10
HLA-A*01:01 0.9659 0.9668 0.1173 0.1177
HLA-A*02:01 0.9473 0.9479 0.1720 0.1711
HLA-A*02:03 0.9111 0.9143 0.1848 0.1805
HLA-A*03:01 0.9191 0.9218 0.1678 0.1649
HLA-A*11:01 0.9301 0.9372 0.1748 0.1702
HLA-A*24:02 0.8048 0.8352 0.2096 0.2016
HLA-A*29:02 0.9377 0.9420 0.1754 0.1725
HLA-A*31:01 0.9249 0.9262 0.1650 0.1616
HLA-A*68:01 0.8674 0.8752 0.1988 0.1928
HLA-B*07:02 0.9624 0.9653 0.1354 0.1344
HLA-B*35:01 0.8786 0.8913 0.1889 0.1843
HLA-B*53:01 0.8646 0.8764 0.2384 0.2297
AVG 0.9095 0.9166 0.1773 0.1734
The column K9 refers to the kernel method trained on 9-mer peptides, K9/10 to the
method trained on 9-mers enriched with 10-mer peptides. In bold is the best performing
method for a given allele. Data set sizes for each allele are listed in Table 5.1
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The addition of 10-mer peptides lead to improved performance on all al-
leles based on AUC, and 11/12 alleles based on RMSE (see Table 5.2). The
increase in performance is signiﬁcant (p<0.01, binomial test) and appeared
more pronounced on alleles with few data points, such as A*24:02, B*35:01
and B*53:01. The average performance on the 12 alleles in AUC is 0.917, com-
parable to SMM [125] (AUC=0.915) and ANN [25] (AUC=0.922) on the same
9-mer data sets.
5.3.2 Enriching 10-mer data with 9-mers
Compared to 9 amino acid long peptides, there are relatively few data for 10-
mers (see Table 5.1). For example, in the class I benchmarkdata set therewere
only 56 10-mer peptides with measured binding aﬃnities for HLA-A*01:01,
compared to over a thousand data points for 9-mer peptides. We investi-
gated whether the large 9-mer data sets could be used to improve the bind-
ing predictions for 10-mers peptides. The enriched data sets were prepared
in a similar manner as described above for 9-mers, only including enrich-
ing peptides that diﬀer from 10-mers after removing any of the amino acids
between P3 and P9 in the 10-mers.
The benchmark calculations, shown in Table 5.3, demonstrate that pre-
diction of binding aﬃnity for 10-mers beneﬁted greatly from inclusion of
9-mers in the training set. Training a kernel method on 10-mers enriched
with 9-mers was optimal on 10 out of 12 alleles (11/12 based on RMSE), and
in the other cases the best methodwas trained only on 9-mers. In no instance
Table 5.3. Prediction performance of the kernel method for prediction of binding aﬃnity
of 10-mer peptides
Allele AUC RMSEK9 K10 K9/10 K9 K10 K9/10
HLA-A*01:01 0.9518 0.9298 0.9678 0.2243 0.1857 0.1744
HLA-A*02:01 0.9056 0.9003 0.9195 0.1863 0.1824 0.1726
HLA-A*02:03 0.8363 0.8375 0.8555 0.1932 0.1860 0.1765
HLA-A*03:01 0.8347 0.8582 0.8673 0.2048 0.1894 0.1830
HLA-A*11:01 0.8675 0.8896 0.9001 0.2021 0.1900 0.1820
HLA-A*24:02 0.8543 0.8786 0.8986 0.2016 0.1983 0.1787
HLA-A*29:02 0.8245 0.5213 0.7926 0.2100 0.2425 0.2155
HLA-A*31:01 0.8554 0.8654 0.8787 0.1774 0.1730 0.1663
HLA-A*68:01 0.8285 0.8527 0.8682 0.2044 0.1901 0.1808
HLA-B*07:02 0.8200 0.8068 0.8426 0.2233 0.2212 0.2091
HLA-B*35:01 0.8609 0.8211 0.8604 0.2035 0.1946 0.1797
HLA-B*53:01 0.7779 0.7131 0.7781 0.2200 0.2223 0.2085
AVG 0.8514 0.8229 0.8691 0.2042 0.1980 0.1856
The column K9 refers to the kernel method trained on 9-mer peptides, K10 trained on
10-mers, K9/10 to the method trained on 10-mers enriched with 9-mer peptides. In bold is
the best performing method for a given allele.
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training uniquely on 10-mers was optimal for the prediction of 10-mers. It is
interesting to note that a rather accuratemethod, with averageAUC= 0.8514,
could be obtained by only training on 9-mers. In other words, we could pre-
dict binding of 10-mer peptides with a method that had never seen a 10-mer
peptide.
5.3.3 SMMwith 9-mer approximation
An attempt to deal with the scarcity (or lack) of data for certain peptide
lengths was proposed by Lundegaard et al. for the NetMHC method [126].
Here, the authors trained the method on 9-mers and extrapolated predic-
tions for other lengths by artiﬁcially shortening or elongating the evaluation
sequences. In particular, it was shown that the 9-mer approximation per-
formed better than ANNs trained on 10-mers in 12 out of 16 alleles.
The matrix-based SMM method [125], which as mentioned in section
5.3.1 reaches comparable performance to the Kernel method on MHC class
I data, can be readily adapted to employ the 9-mer approximation for bind-
ing aﬃnity prediction of 10-mers. After training SMM on 9-mers from the
above data set of 12 MHC class I molecules, we evaluated its performance in
predicting 10-mers compared to the Kernel method.
The ﬁrst observation is that the 9-mer approximation gives on average
better performance in terms of AUC than the method trained directly on 10-
mer data (Table 5.4). Only on three alleles the SMM trained on 10-mers is su-
perior to the approximation, in agreement with the ﬁndings of Lundegaard
Table 5.4. Comparison between Kernel method and SMM method for the prediction of
10-mer peptides.
Allele AUC RMSE
K9/10 SMM-9 SMM-10 K9/10 SMM-9 SMM-10
HLA-A*01:01 0.9678 1.0000 0.9488 0.1744 0.1964 0.1805
HLA-A*02:01 0.9195 0.9060 0.9035 0.1726 0.1852 0.1858
HLA-A*02:03 0.8555 0.8164 0.8157 0.1765 0.1952 0.1912
HLA-A*03:01 0.8673 0.8497 0.8635 0.1830 0.1939 0.1845
HLA-A*11:01 0.9001 0.8868 0.8987 0.1820 0.1925 0.1854
HLA-A*24:02 0.8986 0.8679 0.8043 0.1787 0.2204 0.2485
HLA-A*29:02 0.7926 0.7766 0.6250 0.2155 0.2608 0.2313
HLA-A*31:01 0.8787 0.8562 0.8642 0.1663 0.1744 0.1729
HLA-A*68:01 0.8682 0.8713 0.8589 0.1808 0.1932 0.1910
HLA-B*07:02 0.8426 0.8727 0.8404 0.2091 0.2212 0.2202
HLA-B*35:01 0.8604 0.8951 0.8511 0.1797 0.2049 0.1877
HLA-B*53:01 0.7781 0.7982 0.7719 0.2085 0.2157 0.2020
AVG 0.8691 0.8664 0.8372 0.1856 0.2045 0.1984
The column K9/10 refers to the kernel method trained on 10-mers enriched with 9-mer
peptides, SMM-9 to the SMMmethod trained on 9-mers and using the 9-mer approximation,
SMM-10 to the SMMmethod trained on 10-mer peptides.
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et al. [126], where 2 of these 3 alleles (A*03:01 and A*31:01) also appeared
not to beneﬁt from the 9-mer approximation. Secondly, if performance is
judged upon AUC values, the 9-mer approximation shows to be very pow-
erful and reaches performances comparable to the Kernel method trained
on both 9-mers and 10-mers. The kernel prevails on 7 out of 12 alleles, while
the SMM trained on 9-mers is best on 5 alleles. However, when considering
the RMSE between target and predicted values, the Kernel method performs
signiﬁcantly better than the SMM (p<0.01, binomial test).
5.3.4 Combining Kernel and SMM in a consensus method
Aconsensusmethod combines predictions between two ormoremethods on
the same data with the aim of boosting predictive performance. Systematic
benchmarks have shown that, forMHCclass I and class II bindingprediction,
consensus methods are generally superior to any of the individual methods
included in the benchmark [127, 128]. In particular, NetMHCcons [116] is
a method that deﬁnes the optimal combination of prediction methods for
MHC class I binding in several species, and combines them in a consensus
predictor with enhanced performance. The general idea behind consensus
strategies is that distinct methods, especially if they exploit diﬀerent aspects
of the data, distribute their errors in diﬀerent areas of the evaluation space.
A polled opinion from two or more methods may be able to correct, or at
least reduce, such errors.
Observing that the Kernel and SMM methods appear to have compara-
ble performance, with each of them prevailing on diﬀerent alleles, we inves-
tigated whether a combination of the two methods could lead to a consen-
sus with higher predictive performance. SMM was trained on 9-mer data
(SMM-9), whereas the Kernel method was trained on both 9-mer and 10-
mer peptides (K9/10). The two methods were then applied to predict, in a
5-fold cross-validation, the binding aﬃnity of 9-mer and 10-mer peptides (in
the case of SMM, using the 9-mer approximation described above). The con-
sensus was obtained simply by averaging the prediction values of the two
methods for each evaluation sequence.
Prediction performances for the individual methods and their consensus
are shown in Table 5.5. In terms of AUC, the consensus method is signif-
icantly better than any of the two individual methods on 19 out of 24 in-
stances (p < 0.0005, pairwise binomial tests). However there appears to be
no signiﬁcant improvement (p > 0.5, binomial test) in terms of RMSE from
K9/10 to the consensus method (K9/10 is best in 10 cases, Cons is best in
13 cases, they have same RMSE in 1 case). This is likely due to the rather
mediocre RMSE of SMM-9, although the samemethod achieves AUC values
comparable to K9/10. Understandably, if one of the methods in the con-
sensus is consistently worse than the other, then including such method will
not result beneﬁcial, or be even deleterious, to the overall performance of the
consensus method.
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Table 5.5. Performance of Kernel and SMMmethods for prediction of 9-mer and 10-mer
peptides, and consensus of the two methods.
Allele L AUC RMSE
SMM-9 K9/10 Cons SMM-9 K9/10 Cons
HLA-A*01:01 9 0.9685 0.9668 0.9734 0.1272 0.1177 0.1195
HLA-A*02:01 9 0.9459 0.9479 0.9503 0.1817 0.1711 0.1733
HLA-A*02:03 9 0.9133 0.9143 0.9233 0.1843 0.1805 0.1759
HLA-A*03:01 9 0.9270 0.9218 0.9292 0.1678 0.1649 0.1634
HLA-A*11:01 9 0.9380 0.9372 0.9415 0.1743 0.1702 0.1689
HLA-A*24:02 9 0.7748 0.8352 0.8209 0.2307 0.2016 0.2066
HLA-A*29:02 9 0.9197 0.9420 0.9421 0.1909 0.1725 0.1707
HLA-A*31:01 9 0.9282 0.9262 0.9318 0.1654 0.1616 0.1600
HLA-A*68:01 9 0.8818 0.8752 0.8871 0.1907 0.1928 0.1862
HLA-B*07:02 9 0.9595 0.9653 0.9655 0.1419 0.1344 0.1346
HLA-B*35:01 9 0.8800 0.8913 0.8990 0.1946 0.1843 0.1836
HLA-B*53:01 9 0.8517 0.8764 0.8775 0.2428 0.2297 0.2261
HLA-A*01:01 10 1.0000 0.9678 0.9898 0.1964 0.1744 0.1801
HLA-A*02:01 10 0.9060 0.9195 0.9210 0.1852 0.1726 0.1740
HLA-A*02:03 10 0.8164 0.8555 0.8483 0.1952 0.1765 0.1767
HLA-A*03:01 10 0.8497 0.8673 0.8738 0.1939 0.1830 0.1830
HLA-A*11:01 10 0.8868 0.9001 0.9061 0.1925 0.1820 0.1816
HLA-A*24:02 10 0.8679 0.8986 0.9021 0.2204 0.1787 0.1870
HLA-A*29:02 10 0.7766 0.7926 0.8085 0.2608 0.2155 0.2183
HLA-A*31:01 10 0.8562 0.8787 0.8801 0.1744 0.1663 0.1651
HLA-A*68:01 10 0.8713 0.8682 0.8840 0.1932 0.1808 0.1789
HLA-B*07:02 10 0.8727 0.8426 0.8681 0.2212 0.2091 0.2095
HLA-B*35:01 10 0.8951 0.8604 0.8900 0.2049 0.1797 0.1785
HLA-B*53:01 10 0.7982 0.7781 0.8097 0.2157 0.2085 0.1966
AVG 9 0.9074 0.9166 0.9201 0.1827 0.1734 0.1724
AVG 10 0.8664 0.8691 0.8818 0.2045 0.1856 0.1858
The column L represents the length of the peptides being evaluated. SMM-9 refers to SMM
method trained on 9-mers, K9/10 to the kernel method trained on 10-mers enriched with
9-mer peptides, and Cons is the consensus prediction of the two methods combined.
Predictions for SMM-9 on 10-mer peptides were obtained using the 9-mer approximation
described in section 5.3.3.
5.4 Discussion
Kernel methods have gained popularity mainly because they are at the base
of Support Vector Machines (SVM), mapping data from input space to high-
dimensional feature spaces. If the mapping deﬁned by the kernel is non-
linear, then the separating hyperplane of the SVM can also be made non-
linear with respect to the original input space [129].
However, kernels can also be used directly as functions to measure dis-
tances between strings, such as amino acid strings. For example, string ker-
nels have been applied to MHC binding prediction [130], detection of pro-
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tein homology [131] and fold recognition [132]. The kernel implementation
used in this chapter was originally applied to the prediction of MHC class
II binding and to deﬁne similarities between a large set of DRB molecules
[124]. Combining the two aspects of peptide-peptide and MHC-MHC simi-
larities, the authors also developed a pan-speciﬁc method enabling binding
predictions for any peptide-MHC class II combination. Here, we applied the
kernel functions, coupled with RLS learning, to the prediction of MHC class
I binding.
The kernel method showed performance comparable to state-of-the-art
methods for MHC class I prediction. Notably, improved performance could
be obtained by combining peptides of diﬀerent length in the same training
set. Such property is given by the nature of the K3 kernel, which combines
similarities between shorter stretches of amino acids and by that implicitly al-
lows "gaps" in the pairwise alignments. The positive contribution of several
pairs of sub-sequences was observed previously in the Local Alignment Ker-
nel [130], where incorporating sub-optimal alignments into similarity scores
contributed to improved predictions. Furthermore, themethod is essentially
assumption-free, not being based on any speciﬁc knowledge of the binding
pocket of themolecules or of the binding core length. These properties make
it easily adaptable to various biological problems based on sequence similar-
ity.
Since the method does not produce a multiple sequence alignment in the
proper sense, it cannot directly provide a sequence motif. This is a serious
limitation, if the alignment and/or binding motif were desirable. Another
possible restriction may derive from the computational complexity of the al-
gorithm: the decomposition of the n n kernel matrix is a function ofO(n3)
on n training sequences, which may become prohibitive with more than a
few thousand data points. Finally, specialized substitution matrices may be
employed depending on the problem at hand  the current kernels are based
on BLOSUM62 scores, but matrices speciﬁc for certain systems exist, such as
the PMBEC matrix for peptide-MHC binding [133].
At any rate, our results conﬁrmed the power and usefulness of the
method beyond the cases presented in the original publication, attesting it
as a ﬂexible and promising approach for sequence alignment problems. As
string kernels exploit diﬀerent aspects of the data compared to alignment-
based methods such as NNAlign, we can anticipate improved predictions
on quantitative peptide data by combining these approaches in consensus
methods.
Chapter 6
Epitope prediction from peptide
pool-based ELISPOT and ICS
assays
T - play an essential role in antigen-speciﬁc recognition. T-cellsrearrange the genes encoding the T-cell receptor (TCR) to recognizewith very high speciﬁcity antigens in form of peptide-MHC complexes.
The diversity generated by somatic rearrangement of TCR genes is immense,
with estimates in the order of109 TCR receptor variants [134, 135]. Because
the pool of receptors is so enormous, T-cells speciﬁc for individual antigens
are present at low frequency in blood even after clonal expansion. In order
to detect such rare cells, techniques for measuring T-cell response must be
endowed with very high levels of sensitivity.
The Enzyme-linked immunosorbent spot (ELISPOT) assay has been
widely applied to monitor immune responses for the very reason of its
exquisite sensitivity in detecting rare cell populations. In ELISPOT, T-cell
response is measured in terms of quantity of cytokines secreted by activated
T-cells. In a typical ELISPOT assay (Figure 6.1), T-cells are plated in presence
and absence of antigen. The constitutive production of cytokines in absence
of antigen constitutes the "background" level that must be subtracted from
the antigen-induced signal. As the cytokines are bound by detection anti-
bodies in the location where they are secreted, each spot that develops in the
assay corresponds to an individual reactive T-cell, thus providing a quanti-
tative measure of the response.
An alternative to ELISPOT is the Intracellular Cytokine Staining (ICS) as-
say. As the name suggests, it is based on the detection of cytokines within
the endoplasmic reticulum after cell stimulation. By adding an inhibitor of
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Figure 6.1. A simple schematic of the ELISPOT assay. a) The bottom of the plate is
coated with cytokine-speciﬁc antibodies. b) Then, T-cells are added to the wells, with
and without antigen. c) Antigen-stimulated cells secrete cytokines, which remain bound
to their speciﬁc antibodies after the cells are washed oﬀ. d) Finally, a secondary antibody
is added together with a labeling agent (e.g. avidin) to visually show the presence of
cytokine.
protein transport, cytokines produced by an activated T-cell are retained in-
side the cell, and can be detected by a labelled antibody. Although not as
sensitive as ELISPOT, ICS assays have the advantage of allowing detection
of the responding cell type [136]. The two methods are often used in con-
junction, ﬁrst screening T-cell responses using an ELISPOT assay, and then
using ICS for validation and to identify whether the responses are mediated
by CD4+ or CD8+ T-cells. A further validation technique is tetramer stain-
ing [137], where HLAmolecules are oligomerised (in a 4-molecule complex)
to increase their avidity for T-cells, and can be used to study T-cell activation
in vitro following antigen recognition by the MHC tetramer complex.
6.1 T-cell epitope mapping using peptide pools
Both in ELISPOT and ICS assays, the most precise approach to deﬁne the
determinants of T-cell response is to test individual peptides, each in its own
well. However, when the number of peptides is large, for instance when
scanning a whole viral genome, testing individual peptides becomes unfea-
sible. A sharp reduction in the number of tests can be obtained by the use
of peptide matrix pools, where each pool contains a mixture of several pep-
tides. Matrices are organized into row pools and column pools, where each
6.1. T-CELL EPITOPE MAPPING USING PEPTIDE POOLS 83
!
Figure 6.2. Structure of a peptide pool matrix. Pools are organized in rows and columns,
with each peptide contained exactly in one row-pool and one column-pool. In this exam-
ple, thematrix is composed of 12 pools (6 rows and 6 columns). If the assay on the 12 pools
revealed that three columns (C2, C3, C5) and 2 rows (R1, R3) give a positive response, this
leaves only 6 peptides as possible epitopes in this donor, those in the intersections of the
responding pools (dark grey).
particular peptide is contained exactly in one row and one column (see for
example [138, 139]).
In the example of Figure 6.2, a small matrix of 6x6 pools can be con-
structed for 36 peptides. Each peptide is present in one row and one col-
umn pool, so that a given row-column intersection identiﬁes unequivocally
one particular peptide. For example, peptide 11 is contained in row R2 and
columnC5, and no other peptide is found in this particular row-column com-
bination. Instead of testing individual peptides for T-cell response, the row
and column pools are tested. In the case of a 6x6 matrix, the 12 pools would
be tested instead of the 36 individual peptide sequences. Then, the matrix
intersection between rows and columns that gave a positive response pin-
point the peptides that could be responsible for the response. For instance,
if rows R1 and R3, and columns C2, C3 and C5 produced response, the list
of possible epitopes is narrowed down to the peptides found in the intersec-
tions of these pools (2,3,5,14,15,17). The 6 peptides would normally have to
be then tested individually to determine the actual epitopes.
If the response is limited to very few pools, this approach is extremely
eﬀective, and reduces greatly the number of tests. However, matrices are
commonly in the range of 10x10 up to 30x30, and there might be several epi-
topes contained in the peptide pools. In this case, many pools would pro-
duce a positive response, leading to a large number of intersections in the
matrix and consequently prohibitive numbers of peptides to be tested indi-
vidually. Furthermore, diﬀerent individuals are characterized by diﬀerent
HLA phenotypes, and consequently they would generally respond to diﬀer-
ent epitopes depending on the MHC alleles involved in the response. The
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matrices of each donor would need to be deconvoluted to obtain a reliable
picture of the peptides consistently generating immune response in several
donors, and spanning the HLA polymorphism of the cohort.
The following sections of this chapter describe a strategy to reduce the
number of tests needed to identify epitopes, or rather rank the candidate
peptides that are most likely to produce a T-cell response, based both on
the matrix structure and allelic composition of the donors. Then we show
how this method was used to identify T-cell epitopes from a large cohort of
patients vaccinated for Yellow Fever, based on both ELISPOT and ICS data.
6.2 Filters and scoring
The ﬁrst step in the analysis is to establish what should be considered as a
positive T-cell response in an ELISPOT assay, as opposed to a negative re-
sponse. There is no universally accepted rule for setting such a threshold on
ELISPOT signal, but it is rather ￿sensibly￿ chosen based on experimentalists￿
experience. Generally, this threshold should depend on the donor-speciﬁc
background (BG), where the background is the ELISPOT signal detected in
absence of antigen. For example, wemay design a threshold tp for separating
positive and negative responses according to the function:
tp(BG) =
8<: BG+ 25 if BG < 25BG+ 2 BG if 25  BG < 50BG+ 100 if BG  50 (6.1)
Once a threshold tp is set, for each donor in the cohort there will be a
number of positive pools, i.e. pools with ELISPOT score S > tp. What is
unknown is: 1) which peptide(s) in the pool determined the response, and
2) the restriction of the recognized peptide(s) to the donor'sHLA alleles. Two
ﬁlters are applied to the potential epitopes, and then results from diﬀerent
donors are combined to raise evidence for epitope candidates.
Filter I - Row/Column intersections
The ﬁrst ﬁlter aims at reducing the number of possible peptides that could
have determined a T-cell response in a given donor. It exploits the struc-
ture of the pools matrix, where each peptide is present in exactly one row
and one column pool, so that a given row-column intersection identiﬁes un-
equivocally one particular peptide. As also described above and illustrated
in Figure 6.2, potential epitopes in a speciﬁc donor are only the peptides
found in intersections where both row and column produced a response.
This procedure of identifying positive intersections is applied to all donors,
with the outcome of a list of epitope candidates for each donor. Whilst prior
to applying this ﬁlter all peptideswere possible epitopes, now the candidates
(for a certain donor) are limited to those in the positive intersections.
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Filter II - HLA allele restriction
The second ﬁlter exploits the knowledge on the HLA phenotype of the
donors. Only peptides that are predicted to bind to any of the alleles of a
given donor are retained as potential epitopes. This step clearly depends on
the quality of the predictions, which diﬀers betweenMHCmolecules: MHC
class I predictions are very accurate, withNetMHCcons [116] being currently
the best method available for the task. Not nearly as good are methods for
MHC class II binding, but the best publicly available is NetMHCIIpan [79].
However, it can only be applied to HLA-DRB molecules, and currently it
has not been trained for HLA-DP and HLA-DQ molecules. For the lattest
two, we may use NetMHCII [36], although this method is only limited to 6
HLA-DP and 6 HLA-DQ alleles.
To illustrate how the diﬀerent ﬁlters operate consider the following exam-
ple. Suppose that, in a given donor, the ELISPOT analysis produced positive
scores for 7 row pools and 2 column pools, leading to 14 possible epitopes
given by the row/column intersections (Filter I):
Peptide Row Col
MSGRKAQGKTLGVNM R:2 C:7
KTLGVNMVRRGVRSL R:9 C:7
QIGNRPGPSRGVQGF R:11 C:7
RPGPSRGVQGFIFFF R:14 C:7
QGFIFFFLFNILTGK R:19 C:7
FFFLFNILTGKKITA R:24 C:7
FNILTGKKITAHLKR R:26 C:7
TGKKITAHLKRLWKM R:2 C:26
GLAVLRKVKRVVASL R:9 C:26
LRKVKRVVASLMRGL R:11 C:26
ASLMRGLSSRKRRSH R:14 C:26
RGLSSRKRRSHDVLT R:19 C:26
SRKRRSHDVLTVQFL R:24 C:26
RSHDVLTVQFLILGM R:26 C:26
Then let us assume that this donor has the following phenotype for
HLA-A, -B and -C:
HLA-A03:01,HLA-A11:01,HLA-B07:02,HLA-B08:02,HLA-C04:01,HLA-C07:01
Using NetMHCcons, we predict which of the 6 MHC class I molecules of
the donor can potentially bind peptides in positive intersections, consider-
ing as binders peptides with predicted binding aﬃnity stronger than 500nM
(log-aﬃnity > 0.426), or ranked among the top 2% peptides for a given allele.
On the sequences above, we obtain (Filter II):
Peptide Allele LogAff Rank Epitope
FFFLFNILTGKKITA HLA-A*03:01 0.629 0.25 FLFNILTGK
ASLMRGLSSRKRRSH HLA-A*03:01 0.718 0.05 SLMRGLSSRK
KTLGVNMVRRGVRSL HLA-A*11:01 0.655 0.80 KTLGVNMVR
KTLGVNMVRRGVRSL HLA-B*07:02 0.749 0.08 MVRRGVRSL
RPGPSRGVQGFIFFF HLA-B*07:02 0.605 0.40 RPGPSRGVQGF
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For this particular donor, after the two ﬁlters the possible peptides pro-
ducing a T-cell response are reduced to those listed above. Not only the list
of candidates is narrowed down to fewer peptides, but in the process the
restriction elements and minimal peptide epitopes are also predicted. Note
that one peptide might be associated with several HLA alleles.
Combining predictions from diﬀerent donors
After the two ﬁlters, we obtain a list of possible peptide/allele combinations
for each donor. Predictions for the diﬀerent donors are combined in a very
straightforwardmanner: simply by counting the number of occurrences Cp,a
of each peptide/allele pair p, a over all the donors. For example, the pep-
tide/allele association FFFLFNILTGKKITA/HLA-A*03:01 might be observed in
Cp,a = 9 donors. The next question is whether this number is or is not sig-
niﬁcantly diﬀerent from random. It clearly depends to a great extent on the
frequency of that allele across the donors: e.g. if only 10 donors in total carry
the HLA-A*0301 allele, then there is a good chance that the peptide is an
epitope; on the other hand, if A*0301 is found in 100 donors, then the 9 pos-
itive occurrences are likely to be due to other peptides in the same pools as
FFFLFNILTGKKITA. In other words, if an allele is very frequent, then there is
a higher chance to obtain peptide associations to it just by random, because
the allele is found in so many donors. To quantify this eﬀect, we calculate a
Z-score based on a background frequency as described next.
Background counts and Z-scores
The allele-dependent background counts are estimated by random permu-
tations of the pool matrices. Maintaining the samematrix structure, positive
pools are scrambled randomly to obtain new, permuted matrices. The ﬁlters
can then be applied on such permuted matrices, and then calculate a count
BGp,a for each peptide/allele pair. Note that in a scrambled matrix, each
row-column pool intersection (and consequently any peptide) has the same
probability of being positive, therefore the background count can be more
conveniently expressed as BGa to only depend on the allele. The background
count BGa expresses the probability of obtaining a positive association to al-
lele a after the ﬁlters given the number of positive pools in the matrices and
the HLA allele distribution of the donors. Evidently, more common alleles
obtain higher background counts simply because they have higher probabil-
ity of generating random intersections.
For more reliable estimates of the BGa values, multiple versions (e.g.
1000) of the scrambled matrices can be calculated. This allows drawing a
distribution of BGa values, with mean ma and standard deviation sa. Within
this distribution, where is the observed count Cp,a located? This question
can be answered quantitatively by means of a Z-score, that indicates by how
many standard deviations Cp,a is above or below the mean ma:
Zp,a =
Cp,a   ma
sa
(6.2)
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Ranking epitope predictions
Higher Z-score means higher signiﬁcance of a certain peptide-allele associ-
ation, and can therefore be used to rank epitope candidates. The predicted
strength of MHC binding aﬀLp,a (in log-transformed units, aﬀL =
1 log(aﬀ)
log(50,000) )
for peptide p to allele a can also be included in the score, using:
Zp,a = Zp,a  aﬀLp,a (6.3)
As aﬀLp,a varies between 0 for a non-binder to 1 for the strongest binder,
its inclusion in equation 6.3 penalizes in a linear manner weak binders com-
pared to strong binders. In summary, ranking potential epitopes by Zp,a
favors peptides found in several intersections, where the donors have a par-
ticular HLA phenotype and the peptides are preferentially predicted to be
strong binders to their MHC molecule.
6.3 Predicting CD8+ T-cell epitopes for YF virus
One of the most common vaccines against yellow fever (YF) is based on a
3,411 amino acids-long polyprotein (GenBankAF052437 [140]) from the 17D-
204 yellow fever virus strain. A total of 875 peptides, mostly of length 15
amino acids and overlapping by 11 amino acids, were generated to cover the
whole length of the construct, and distributed into a 30x30 matrix composed
of 30 rows + 30 columns = 60 peptide pools. As discussed in section 6.1
each row-column intersection identiﬁes unambiguously one and only one
peptide. T-cell response for the 60 pools was measured using ELISPOT on
blood sample from 92 donors, fully typed for HLA phenotype, who received
vaccination against YF.
6.3.1 ELISPOT analysis
Using the rules of equation 6.1 to deﬁne positive responses, the matrices ap-
peared very dense with 58% of row pools and 65% of column pools giving
signal above the threshold. On such data, up to several hundreds of peptides
for each donor should be individually tested to identify epitopes, a huge ef-
fort that deﬁes the utility of using pools to reduce the number of tests. In or-
der to reduce the complexity of this data set, we applied the computational
ﬁlters introduced in the previous section to combine information from dif-
ferent donors and compile a prioritized list of candidate epitopes.
The predicted epitopes for three among the most common alleles (HLA-
A*01:01, A*02:01 and B*07:02) are shown respectively in Tables 6.1, 6.2 and
6.3. Peptides are ranked according to Z (see equation 6.3), limiting the list
to peptides with Z > 2. We note that only few peptides are predicted as
likely epitopes for A*01:01 and B*07:02, as opposed to A*02:01 where many
peptides survive the ﬁlters with signiﬁcant Z. A*02:01, compared to other
HLA-I alleles, has a more promiscuous binding motif, with several residues
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Table 6.1. Top predicted epitopes for HLA-A*01:01 from ELISPOT matrices.
Peptide sequence Count Predicted Epitope Z-score Aﬃnity Z* P/T
YTDYLTVMDRYSVDA 17 YTDYLTVMDRY 3.957 0.934 3.695 5/6
MSNPLTSPISCSYSL 19 LTSPISCSY 4.935 0.670 3.307 0/3
GQEKYTDYLTVMDRY 16 YTDYLTVMDRY 3.467 0.934 3.238 5/6
ERIKSEYMTSWFYDN 16 KSEYMTSWFY 3.467 0.712 2.469 3/4
Green: predicted epitopes that give positive response in experimental validation (the fraction of positive re-
sponding donors is in columnP/T). Red: peptides not giving response in any donorwhen tested individually.
The HLA-A*01:01 background count for Z-score calculation is m = 8.91.
Table 6.2. Top predicted epitopes for HLA-A*02:01 from ELISPOT matrices.
Peptide sequence Count Predicted Epitope Z-score Aﬃnity Z* P/T
SLLWNGPMAVSMTGVK 40 LLWNGPMAV 8.306 0.838 6.96 31/33
MVLAGWLFHVRGARR 30 VLAGWLFHV 4.823 0.913 4.404 7/9
SRGVQGFIFFFLFNIKK 31 FIFFFLFNI 5.171 0.819 4.235 NB
MLMTGGVTLVRKNRW 30 MLMTGGVTLV 4.823 0.860 4.148 0/2
PSELQMSWLPLCVRL 30 LQMSWLPLCV 4.823 0.805 3.883 0/1
VYMDAVFEYTIDCDG 28 YMDAVFEYTI 4.127 0.876 3.615 1/14
QGFIFFFLFNILTGK 28 FIFFFLFNI 4.127 0.819 3.38 NB
ELNLLDKRQFELYKR 31 LLDKRQFEL 5.171 0.643 3.325 1/6
FLDPASIAARGWAAH 28 FLDPASIAA 4.127 0.773 3.190 10/18
KKNGGDAMYMALIAAFS 29 AMYMALIAA 4.475 0.704 3.150 0/6
MYMWLGARYLEFEAL 28 YMWLGARYL 4.127 0.762 3.145 0/7
AMYMALIAAFSIRPGK 27 YMALIAAFSI 3.778 0.81 3.061
SGSAASMVNGVIKIL 30 SMVNGVIKI 4.823 0.624 3.010 0/12
DEAHFLDPASIAARG 27 FLDPASIAA 3.778 0.773 2.921 10/16
MVTMLSPMLHHWIKV 27 MLSPMLHHWI 3.778 0.741 2.800
TGVMRGNHYAFVGVM 28 GVMRGNHYAFV 4.127 0.676 2.79 0/6
ALYEKKLALYLLLAL 27 ALYEKKLALYL 3.778 0.729 2.755 0/7
NLYKLHGGHVSCRVK 29 KLHGGHVSCRV 4.475 0.61 2.730
RGNHYAFVGVMYNLW 29 YAFVGVMYNL 4.475 0.554 2.479
LASVAMCRTPFSLAE 28 AMCRTPFSL 4.127 0.594 2.451 0/6
ILMTATPPGTSDEFP 27 ILMTATPPGT 3.778 0.638 2.411 0/4
VIIMDEAHFLDPASI 25 IIMDEAHFL 3.082 0.77 2.373 1/11
QTKIQYVIRAQLHVG 28 YVIRAQLHV 4.127 0.564 2.327 0/5
SLDISLETVAIDRPA 27 SLDISLETV 3.778 0.608 2.297 3/10
SMSLFEVDQTKIQYV 27 SLFEVDQTKI 3.778 0.607 2.294
GKATLECQVQTAVDFKK 28 ATLECQVQTAV 4.127 0.551 2.274
KILTYPWDRIEEVTR 29 KILTYPWDRI 4.475 0.498 2.229
VRNGKKLIPSWASVK 24 KLIPSWASV 2.734 0.796 2.176 0/5
IVDRQWAQDLTLPWQ 29 RQWAQDLTL 4.475 0.481 2.152 0/4
NSFQIEEFGTGVFTT 24 FQIEEFGTGV 2.734 0.78 2.132 0/2
Green: predicted epitopes that give positive response in experimental validation (the fraction of positive
responding donors is in column P/T). Red: peptides not giving response in any donor when tested indi-
vidually. Yellow: there could not be established binding between the MHC molecule and the peptide. The
HLA-A*02:01 background count for Z-score calculation is m = 16.15.
allowed at its anchor positions, and many of these residues being among
the most frequent in natural protein sequences. Out of the 875 peptides in
the pools, 363 are predicted to have binding aﬃnity < 500nM for A*02:01, as
opposed to only 46 and 173 for A*01:01 and B*07:02 respectively. Predicted
epitopes were then validated by tetramer staining on individual vaccinated
donors. For HLA-A*01:01, for example, 3 out of 4 predicted epitopes were
validated by tetramer staining (green rows in Table 6.1). Several epitopes
were also conﬁrmed for A*02:01, although a considerable number of false
positives were found. Three epitopes were conﬁrmed for B*07:02.
There are two major factors in the experimental setup that may lead to
false positives. Firstly, the size of the peptide pools. Using a 30x30 matrix
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Table 6.3. Top predicted epitopes for HLA-B*07:02 from ELISPOT matrices.
Peptide sequence Count Predicted Epitope Z-score Aﬃnity Z* P/T
LWSPRERLVLTLGAA 21 SPRERLVLTL 4.048 0.811 3.283 7/8
DDCVVRPIDDRFGLA 21 RPIDDRFGL 4.048 0.690 2.793 9/9
MPRSIGGPVSSHNHI 19 MPRSIGGPV 3.174 0.831 2.638 0/5
VRPIDDRFGLALSHL 19 RPIDDRFGLAL 3.174 0.799 2.536 9/9
MSNPLTSPISCSYSL 19 SPISCSYSL 3.174 0.759 2.409
KTLGVNMVRRGVRSL 19 MVRRGVRSL 3.174 0.749 2.377 0/3
PPHAATIRVLALGNQ 22 HAATIRVLAL 4.485 0.514 2.305
GKNLVFSPGRKNGSF 20 SPGRKNGSF 3.611 0.634 2.289
VFSPGRKNGSFIIDG 20 SPGRKNGSF 3.611 0.634 2.289
TILPLMALLTPVTMA 21 LPLMALLTPV 4.048 0.558 2.259
Green: predicted epitopes that give positive response in experimental validation (the fraction of positive re-
sponding donors is in columnP/T). Red: peptides not giving response in any donorwhen tested individually.
The HLA-B*07:02 background count for Z-score calculation is m = 11.74.
setup implies that each pool is composed of 30 peptides, and if at least one
peptide can generate a response to any of the HLA alleles of the donor the
pool will be positive. Indeed, we observed a very high rate of positive re-
sponses (> 50% of the pools), and consequently very dense matrices, diﬃ-
cult to deconvolute. Secondly, ELISPOT cannot distinguish between CD4+
and CD8+ responses. In the ELISPOT analysis we assumed that the T-cell
response was CD8-restricted and ignored the other kind of response. How-
ever, a considerable portion of positive pools are likely due to CD4-restricted
responses, introducing a high level of noise in the data. This may have a par-
ticularly large impact on A2, which has a motif characterized by hydropho-
bic anchors similarly to the prevalent HLA-DR molecules. For example the
predicted A2 epitope FIFFFLFNI, which did not bind to the HLA-I molecule
(table 6.2), is contained in a 15-mer shown to be a dominant DRB1*01:01 epi-
tope. A subsequent analysis based on Intracellular Cytokine Staining (ICS),
described next, aims to address both these sources of noise, by reducing the
sizes of the matrices and diﬀerentiating the type of T-cell response.
6.3.2 ICS analysis
The ICS assay allows monitoring which T-cell type is responding to a given
antigen. Therefore we can study CD8+ responses separately from CD4+ re-
sponses, and by that remove one of the sources of noise. The yellow fever
peptides were arranged into four 15x15 matrices, with the advantage of hav-
ing smaller pools (15 peptides), but the drawback of a larger number of pools
to be tested for each donor (15 2 4 = 120). ICS assays on the complete
set of pools were performed on a total of 20 donors. As in the case of the
ELISPOTdata, we applied the ﬁlters to predict and rankCD8-restricted T-cell
epitopes. The matrices appear less dense than in the ELISPOT experiment,
with 28% of the row pools and 37% of the column pools being positive. From
the observation thatmost of the validated epitopeswere strong binders, here
we applied a stronger threshold for the ﬁlter on predicted binding aﬃnity,
limiting the NetMHCcons predictions to aﬃnity < 50nM or %rank < 0.5.
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Table 6.4. Top predicted epitopes for HLA-A*01:01 from ICS matrices.
Peptide sequence Count BG Predicted Epitope Z-score Aﬃnity Z*
YTDYLTVMDRYSVDA 6 0.660 YTDYLTVMDRY 6.736 0.934 6.291
GQEKYTDYLTVMDRY 5 0.660 YTDYLTVMDRY 5.474 0.934 5.113
ERIKSEYMTSWFYDN 4 0.660 KSEYMTSWFY 4.213 0.712 3.000
MSNPLTSPISCSYSL 4 0.660 LTSPISCSY 4.213 0.670 2.823
Green: validated epitopes. Red: false positives.
Table 6.5. Top predicted epitopes for HLA-A*02:01 from ICS matrices.
Peptide sequence Count BG Predicted Epitope Z-score Aﬃnity Z*
SLLWNGPMAVSMTGVK 8 1.037 LLWNGPMAV 6.962 0.838 5.834
KKEGNTSLLWNGPMAVS 8 1.037 LLWNGPMAV 6.962 0.838 5.834
IVLASAALGPLIEGN 9 1.037 VLASAALGPLI 7.961 0.654 5.207
KKPFALLLVLAGWLFHV 4 1.037 VLAGWLFHV 2.963 0.913 2.705
LLVLAGWLFHVRGAR 4 1.037 VLAGWLFHV 2.963 0.913 2.705
NMEVRGGMVAPLYGV 4 1.037 GMVAPLYGV 2.963 0.852 2.524
RGGMVAPLYGVEGTK 4 1.037 GMVAPLYGV 2.963 0.852 2.524
NALSMMPEAMTIVML 4 1.037 SMMPEAMTIV 2.963 0.826 2.447
TMAEVRLAAMFFCAVKK 4 1.037 RLAAMFFCAV 2.963 0.816 2.417
LMALLTPVTMAEVRL 4 1.037 ALLTPVTMAEV 2.963 0.775 2.296
IWYMWLGARYLEFEAKK 4 1.037 YMWLGARYL 2.963 0.762 2.257
Green: validated epitopes. Red: false positives.
Table 6.6. Top predicted epitopes for HLA-B*07:02 from ICS matrices.
Peptide sequence Count BG Predicted Epitope Z-score Aﬃnity Z*
LWSPRERLVLTLGAA 4 0.713 SPRERLVLTL 3.995 0.811 3.240
VRPIDDRFGLALSHL 4 0.713 RPIDDRFGLAL 3.995 0.799 3.192
NGPMAVSMTGVMRGN 4 0.713 GPMAVSMTGVM 3.995 0.727 2.904
SAALGPLIEGNTSLL 4 0.713 GPLIEGNTSL 3.995 0.585 2.337
GPLIEGNTSLLWNGP 4 0.713 GPLIEGNTSL 3.995 0.585 2.337
PEMPALYEKKLALYL 3 0.713 MPALYEKKLAL 2.780 0.769 2.137
FFMSPKGISRMSMAM 3 0.713 SPKGISRMSM 2.780 0.753 2.093
Green: validated epitopes.
The predicted epitopes for the HLA alleles A*01:01, A*02:01 and B*07:02
with Z > 2 are listed in Tables 6.4, 6.5 and 6.6 respectively. We note that
for A*01:01 the same 4 peptides as in ELISPOT are predicted to be epitopes,
with 3 of themvalidated experimentally. Similarly, 2 out of 3 B*07:02 epitopes
found with ELISPOT are replicated in ICS, additionally a new one is found
and there are no false positives. As for A*02:01, most of the false positives
predicted on ELISPOT data disappear. However, at the same time several
validatedA2 epitopes are not predictedwith signiﬁcant Z-scores on ICSdata.
For example, both 15-mers containing the 9-mer FLDPASIAA obtained high
ranking on ELISPOT data, and were tetramer-validated on more than half
of the donors. In the ICS assay, the intersections identifying these peptides
responded positive only in 2 donors out of the 10 carrying A*02:01, clearly
not a signiﬁcant ratio. Similar arguments can be made for the other false
negatives.
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6.3.3 Discussion
Only a small fraction of the 875 YF peptides were tested using tetramers thus
far: 3 positive and 1 negative for A*01:01, 25 positive and 13 negative for
A*02:01, 7 positive and 5 negative for B*07:02. Although one can safely as-
sume that the large majority of the 875 peptides do not contain epitopes for
a given HLA-I molecule, we are far from having a picture of the totality of
CD8+ epitopes in the YF proteome. However, based on these preliminary re-
sults, there appears to be a large overlap in the epitope predictions based on
ELISPOTand ICS.Anumber of epitopeswere suggested by both approaches,
and several of these candidates were later conﬁrmed by tetramer staining.
On the validated epitopes, we estimated the predictive power of dif-
ferent ranking methods by evaluating the sensitivity as a function of the
%rank. That is, based on a given epitope ranking strategy, how many pep-
tides should be tested to discover a certain fraction of known epitopes. Figure
6.3 compares three ranking criteria for each of the 3 class I alleles: predicted
binding aﬃnity of the optimal 9-mer, Z-scores based on ELISPOT data, and
Z-scores on ICS data. In the case of A*01:01, the 3 validated epitopes are ef-
fectively recovered by all methods, in particular by the Z-scores where they
were all found among the top 4 ranking candidates.
For what concerns A*02:01, about half of the validated epitopes could
have been found by testing only a handful of peptides based on any of the
three proposed rankings. However, when it came to recover the totality of
the known epitopes, there were major diﬀerences between the methods. In
particular, it appeared that a number of epitopes were completely missed
by the Z-score-based methods. Examining the experimental data for these
peptides, we observed that they did not give positive response signiﬁcantly
more often than random in the ELISPOT and ICS experimental pools. For
example, the validated A*02:01 epitope GLYGNGILV was contained in two
15-mer peptides: VIGLYGNGILVGDNS and RNGEVIGLYGNGILV. In the
ELISPOT assay, respectively 18 and 17 of the 43 donors carrying A*02:01 re-
sponded to the two peptides, not signiﬁcantly higher than m = 16.15 expected
by chance given the frequency of the allele (Z = 0.644 and Z = 0.296, respec-
tively). Moreover, on ICS matrices none of the 10 A2 donors responded pos-
itive to either of the two 15-mer peptides. Based on such evidence, nothing
would suggest that these two peptides contain an epitope. We canmake sim-
ilar arguments for the remaining epitopes not identiﬁed by the matrix-based
methods.
Out of the 7 validated B*07:02 epitopes, all three ranking strategies identi-
ﬁed rapidly 4 epitopes among the highest ranking peptides. However, com-
pared to the other two approaches, the Z-score based on ICSmatrices fails to
identify the remaining 3 validated epitopes. As in the case of the undetected
A2 epitopes, the explanation can be found in the peptide pool responses  
there were few or no positive intersections for these peptides in the ICS ma-
trices.
In summary, it appears that predicted binding aﬃnity is the most impor-
tant factor to consider when ranking potential epitopes. The experimental
92 CHAPTER 6. EPITOPE PREDICTION FROM ELISPOT AND ICS
0 200 400 600 800
0
5
1
0
1
5
2
0
2
5
HLA!A*02:01
Rank (of 875 peptides)
V
a
lid
a
te
d
 e
p
it
o
p
e
s
0 200 400 600 800
0
1
2
3
4
5
6
7
HLA!B*07:02
Rank (of 875 peptides)
V
a
lid
a
te
d
 e
p
it
o
p
e
s
!Affinity!
!Z* on ELISPOT!
!Z* on ICS!
!Random!
Ranked by!
0 200 400 600 800
HLA!A*01:01
Rank (of 875 peptides)
V
a
lid
a
te
d
 e
p
it
o
p
e
s
0
1
2
3
Figure 6.3. Rank vs. sensitivity for the three HLA-I alleles A*01:01, A*02:01, B*07:02.
The 875 YF peptides were ranked, for each allele, using three diﬀerent schemes: by pre-
dicted binding aﬃnity of the optimal 9-mer, by Z-score from ELISPOT matrices, by Z-
score from ICS matrices. The dashed diagonal lines represent the expected rank by a
random ordering of peptides.
peptide pool-based approaches, though eﬀectively identifying a number of
CD8+ epitopes, could not ﬁnd the totality of the validated epitopes. One
aspect to consider is that peptide pools were composed mainly of 15-mer
peptides, which would have to undergo digestion and processing during an
ELISPOT or ICS assay before being presented to the MHC class I molecules
in the form of a 9-mer (or 10/11-mer). As such trimming may not always
happen, some epitopesmay be overlooked in these assays. In the case of ICS,
perhaps stronger evidence could have been collectedwith a larger number of
donors. The present data set contained peptide-pool measurements for only
20 donors, and even the most commonHLAmolecule (A*02:01) was present
in only 10 donors. Statistical signiﬁcance on such small data sets is diﬃcult
to achieve, and it would certainly beneﬁt from a larger number of observa-
tions. Finally, as discussed previously only a small fraction of the 875 YF
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peptideswere tetramer-validated on their restriction element, and these pep-
tides were not singled out for validation randomly. A complete benchmark
of themethodwould require an unbiasedmapping of all epitopes in the data
set. Yet, these preliminary results suggest that by employing computational
techniques it is possible to reduce greatly the number of tests necessary to
identify T-cell epitopes. Experimental analysis of all possible peptides, even
in a peptide-pools setup, can be extremely time-consuming and automated
ranking strategies are necessary to rationally guide epitope discovery.

Chapter 7
Epilogue
T  research presented in this thesis was conductedwith onemajor ob-jective: to provide computational methods for the analysis of peptidedata. In the era of "big data", bioinformatics techniques are indispens-
able to extract in an automatic manner meaningful patterns from extremely
large experimental data sets. In this thesis, I presented a series of diﬀerent
algorithms and tools to identify sequence motifs in peptide data, tackling
the problem from diﬀerent angles and applying these methods to several
biological problems.
First, we demonstrated the power of artiﬁcial neural networks in identi-
fying sequence motifs in large-scale peptide data sets. TheNNAlignmethod
presented in chapter 2, based onANNs, was benchmarked on diﬀerent kinds
of peptide-based data sets, but also applied for motif discovery to character-
ize the binding motifs of HLAmolecules to an unprecedented level of detail.
Part of the success of ANNs derives from their ability to exploit the quanti-
tative nature of peptide data. In the example of peptide-MHC binding used
widely in this thesis, peptide binding can be considered as a quantitative
event, for example in terms of the ligand concentration required for at least
half of the peptides to be bound to the MHC (IC50 binding aﬃnity). In other
words, one can measure with some numerical scale the strength of the inter-
action. Regressionmethods such as neural networks are capable of capturing
these quantitative aspects.
Although ANNs are able to pick up higher-order correlations, they do
not provide an ideal framework for the detection of multiple speciﬁcities in
peptide data. In chapter 4 we suggested a new approach, based on mul-
tiple position-speciﬁc scoring matrices, that facilitates the interpretation of
peptide data in terms of poly-speciﬁcity of the receptor. It was applied to
deconvolute mixtures of MHC class I and class II molecules, to identify di-
verse classes of binders to the SH3 domain, and in the characterization of
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sub-motifs of the HLA-A*02:01 molecule. The Gibbs clustering method has
the limitation that it only exploits the qualitative nature of the data, i.e. only
positive instances of a given biological event are considered to derive the
sequence motif(s). In future perspective, it is possible to envision the in-
corporation of quantitative aspects into the poly-speciﬁcity framework, for
example by training multiple ANNs in parallel, each "responsible" for one of
the multiple speciﬁcities.
Yet another method for pattern analysis is presented in chapter 5, which
constructs kernel functions for sequence similarity based uniquely on the
BLOSUM62 substitution matrix. In particular, we employed this algorithm
to overcome one of the limitations of current methods for prediction ofMHC
class I binding: that training sequences must be of equal length. Themethod
combines peptides of diﬀerent length to achieve predictive performance
higher than when trained on the individual peptide lengths. This may be
particularly useful for prediction of peptide-MHC interactions where exper-
imental data for a certain peptide length is scarce.
Finally, chapter 6 outlined a computational strategy to aid the discovery
of T-cell epitopes from ELISPOT and ICS experiments based on peptide-pool
matrices. We demonstrated that the method reduced greatly the number of
tests necessary to discover T-cell epitopes in the yellow fever proteome.
There are numerous directions in which the work in this thesis could be
continued, and room for improvement. It would be pretentious to state oth-
erwise. But I remain with the hope that it advanced ever so little our under-
standing of sequence alignment problems and that itmay serve as inspiration
for others.
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